disease_id,name
0,Galloway-Mowat syndrome 1 
1,Mitochondrial complex 1 deficiency, nuclear type 19 
2,not provided 
3,Leigh syndrome 
4,Inborn genetic diseases 
5,Mitochondrial complex 1 deficiency, nuclear type 21 
6,Alzheimer disease, susceptibility to 
7,Microvascular complications of diabetes, susceptibility to, 7 
8,Hemochromatosis, juvenile, digenic 
9,Transferrin serum level quantitative trait locus 2 
10,Hemochromatosis type 1 
11,Porphyria cutanea tarda, susceptibility to 
12,Porphyria variegata, susceptibility to 
13,Hereditary cancer-predisposing syndrome 
14,Hereditary hemochromatosis 
15,Porphyrinuria;Cutaneous photosensitivity 
16,Hemochromatosis type 2 
17,Bronze diabetes 
18,Alzheimer disease 
19,7 conditions 
20,Cardiomyopathy 
21,HFE-related disorder 
22,6 conditions 
23,Cystic fibrosis 
24,not specified 
25,Abnormality of iron homeostasis 
26,See cases 
27,Variegate porphyria 
28,HFE POLYMORPHISM 
29,Cranioectodermal dysplasia 2 
30,PHARC syndrome 
31,Retinitis pigmentosa 58 
32,Retinitis Pigmentosa, Dominant 
33,Primary hyperoxaluria type 3 
34,Retinitis pigmentosa 28 
35,Retinal dystrophy 
36,Autosomal recessive retinitis pigmentosa 
37,Cone-rod dystrophy 
38,Retinitis pigmentosa 
39,Microcephaly 2, primary, autosomal recessive, with or without cortical malformations 
40,Autosomal recessive primary microcephaly 
41,Bardet-Biedl syndrome 12, modifier of 
42,Meckel syndrome, type 6, modifier of 
43,Familial infantile myoclonic epilepsy 
44,Autosomal dominant nonsyndromic hearing loss 65;Developmental and epileptic encephalopathy, 1;Caused by mutation in the TBC1 domain family, member 24 
45,DOORS syndrome 
46,Nephronophthisis-like nephropathy 1 
47,Microcephaly 9, primary, autosomal recessive 
48,Seckel syndrome 5;Microcephaly 9, primary, autosomal recessive 
49,CEP152-Related Disorders 
50,Bardet-Biedl syndrome 16 
51,Blue color blindness 
52,Familial porphyria cutanea tarda 
53,Hepatoerythropoietic porphyria 
54,Porphyria cutanea tarda 
55,Sporadic porphyria cutanea tarda 
56,Wolman disease 
57,Lysosomal acid lipase deficiency 
58,Cholesteryl ester storage disease 
59,Urofacial syndrome type 1 
60,Congenital anomaly of kidney and urinary tract 
61,Farber lipogranulomatosis 
62,TRANSCOBALAMIN II POLYMORPHISM 
63,Transcobalamin II deficiency 
64,Retinitis pigmentosa 54 
65,Pheochromocytoma, susceptibility to 
66,Pheochromocytoma 
67,Hereditary pheochromocytoma-paraganglioma 
68,Arthrogryposis, renal dysfunction, and cholestasis 2 
69,Homocystinuria, pyridoxine-nonresponsive 
70,HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED 
71,Classic homocystinuria 
72,Homocystinuria 
73,Cardiovascular phenotype 
74,Homocystinuria, pyridoxine-responsive 
75,Intellectual disability 
76,Connective tissue disorder 
77,Autosomal recessive nonsyndromic hearing loss 79 
78,Hearing loss, autosomal recessive 
79,Brown-Vialetto-van Laere syndrome 1 
80,Progressive bulbar palsy of childhood 
81,Ornithine aminotransferase deficiency 
82,Hyperornithinemia 
83,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia 
84,Dihydropyrimidinase deficiency 
85,Frank-Ter Haar syndrome 
86,Autosomal recessive nonsyndromic hearing loss 25 
87,Joubert syndrome 2 
88,Meckel syndrome, type 2 
89,Joubert syndrome 
90,TMEM216-Related Disorders 
91,Meckel syndrome, type 2;Joubert syndrome 2 
92,Poikiloderma with neutropenia 
93,Thyrotoxic periodic paralysis, susceptibility to, 2 
94,Thyrotoxic periodic paralysis, susceptibility to, 1 
95,Prolidase deficiency 
96,Aspartylglucosaminuria, finnish type 
97,Aspartylglucosaminuria 
98,Amelogenesis imperfecta hypomaturation type 2A3 
99,Methemoglobinemia type 2 
100,Methemoglobinemia, type I 
101,NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM 
102,Xeroderma pigmentosum, group C 
103,Xeroderma pigmentosum 
104,Primary ciliary dyskinesia 13 
105,Primary ciliary dyskinesia 
106,Kartagener syndrome 
107,Dilated cardiomyopathy 1DD 
108,Primary dilated cardiomyopathy 
109,Dilated cardiomyopathy 1S 
110,Dilated cardiomyopathy 1A 
111,Primary familial dilated cardiomyopathy 
112,Alpha-2-plasmin inhibitor deficiency 
113,Desbuquois dysplasia 1 
114,Von Willebrand disease type 2A 
115,von Willebrand disorder 
116,von Willebrand disease type 2 
117,Von Willebrand disease type 2B 
118,Abnormality of coagulation 
119,VON WILLEBRAND FACTOR POLYMORPHISM 
120,von Willebrand disease type 1 
121,von Willebrand disease type 2N 
122,Abnormal bleeding 
123,von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3 
124,Abnormal bleeding;Thrombocytopenia 
125,von Willebrand disease type 3 
126,Abnormality of blood and blood-forming tissues 
127,von Willebrand disease type 2M 
128,von Willebrand factor Vicenza 
129,Reduced von Willebrand factor activity;Reduced quantity of Von Willebrand factor 
130,von Willebrand disease, type 1, susceptibility to 
131,Thrombus 
132,Exudative vitreoretinopathy 5 
133,Dilated cardiomyopathy 1CC 
134,Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC 
135,Neuropathy, hereditary sensory and autonomic, type 2B 
136,Charcot-Marie-Tooth disease 
137,Neurofibromatosis, type 1 
138,Optic nerve glioma;Neurofibroma;Cafe au lait spots, multiple;Axillary freckling 
139,Caf√©-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal;Juvenile myelomonocytic leukemia;Neurofibromatosis, type 1 
140,Tibial pseudarthrosis;Neurofibromatosis, type 1 
141,Juvenile myelomonocytic leukemia 
142,Rhabdomyosarcoma 
143,Abnormality of the skin 
144,Neurofibromatosis, familial spinal 
145,Galactosialidosis, late infantile 
146,Combined deficiency of sialidase AND beta galactosidase 
147,Galactosialidosis, early infantile 
148,Tay-Sachs disease, variant AB 
149,Autosomal recessive nonsyndromic hearing loss 77 
150,MORM syndrome 
151,Joubert syndrome 1 
152,16 conditions 
153,Joubert syndrome and related disorders 
154,Paragangliomas 2 
155,Tyrosinemia type II 
156,Urocanate hydratase deficiency 
157,Autosomal recessive optic atrophy, OPA7 type 
158,Cystic leukoencephalopathy without megalencephaly 
159,Glycogen storage disease type X 
160,Mitochondrial complex 1 deficiency, nuclear type 18 
161,Macrothrombocytopenia, isolated, 1, autosomal dominant 
162,Macrothrombocytopenia 
163,Complex cortical dysplasia with other brain malformations 7 
164,Mitochondrial complex 2 deficiency, nuclear type 2 
165,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 
166,Fluorouracil response 
167,Dihydropyrimidine dehydrogenase deficiency 
168,capecitabine response - Toxicity 
169,fluorouracil response - Toxicity 
170,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b) 
171,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b) 
172,BLOOD GROUP--LUTHERAN NULL 
173,Thyroglobulin synthesis defect 
174,Hennekam lymphangiectasia-lymphedema syndrome 1 
175,Coproporphyria 
176,Harderoporphyria 
177,Hereditary coproporphyria 
178,Coproporphyria, digenic 
179,Hereditary fructosuria 
180,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 
181,Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency 
182,Dihydropteridine reductase deficiency 
183,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 
184,Primary ciliary dyskinesia 11 
185,Hereditary spherocytosis type 1 
186,Congenital contractural arachnodactyly 
187,Primary ciliary dyskinesia 10 
188,Retinitis pigmentosa 25 
189,Autosomal recessive nonsyndromic hearing loss 63 
190,Rare genetic deafness 
191,Mitochondrial complex 1 deficiency, nuclear type 17 
192,Protoporphyria, erythropoietic, 1 
193,- 
194,H syndrome 
195,Mitochondrial complex 1 deficiency, nuclear type 16 
196,Mitochondrial complex I deficiency 
197,Kininogen deficiency, total 
198,Phenylketonuria 
199,Hyperphenylalaninemia 
200,Mild non-PKU hyperphenylalanemia 
201,Marfanoid habitus and intellectual disability 
202,Endocrine-cerebro-osteodysplasia syndrome 
203,Cytochrome-c oxidase deficiency disease 
204,Combined oxidative phosphorylation deficiency 44 
205,Ischemic stroke 
206,Budd-Chiari syndrome, susceptibility to 
207,Pregnancy loss, recurrent, susceptibility to, 1 
208,Factor V deficiency 
209,Thrombophilia due to activated protein C resistance 
210,Thrombophilia due to activated protein C resistance;Factor V deficiency 
211,Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process 
212,Factor V Hong Kong 
213,Thrombophilia due to protein C deficiency, autosomal dominant 
214,Thrombophilia due to protein C deficiency, autosomal recessive 
215,Reduced protein C activity 
216,Abnormal thrombosis 
217,Cerebral palsy 
218,Thromboembolism 
219,Deep venous thrombosis 
220,Fucosidosis 
221,FU1/FU2 POLYMORPHISM 
222,Geleophysic dysplasia 1 
223,Mucopolysaccharidosis, MPS-IV-A 
224,Morquio syndrome 
225,Diabetes mellitus, transient neonatal, 1 
226,Slow acetylator due to N-acetyltransferase enzyme variant 
227,Skin/hair/eye pigmentation, variation in, 10 
228,Mitochondrial complex III deficiency nuclear type 4 
229,ANE syndrome 
230,Arrhythmogenic right ventricular dysplasia 5 
231,Arrhythmogenic right ventricular cardiomyopathy 
232,Familial isolated arrhythmogenic right ventricular dysplasia 
233,Hypertrophic cardiomyopathy 
234,Iodotyrosine deiodination defect 
235,Meckel syndrome, type 6 
236,Meckel-Gruber syndrome;Joubert syndrome 
237,Joubert syndrome 9 
238,COACH syndrome 1 
239,Joubert syndrome;Meckel-Gruber syndrome 
240,COACH syndrome 2 
241,Joubert syndrome 9/15, digenic 
242,COACH syndrome 1;Joubert syndrome 9;Meckel syndrome, type 6 
243,Hereditary spastic paraplegia 15 
244,Spastic paraplegia 
245,Parkinson disease 11, autosomal dominant, susceptibility to 
0,Galloway-Mowat syndrome 1 
1,Mitochondrial complex 1 deficiency, nuclear type 19 
2,Leigh syndrome 
3,Inborn genetic diseases 
4,Mitochondrial complex 1 deficiency, nuclear type 21 
5,Alzheimer disease, susceptibility to 
6,Microvascular complications of diabetes, susceptibility to, 7 
7,Hemochromatosis, juvenile, digenic 
8,Transferrin serum level quantitative trait locus 2 
9,Hemochromatosis type 1 
10,Porphyria cutanea tarda, susceptibility to 
11,Porphyria variegata, susceptibility to 
12,Hereditary cancer-predisposing syndrome 
13,Hereditary hemochromatosis 
14,Porphyrinuria;Cutaneous photosensitivity 
15,Hemochromatosis type 2 
16,Bronze diabetes 
17,Alzheimer disease 
18,7 conditions 
19,Cardiomyopathy 
20,HFE-related disorder 
21,6 conditions 
22,Cystic fibrosis 
23,Abnormality of iron homeostasis 
24,See cases 
25,Variegate porphyria 
26,HFE POLYMORPHISM 
27,Cranioectodermal dysplasia 2 
28,PHARC syndrome 
29,Retinitis pigmentosa 58 
30,Retinitis Pigmentosa, Dominant 
31,Primary hyperoxaluria type 3 
32,Retinitis pigmentosa 28 
33,Retinal dystrophy 
34,Autosomal recessive retinitis pigmentosa 
35,Cone-rod dystrophy 
36,Retinitis pigmentosa 
37,Microcephaly 2, primary, autosomal recessive, with or without cortical malformations 
38,Autosomal recessive primary microcephaly 
39,Bardet-Biedl syndrome 12, modifier of 
40,Meckel syndrome, type 6, modifier of 
41,Familial infantile myoclonic epilepsy 
42,Autosomal dominant nonsyndromic hearing loss 65;Developmental and epileptic encephalopathy, 1;Caused by mutation in the TBC1 domain family, member 24 
43,DOORS syndrome 
44,Nephronophthisis-like nephropathy 1 
45,Microcephaly 9, primary, autosomal recessive 
46,Seckel syndrome 5;Microcephaly 9, primary, autosomal recessive 
47,CEP152-Related Disorders 
48,Bardet-Biedl syndrome 16 
49,Blue color blindness 
50,Familial porphyria cutanea tarda 
51,Hepatoerythropoietic porphyria 
52,Porphyria cutanea tarda 
53,Sporadic porphyria cutanea tarda 
54,Wolman disease 
55,Lysosomal acid lipase deficiency 
56,Cholesteryl ester storage disease 
57,Urofacial syndrome type 1 
58,Congenital anomaly of kidney and urinary tract 
59,Farber lipogranulomatosis 
60,TRANSCOBALAMIN II POLYMORPHISM 
61,Transcobalamin II deficiency 
62,Retinitis pigmentosa 54 
63,Pheochromocytoma, susceptibility to 
64,Pheochromocytoma 
65,Hereditary pheochromocytoma-paraganglioma 
66,Arthrogryposis, renal dysfunction, and cholestasis 2 
67,Homocystinuria, pyridoxine-nonresponsive 
68,HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED 
69,Classic homocystinuria 
70,Homocystinuria 
71,Cardiovascular phenotype 
72,Homocystinuria, pyridoxine-responsive 
73,Intellectual disability 
74,Connective tissue disorder 
75,Autosomal recessive nonsyndromic hearing loss 79 
76,Hearing loss, autosomal recessive 
77,Brown-Vialetto-van Laere syndrome 1 
78,Progressive bulbar palsy of childhood 
79,Ornithine aminotransferase deficiency 
80,Hyperornithinemia 
81,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia 
82,Dihydropyrimidinase deficiency 
83,Frank-Ter Haar syndrome 
84,Autosomal recessive nonsyndromic hearing loss 25 
85,Joubert syndrome 2 
86,Meckel syndrome, type 2 
87,Joubert syndrome 
88,TMEM216-Related Disorders 
89,Meckel syndrome, type 2;Joubert syndrome 2 
90,Poikiloderma with neutropenia 
91,Thyrotoxic periodic paralysis, susceptibility to, 2 
92,Thyrotoxic periodic paralysis, susceptibility to, 1 
93,Prolidase deficiency 
94,Aspartylglucosaminuria, finnish type 
95,Aspartylglucosaminuria 
96,Amelogenesis imperfecta hypomaturation type 2A3 
97,Methemoglobinemia type 2 
98,Methemoglobinemia, type I 
99,NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM 
100,Xeroderma pigmentosum, group C 
101,Xeroderma pigmentosum 
102,Primary ciliary dyskinesia 13 
103,Primary ciliary dyskinesia 
104,Kartagener syndrome 
105,Dilated cardiomyopathy 1DD 
106,Primary dilated cardiomyopathy 
107,Dilated cardiomyopathy 1S 
108,Dilated cardiomyopathy 1A 
109,Primary familial dilated cardiomyopathy 
110,Alpha-2-plasmin inhibitor deficiency 
111,Desbuquois dysplasia 1 
112,Von Willebrand disease type 2A 
113,von Willebrand disorder 
114,von Willebrand disease type 2 
115,Von Willebrand disease type 2B 
116,Abnormality of coagulation 
117,VON WILLEBRAND FACTOR POLYMORPHISM 
118,von Willebrand disease type 1 
119,von Willebrand disease type 2N 
120,Abnormal bleeding 
121,von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3 
122,Abnormal bleeding;Thrombocytopenia 
123,von Willebrand disease type 3 
124,Abnormality of blood and blood-forming tissues 
125,von Willebrand disease type 2M 
126,von Willebrand factor Vicenza 
127,Reduced von Willebrand factor activity;Reduced quantity of Von Willebrand factor 
128,von Willebrand disease, type 1, susceptibility to 
129,Thrombus 
130,Exudative vitreoretinopathy 5 
131,Dilated cardiomyopathy 1CC 
132,Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC 
133,Neuropathy, hereditary sensory and autonomic, type 2B 
134,Charcot-Marie-Tooth disease 
135,Neurofibromatosis, type 1 
136,Optic nerve glioma;Neurofibroma;Cafe au lait spots, multiple;Axillary freckling 
137,Caf√©-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal;Juvenile myelomonocytic leukemia;Neurofibromatosis, type 1 
138,Tibial pseudarthrosis;Neurofibromatosis, type 1 
139,Juvenile myelomonocytic leukemia 
140,Rhabdomyosarcoma 
141,Abnormality of the skin 
142,Neurofibromatosis, familial spinal 
143,Galactosialidosis, late infantile 
144,Combined deficiency of sialidase AND beta galactosidase 
145,Galactosialidosis, early infantile 
146,Tay-Sachs disease, variant AB 
147,Autosomal recessive nonsyndromic hearing loss 77 
148,MORM syndrome 
149,Joubert syndrome 1 
150,16 conditions 
151,Joubert syndrome and related disorders 
152,Paragangliomas 2 
153,Tyrosinemia type II 
154,Urocanate hydratase deficiency 
155,Autosomal recessive optic atrophy, OPA7 type 
156,Cystic leukoencephalopathy without megalencephaly 
157,Glycogen storage disease type X 
158,Mitochondrial complex 1 deficiency, nuclear type 18 
159,Macrothrombocytopenia, isolated, 1, autosomal dominant 
160,Macrothrombocytopenia 
161,Complex cortical dysplasia with other brain malformations 7 
162,Mitochondrial complex 2 deficiency, nuclear type 2 
163,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 
164,Fluorouracil response 
165,Dihydropyrimidine dehydrogenase deficiency 
166,capecitabine response - Toxicity 
167,fluorouracil response - Toxicity 
168,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b) 
169,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b) 
170,BLOOD GROUP--LUTHERAN NULL 
171,Thyroglobulin synthesis defect 
172,Hennekam lymphangiectasia-lymphedema syndrome 1 
173,Coproporphyria 
174,Harderoporphyria 
175,Hereditary coproporphyria 
176,Coproporphyria, digenic 
177,Hereditary fructosuria 
178,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 
179,Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency 
180,Dihydropteridine reductase deficiency 
181,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 
182,Primary ciliary dyskinesia 11 
183,Hereditary spherocytosis type 1 
184,Congenital contractural arachnodactyly 
185,Primary ciliary dyskinesia 10 
186,Retinitis pigmentosa 25 
187,Autosomal recessive nonsyndromic hearing loss 63 
188,Rare genetic deafness 
189,Mitochondrial complex 1 deficiency, nuclear type 17 
190,Protoporphyria, erythropoietic, 1 
191,- 
192,H syndrome 
193,Mitochondrial complex 1 deficiency, nuclear type 16 
194,Mitochondrial complex I deficiency 
195,Kininogen deficiency, total 
196,Phenylketonuria 
197,Hyperphenylalaninemia 
198,Mild non-PKU hyperphenylalanemia 
199,Marfanoid habitus and intellectual disability 
200,Endocrine-cerebro-osteodysplasia syndrome 
201,Cytochrome-c oxidase deficiency disease 
202,Combined oxidative phosphorylation deficiency 44 
203,Ischemic stroke 
204,Budd-Chiari syndrome, susceptibility to 
205,Pregnancy loss, recurrent, susceptibility to, 1 
206,Factor V deficiency 
207,Thrombophilia due to activated protein C resistance 
208,Thrombophilia due to activated protein C resistance;Factor V deficiency 
209,Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process 
210,Factor V Hong Kong 
211,Thrombophilia due to protein C deficiency, autosomal dominant 
212,Thrombophilia due to protein C deficiency, autosomal recessive 
213,Reduced protein C activity 
214,Abnormal thrombosis 
215,Cerebral palsy 
216,Thromboembolism 
217,Deep venous thrombosis 
218,Fucosidosis 
219,FU1/FU2 POLYMORPHISM 
220,Geleophysic dysplasia 1 
221,Mucopolysaccharidosis, MPS-IV-A 
222,Morquio syndrome 
223,Diabetes mellitus, transient neonatal, 1 
224,Slow acetylator due to N-acetyltransferase enzyme variant 
225,Skin/hair/eye pigmentation, variation in, 10 
226,Mitochondrial complex III deficiency nuclear type 4 
227,ANE syndrome 
228,Arrhythmogenic right ventricular dysplasia 5 
229,Arrhythmogenic right ventricular cardiomyopathy 
230,Familial isolated arrhythmogenic right ventricular dysplasia 
231,Hypertrophic cardiomyopathy 
232,Iodotyrosine deiodination defect 
233,Meckel syndrome, type 6 
234,Meckel-Gruber syndrome;Joubert syndrome 
235,Joubert syndrome 9 
236,COACH syndrome 1 
237,Joubert syndrome;Meckel-Gruber syndrome 
238,COACH syndrome 2 
239,Joubert syndrome 9/15, digenic 
240,COACH syndrome 1;Joubert syndrome 9;Meckel syndrome, type 6 
241,Hereditary spastic paraplegia 15 
242,Spastic paraplegia 
243,Parkinson disease 11, autosomal dominant, susceptibility to 
244,Intellectual disability, autosomal recessive 13 
245,Abnormality of the nervous system 
246,Homocystinuria, cblD type, variant 1 
247,Methylmalonic aciduria and homocystinuria type cblD 
248,Cobalamin C disease 
249,Vitamin B12-responsive methylmalonic acidemia, type cblDv2 
250,Amelogenesis imperfecta, hypocalcification type 
251,Hereditary myopathy with lactic acidosis due to ISCU deficiency 
252,Juvenile cataract-microcornea-renal glucosuria syndrome 
253,RFT1-CDG 
254,Brugada syndrome 2 
255,Death in infancy 
256,Brugada syndrome 
257,Brugada syndrome (shorter-than-normal QT interval) 
258,SUDDEN INFANT DEATH SYNDROME 
259,Long QT syndrome;Primary familial hypertrophic cardiomyopathy 
260,Persistent truncus arteriosus 
261,Lipase deficiency, combined 
262,Familial adenomatous polyposis 1 
263,Gardner syndrome 
264,APC-Associated Polyposis Disorders 
265,Colorectal cancer, susceptibility to 
266,Familial multiple polyposis syndrome 
267,Carcinoma of colon 
268,Neoplasm of the large intestine 
269,Gastric cancer 
270,Brain tumor-polyposis syndrome 2 
271,Desmoid disease, hereditary;Hepatocellular carcinoma;Carcinoma of colon;Neoplasm of stomach;Familial adenomatous polyposis 1 
272,Hepatoblastoma 
273,Adenomatous polyposis coli, susceptibility to 
274,Breast cancer, susceptibility to 
275,Colorectal cancer 
276,Breast carcinoma 
277,Familial colorectal cancer 
278,Progressive myoclonic epilepsy type 3 
279,Cutis laxa with osteodystrophy 
280,Porokeratosis 3, disseminated superficial actinic type 
281,Congenital defect of folate absorption 
282,Schnyder crystalline corneal dystrophy 
283,Fructose-biphosphatase deficiency 
284,Congenital anomalies of kidney and urinary tract 1 
285,Renal hypodysplasia/aplasia 1 
286,Mucopolysaccharidosis, type vi, intermediate 
287,Mucopolysaccharidosis type 6 
288,Mucopolysaccharidosis, type vi, severe 
289,Mucopolysaccharidosis, type vi, mild 
290,Metachromatic leukodystrophy 
291,Bowen-Conradi syndrome 
292,Wolfram syndrome 2 
293,Mucopolysaccharidosis type 7 
294,Non-immune hydrops fetalis 
295,Autosomal recessive congenital ichthyosis 5 
296,Lamellar ichthyosis 
297,CARBONIC ANHYDRASE II VARIANT 
298,Osteopetrosis with renal tubular acidosis 
299,Infantile GM1 gangliosidosis 
300,GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B;Infantile GM1 gangliosidosis 
301,GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B 
302,Mucopolysaccharidosis, MPS-IV-B 
303,GM1 gangliosidosis 
304,GM1 gangliosidosis type 2 
305,GM1 gangliosidosis type 3 
306,GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B 
307,GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis 
308,Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis 
309,Spondyloepiphyseal dysplasia 
310,GM1-gangliosidosis, type I, with cardiac involvement 
311,GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3 
312,Spastic ataxia 
313,Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B 
314,GLB1-Related Disorders 
315,Combined immunodeficiency due to DOCK8 deficiency 
316,Tyrosinase-positive oculocutaneous albinism 
317,Skin/hair/eye pigmentation, variation in, 1;Tyrosinase-positive oculocutaneous albinism 
318,Nonsyndromic Oculocutaneous Albinism 
319,Skin/hair/eye pigmentation, variation in, 1 
320,Leber congenital amaurosis 5 
321,Leber congenital amaurosis 
322,Fanconi anemia complementation group I 
323,Fanconi anemia 
324,Macrocephaly, macrosomia, facial dysmorphism syndrome 
325,Age related macular degeneration 8 
326,Cernunnos-XLF deficiency 
327,Asphyxiating thoracic dystrophy 2 
328,Xeroderma pigmentosum group A 
329,Diabetes mellitus type 2, susceptibility to 
330,Neuronal ceroid lipofuscinosis 7 
331,Seizure 
332,Neuronal ceroid lipofuscinosis 
333,Late-infantile neuronal ceroid lipofuscinosis 
334,Retinitis pigmentosa 42 
335,Charcot-Marie-Tooth disease type 4H 
336,Charcot-Marie-Tooth disease type 4 
337,Autosomal recessive lower motor neuron disease with childhood onset 
338,Hereditary motor neuron disease 
339,MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF 
340,Lethal osteosclerotic bone dysplasia 
341,Schinzel-Giedion syndrome 
342,Intellectual disability, autosomal dominant 29 
343,Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita 
344,Intellectual disability, autosomal dominant 29;Schinzel-Giedion syndrome 
345,Chronic myelogenous leukemia, BCR-ABL1 positive 
346,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency 
347,Hereditary spastic paraplegia 35 
348,3M syndrome 2 
349,Focal segmental glomerulosclerosis 5 
350,Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5 
351,Lethal polymalformative syndrome, Boissel type 
352,Myopathy, lactic acidosis, and sideroblastic anemia 2 
353,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome 
354,Joubert syndrome 7 
355,RPGRIP1L-Related Disorders 
356,Meckel syndrome, type 5 
357,COACH syndrome 1;Joubert syndrome 7;Meckel syndrome, type 5 
358,Abnormality of prenatal development or birth 
359,Retinitis pigmentosa in ciliopathies, modifier of 
360,Nephronophthisis 
361,Nephronophthisis 8 
362,COACH syndrome 3 
363,PSAT deficiency 
364,Premature ovarian failure 5 
365,Genetic non-acquired premature ovarian failure 
366,Cataract 31 multiple types 
367,Fowler syndrome 
368,Posterior column ataxia-retinitis pigmentosa syndrome 
369,Glycogen storage disease IIIb 
370,Glycogen storage disease type III 
371,Glycogen storage disease IIIa 
372,Glycogen storage disease IIIc 
373,Hereditary spastic paraplegia 11 
374,Charcot-Marie-Tooth disease axonal type 2X 
375,Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X 
376,Amyotrophic lateral sclerosis type 5 
377,Sideroblastic anemia 2 
378,Schneckenbecken dysplasia 
379,Inflammatory bowel disease 10, susceptibility to 
380,DK1-CDG 
381,Matthew-Wood syndrome 
382,Beta-hydroxyisobutyryl-CoA deacylase deficiency 
383,Bardet-Biedl syndrome 12 
384,Bardet-Biedl syndrome 
385,Polydactyly, postaxial, type A1;Visual impairment;Inability to walk;Abnormality of cardiovascular system morphology 
386,Glycogen storage disease, type VII 
387,Hereditary spastic paraplegia 8 
388,Hereditary spastic paraplegia 8;Ritscher-Schinzel syndrome 
389,Hereditary spastic paraplegia 
390,Ritscher-Schinzel syndrome;Hereditary spastic paraplegia 8 
391,FACTOR XII (WASHINGTON D.C.) 
392,FACTOR XII (LOCARNO) 
393,FACTOR XII (TENRI) 
394,Factor XII deficiency disease 
395,Hereditary angioedema type 3 
396,Hereditary angioneurotic edema 
397,Hereditary angioedema type 3;Factor XII deficiency disease 
398,Angioedema;Hyperbilirubinemia;Hypertensive disorder;Urticaria 
399,Deficiency of steroid 11-beta-monooxygenase 
400,Glucocorticoid-remediable aldosteronism 
401,Congenital adrenal hyperplasia 
402,Retinitis pigmentosa 36 
403,Coronary artery spasm 3, susceptibility to 
404,Anonychia 
405,Autosomal recessive nonsyndromic hearing loss 49 
406,Ear malformation 
407,Coenzyme Q10 deficiency, primary, 3 
408,Nephrotic syndrome 
409,Hepatic methionine adenosyltransferase deficiency 
410,Hypomyelination and Congenital Cataract 
411,Kufor-Rakeb syndrome 
412,Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78 
413,Congenital dyserythropoietic anemia, type II 
414,Congenital dyserythropoietic anemia, type II;Cowden syndrome 7 
415,Craniolenticulosutural dysplasia 
416,Normophosphatemic familial tumoral calcinosis 
417,Mucopolysaccharidosis, MPS-III-C 
418,Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C 
419,Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73 
420,Mucopolysaccharidosis 
421,Age related macular degeneration 6 
422,Cone-rod dystrophy 11 
423,Fanconi anemia complementation group N 
424,Familial cancer of breast 
425,PALB2-Related Disorders 
426,Pancreatic cancer, susceptibility to, 3 
427,Osteogenesis imperfecta type 8 
428,Aicardi-Goutieres syndrome 3 
429,Aicardi Goutieres syndrome 
430,Aicardi-Goutieres syndrome 2 
431,Peters plus syndrome 
432,Association with systemic lupus erythematosus 
433,Colorectal cancer, susceptibility to, 1 
434,Congenital myasthenic syndrome 10 
435,Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1 
436,Combined immunodeficiency due to ORAI1 deficiency 
437,Hyperphosphatasia with intellectual disability syndrome 1 
438,Hyperphosphatasia-intellectual disability syndrome 
439,Hereditary spastic paraplegia 33 
440,Spastic tetraparesis 
441,Deafness, mitochondrial, modifier of 
442,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 
443,Autosomal recessive nonsyndromic hearing loss 59 
444,Congenital hereditary endothelial dystrophy of cornea 
445,Corneal dystrophy-perceptive deafness syndrome 
446,Corneal dystrophy, Fuchs endothelial, 4 
447,Charcot-Marie-Tooth disease type 2B2 
448,Charcot-Marie-Tooth disease type 2 
449,Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 
450,Toe walking 
451,Bardet-Biedl syndrome 1, modifier of 
452,Hereditary sensory and autonomic neuropathy with spastic paraplegia 
453,Bardet-Biedl syndrome 10 
454,Joubert syndrome 5 
455,Meckel-Gruber syndrome 
456,Senior-Loken syndrome 6;Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Joubert syndrome 5;Leber congenital amaurosis 10 
457,Joubert syndrome;Nephronophthisis;Meckel-Gruber syndrome 
458,Meckel syndrome, type 4 
459,Senior-Loken syndrome 6;Joubert syndrome 5 
460,Bardet-Biedl syndrome 14 
461,Senior-Loken syndrome 6;Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Joubert syndrome 5 
462,COG7 congenital disorder of glycosylation 
463,Leber congenital amaurosis 10 
464,Blindness 
465,Molar tooth sign on MRI;Nystagmus;Central hypotonia 
466,Joubert syndrome 5;Leber congenital amaurosis 10;Senior-Loken syndrome 6;Bardet-Biedl syndrome 14;Meckel syndrome, type 4 
467,Nephronophthisis;Joubert syndrome;Meckel-Gruber syndrome 
468,Senior-Loken syndrome 6 
469,Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome 
470,Polycystic kidney disease;Severe hydrocephalus;Encephalocele 
471,Caudal regression syndrome 
472,Neural tube defects, susceptibility to 
473,Ectopia lentis 2, isolated, autosomal recessive 
474,Autoimmune disease, susceptibility to, 6 
475,Succinate-semialdehyde dehydrogenase deficiency 
476,Renal hypomagnesemia 5 with ocular involvement 
477,Meckel syndrome, type 3 
478,Joubert syndrome 6 
479,TMEM67-Related Disorders 
480,RHYNS syndrome 
481,Bardet-Biedl syndrome 14, modifier of 
482,Nephronophthisis 11 
483,Joubert syndrome;Renal cyst;Oligohydramnios 
484,14 conditions 
485,COACH syndrome 1;Nephronophthisis 11;Bardet-Biedl syndrome 14;Meckel syndrome, type 3;Joubert syndrome 6 
486,Meckel syndrome, type 1 
487,Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28 
488,Bardet-Biedl syndrome 13 
489,Nystagmus;Polydactyly;Hypotonia 
490,Joubert syndrome 28 
491,Leber congenital amaurosis 3 
492,SPATA7-Related Disorders 
493,RETINITIS PIGMENTOSA 94, VARIABLE AGE AT ONSET 
494,Iron-refractory iron deficiency anemia 
495,Microcytic anemia 
496,Globozoospermia 
497,Sucrase-isomaltase deficiency 
498,Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 
499,cblC type of combined methylmalonic aciduria and homocystinuria 
500,Methylmalonic acidemia with homocystinuria cblC 
501,Abnormality of metabolism/homeostasis 
502,Autosomal recessive hypophosphatemic bone disease 
503,Coenzyme Q10 deficiency, primary, 1 
504,Coenzyme Q10 deficiency 
505,Acute intermittent porphyria 
506,Porphyria, acute intermittent, nonerythroid variant 
507,Nephronophthisis 9 
508,Autosomal recessive nonsyndromic hearing loss 28 
509,Acyl-CoA oxidase deficiency 
510,Pyruvate kinase deficiency of red cells 
511,Pyruvate kinase hyperactivity 
512,Pyruvate kinase hyperactivity;Pyruvate kinase deficiency of red cells 
513,Hyperlipoproteinemia, type I 
514,Hyperlipidemia, familial combined, LPL related;Hyperlipoproteinemia, type I 
515,Hyperlipidemia, familial combined, LPL related 
516,LIPOPROTEIN LIPASE POLYMORPHISM 
517,Hyperlipidemia, familial combined, susceptibility to 
518,Coronary heart disease 
519,LIPOPROTEIN LIPASE (OLBIA) 
520,Mucopolysaccharidosis, MPS-III-B 
521,Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B 
522,Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V 
523,Tyrosinemia type III 
524,Hawkinsinuria;Tyrosinemia type III 
525,Hawkinsinuria 
526,Glaucoma 1, open angle, G 
527,Usher syndrome type 2C 
528,Hydatidiform mole, recurrent, 1 
529,Mitochondrial complex 1 deficiency, nuclear type 10 
530,Mitochondrial complex I deficiency, nuclear type 1 
531,Familial cold autoinflammatory syndrome 2 
532,Autoinflammatory syndrome 
533,Fanconi anemia, complementation group M 
534,Ectodermal dysplasia-syndactyly syndrome 1 
535,Sideroblastic anemia 3 
536,L-2-hydroxyglutaric aciduria 
537,3M syndrome 1 
538,Very long chain acyl-CoA dehydrogenase deficiency 
539,Abnormality of circulating enzyme level;Rhabdomyolysis 
540,Sj√∂gren-Larsson syndrome 
541,Torsion dystonia 6 
542,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 
543,Vitamin D-dependent rickets, type 1 
544,Vitamin D-dependent rickets, type 1A 
545,Beta-D-mannosidosis 
546,Deficiency of alpha-mannosidase 
547,Histidinemia 
548,Hurthle cell carcinoma of thyroid 
549,Autosomal recessive nonsyndromic hearing loss 67 
550,Fleck corneal dystrophy 
551,Cockayne syndrome type 2 
552,DE SANCTIS-CACCHIONE SYNDROME 
553,ERCC6-Related Disorders 
554,Cerebrooculofacioskeletal syndrome 1 
555,Cerebrooculofacioskeletal syndrome 1;DE SANCTIS-CACCHIONE SYNDROME;Cockayne syndrome type 2 
556,Age related macular degeneration 5 
557,UV-sensitive syndrome 1 
558,Cockayne syndrome type 1 
559,Cockayne syndrome 
560,Preeclampsia/eclampsia 4 
561,Charcot-Marie-Tooth disease type 4J 
562,Amyotrophic lateral sclerosis type 11 
563,Amyotrophic lateral sclerosis 
564,Yunis-Varon syndrome 
565,Bilateral parasagittal parieto-occipital polymicrogyria 
566,Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome 
567,FIG4-Related Disorders 
568,Autosomal recessive congenital ichthyosis 6 
569,Autosomal recessive congenital ichthyosis 
570,Goldberg-Shprintzen megacolon syndrome 
571,Roberts-SC phocomelia syndrome 
572,Roberts syndrome 
573,Intrinsic factor deficiency, congenital, susceptibility to 
574,Hereditary intrinsic factor deficiency 
575,Dopamine beta-hydroxylase deficiency 
576,Lynch syndrome 1 
577,Lynch syndrome 
578,Hereditary nonpolyposis colorectal neoplasms 
579,Lynch syndrome 1;Muir-Torr√© syndrome;Turcot syndrome 
580,Muir-Torr√© syndrome 
581,Hereditary nonpolyposis colon cancer 
582,MSH2 POLYMORPHISM 
583,Early myoclonic encephalopathy 
584,Early infantile epileptic encephalopathy with suppression bursts 
585,Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency 
586,Deficiency of steroid 17-alpha-monooxygenase 
587,Combined partial 17-alpha-hydroxylase/17,20-lyase deficiency 
588,Isolated 17,20-lyase deficiency 
589,Legius syndrome 
590,Noonan syndrome and Noonan-related syndrome 
591,Neurodevelopmental delay 
592,Microcephaly 6, primary, autosomal recessive 
593,Martsolf syndrome 
594,Martsolf syndrome 1 
595,Intellectual disability, autosomal recessive 2 
596,Hypertriglyceridemia, familial 
597,Chudley-McCullough syndrome 
598,Hypotrichosis 8 
599,Autosomal recessive woolly hair 1, with or without hypotrichosis 
600,Senior-Loken syndrome 5 
601,Renal dysplasia and retinal aplasia 
602,Combined oxidative phosphorylation defect type 2 
603,Glucocorticoid deficiency 2 
604,Glucocorticoid deficiency 1 
605,Trichothiodystrophy 4, nonphotosensitive 
606,Glutaryl-CoA oxidase deficiency 
607,D-2-hydroxyglutaric aciduria 1 
608,Hereditary spastic paraplegia 31 
609,Neuronopathy, distal hereditary motor, type 5B 
610,Cerebral cavernous malformation 3 
611,Wilms tumor 5 
612,Neutral lipid storage myopathy 
613,METHYLMALONIC ACIDURIA, mut(0) TYPE 
614,Methylmalonic acidemia 
615,Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency 
616,METHYLMALONIC ACIDURIA, mut(-) TYPE 
617,Pseudofolliculitis barbae 
618,Paroxysmal nonkinesigenic dyskinesia 1 
619,Paroxysmal dystonia;Paroxysmal dyskinesia;Episodic hemiplegia 
620,Paroxysmal nonkinesigenic dyskinesia 
621,Biotinidase deficiency 
622,Holocarboxylase synthetase deficiency 
623,SCIANNA BLOOD GROUP SYSTEM, SC:-1,2 
624,Radin blood group 
625,Antigen in Scianna blood group system 
626,3-methylcrotonyl-CoA carboxylase 2 deficiency 
627,3-methylcrotonyl-CoA carboxylase 1 deficiency 
628,Methylcrotonyl-CoA carboxylase deficiency 
629,Autosomal dominant Parkinson disease 8 
630,Parkinson disease, late-onset 
631,Young-onset Parkinson disease 
632,Parkinson disease 
633,Weill-Marchesani syndrome 1 
634,Cone-rod synaptic disorder, congenital nonprogressive 
635,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency 
636,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive 
637,Partial adenosine deaminase deficiency 
638,Severe combined immunodeficiency disease 
639,Adenosine deaminase 2 allozyme 
640,SCID due to ADA deficiency, delayed onset 
641,Fraser syndrome 2 
642,BNAR syndrome 
643,Joubert syndrome 8 
644,Cone-rod dystrophy 5 
645,Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 
646,Familial hemophagocytic lymphohistiocytosis 3 
647,Severe autosomal recessive muscular dystrophy of childhood - North African type 
648,Joubert syndrome 3 
649,Typical Joubert syndrome MRI findings;Global developmental delay 
650,Rod-cone dystrophy 
651,Joubert syndrome with ocular defect 
652,Neutral 1 amino acid transport defect 
653,Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect 
654,Hyperglycinuria 
655,CHARGE association 
656,CHARGE association;Hypogonadotropic hypogonadism 5 with or without anosmia 
657,Hypogonadotropic hypogonadism 5 without anosmia 
658,Hypogonadotropic hypogonadism 5 with or without anosmia 
659,PPARGC1B polymorphism 
660,Bardet-Biedl syndrome 3 
661,Bardet-Biedl syndrome 3;Retinitis pigmentosa 55 
662,Retinitis pigmentosa 55 
663,Leber congenital amaurosis 13 
664,Retinitis pigmentosa 53 
665,Type 1 diabetes mellitus 5 
666,Myoclonic epilepsy, juvenile, susceptibility to, 1 
667,Juvenile myoclonic epilepsy 
668,Juvenile myoclonic epilepsy;Typical absence seizure 
669,Epilepsy, juvenile absence, susceptibility to, 1 
670,Myoclonic epilepsy, juvenile, susceptibility to, 1;Typical absence seizure 
671,Typical absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1 
672,Hypomyelinating leukodystrophy 2 
673,Hereditary spastic paraplegia 44 
674,Lymphatic malformation 3 
675,Glutaric aciduria, type 1 
676,Pyruvate carboxylase deficiency 
677,Trichothiodystrophy 3, photosensitive 
678,Dopamine receptor d2, reduced brain density of 
679,Dextro-looped transposition of the great arteries 1 
680,Impaired intellectual development and distinctive facial features with cardiac defects 
681,Cardiac anomalies - developmental delay - facial dysmorphism syndrome 
682,Pyruvate dehydrogenase E2 deficiency 
683,Pyruvate dehydrogenase E3-binding protein deficiency 
684,Pontocerebellar hypoplasia type 2A 
685,Olivopontocerebellar hypoplasia 
686,Pontocerebellar hypoplasia type 4 
687,Pontocerebellar hypoplasia type 5 
688,Congenital cerebellar hypoplasia 
689,Microcephaly;Global developmental delay 
690,Pontocerebellar hypoplasia type 4;Pontocerebellar hypoplasia type 2A 
691,Amblyopia;Hypertonia;Global developmental delay 
692,Pontoneocerebellar hypoplasia 
693,Pontocerebellar hypoplasia type 4;Pontocerebellar hypoplasia type 2 
694,Pontocerebellar hypoplasia type 4;Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 5 
695,Pontocerebellar hypoplasia type 2C 
696,Pontocerebellar hypoplasia type 2B 
697,Late-onset retinal degeneration 
698,ALG3-CDG 
699,Ehlers-Danlos syndrome, spondylocheirodysplastic type 
700,Vitamin D hydroxylation-deficient rickets, type 1B 
701,Dyslexia, susceptibility to, 1 
702,Primary ciliary dyskinesia 25 
703,Cornelia de Lange syndrome 1 
704,Peroxisome biogenesis disorder 7B 
705,Peroxisome biogenesis disorder 
706,Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B 
707,Peroxisome biogenesis disorder 7A (Zellweger) 
708,Gnathodiaphyseal dysplasia 
709,Autosomal recessive limb-girdle muscular dystrophy type 2L 
710,Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L;Miyoshi muscular dystrophy 3 
711,Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L 
712,ANO5-Related Disorders 
713,Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia 
714,Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3 
715,Miyoshi muscular dystrophy 3 
716,Polycystic liver disease 2 
717,Gaze palsy, familial horizontal, with progressive scoliosis 1 
718,Bietti crystalline corneoretinal dystrophy 
719,Asthma-related traits, susceptibility to, 2 
720,Occult macular dystrophy 
721,Retinitis pigmentosa 88 
722,Autosomal dominant nonsyndromic hearing loss 4A 
723,Arthrogryposis, renal dysfunction, and cholestasis 1 
724,MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO 
725,Age related macular degeneration 1 
726,Vitamin K-dependent clotting factors, combined deficiency of, type 2 
727,Warfarin response 
728,Renal cell carcinoma, papillary, 1 
729,Von Hippel-Lindau syndrome 
730,Von Hippel-Lindau syndrome;Chuvash polycythemia 
731,Chuvash polycythemia;Von Hippel-Lindau syndrome 
732,Familial infantile myasthenia 
733,Nonpapillary renal cell carcinoma 
734,Chuvash polycythemia;Nonpapillary renal cell carcinoma;Von Hippel-Lindau syndrome;Pheochromocytoma 
735,Chuvash polycythemia 
736,Renal cell carcinoma with paraneoplastic erythrocytosis 
737,Acute leukemia of ambiguous lineage 
738,Neoplasm 
739,Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 
740,Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1 
741,Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative 
742,Chronic granulomatous disease 
743,CYBA POLYMORPHISM 
744,Very early onset inflammatory bowel disease 
745,Charcot-Marie-Tooth disease type 2A2 
746,Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease type 2A2;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; 
747,Peripheral neuropathy 
748,Hereditary motor and sensory neuropathy with optic atrophy 
749,Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; 
750,MFN2-Related Disorders 
751,Peripheral axonal neuropathy 
752,Neuropathy, hereditary motor and sensory, type 6A 
753,Charcot-Marie-Tooth disease type 2A2;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Hereditary motor and sensory neuropathy with optic atrophy 
754,Epilepsy, progressive myoclonic, 1B 
755,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 
756,Amyotrophic lateral sclerosis type 4 
757,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4 
758,Distal spinal muscular atrophy 
759,Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 
760,Glycogen storage disease, type V 
761,Muscular atrophy 
762,Ethylmalonic encephalopathy 
763,Emery-Dreifuss muscular dystrophy 5, autosomal dominant 
764,Autosomal recessive ataxia, Beauce type 
765,Emery-Dreifuss muscular dystrophy 4, autosomal dominant 
766,Emery-Dreifuss muscular dystrophy 4, autosomal dominant;Autosomal recessive ataxia, Beauce type 
767,Ehlers-Danlos syndrome, musculocontractural type 
768,Ehlers-Danlos syndrome, musculocontractural type 1 
769,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency 
770,Nephrotic syndrome, type 3 
771,Usher syndrome type 2A 
772,Usher syndrome 
773,Retinitis pigmentosa 39 
774,USH2A-Related Disorders 
775,Usher syndrome type 2A;Retinitis pigmentosa 39 
776,Congenital sensorineural hearing impairment 
777,Hearing impairment 
778,Rare genetic deafness;Usher syndrome 
779,Usher syndrome type 2 
780,Pigmentary retinopathy;Retinal pigment epithelial atrophy;Rod-cone dystrophy;Blindness;Abnormal macular morphology 
781,Autism, susceptibility to, 16 
782,Retinitis pigmentosa 26 
783,Cone dystrophy;Retinal pigment epithelial atrophy 
784,Hemochromatosis type 2A 
785,Maple syrup urine disease type 1A 
786,Maple syrup urine disease 
787,MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA 
788,Iminoglycinuria, digenic 
789,Arginase deficiency 
790,Argininosuccinate lyase deficiency 
791,Autosomal recessive early-onset Parkinson disease 6 
792,Parkinson disease 6 
793,Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1 
794,Congenital hyperammonemia, type I 
795,CARBAMOYL PHOSPHATE SYNTHETASE I POLYMORPHISM 
796,Pulmonary hypertension, neonatal, susceptibility to 
797,Hyperammonemia, type III 
798,Congenital fibrosis of extraocular muscles type 1 
799,Fibrosis of extraocular muscles, congenital, 3B 
800,Sialidosis type 1 
801,Sialidosis type 2 
802,Long QT syndrome 10 
803,Autosomal dominant woolly hair 
804,Adenylosuccinate lyase deficiency 
805,Thrombocytopenia 2 
806,Brugada syndrome 7 
807,Atrial fibrillation, familial, 16 
808,Exostoses, multiple, type 2 
809,Exostoses, multiple, type 2;Seizures-scoliosis-macrocephaly syndrome 
810,Seizures-scoliosis-macrocephaly syndrome 
811,Charcot-Marie-Tooth disease type 4C 
812,Susceptibility to mononeuropathy of the median nerve, mild 
813,SH3TC2-Related Disorders 
814,Charcot-Marie-Tooth disease type 4C;Susceptibility to mononeuropathy of the median nerve, mild 
815,Herpes simplex encephalitis, susceptibility to, 1 
816,Microcephaly 3, primary, autosomal recessive 
817,Multiple congenital exostosis 
818,Exostoses, multiple, type 1 
819,Retinal cone dystrophy 4 
820,Camptomelic dysplasia 
821,Campomelic dysplasia with autosomal sex reversal 
822,Acampomelic campomelic dysplasia 
823,Chromosome 2q32-q33 deletion syndrome 
824,Cleft palate 
825,Hereditary spastic paraplegia 6 
826,Hypogonadotropic hypogonadism 9 with or without anosmia 
827,Autosomal dominant slowed nerve conduction velocity 
828,Bardet-Biedl syndrome 8 
829,Intellectual disability, moderate;Truncal obesity;Postaxial foot polydactyly 
830,Retinitis pigmentosa 51 
831,Pseudoxanthoma elasticum, modifier of severity of 
832,Spondylo-ocular syndrome 
833,Osteogenesis imperfecta 
834,Desbuquois dysplasia 2 
835,Myopathy, lactic acidosis, and sideroblastic anemia 1 
836,Familial Mediterranean fever 
837,9 conditions 
838,8 conditions 
839,Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant 
840,Familial Mediterranean fever, autosomal dominant 
841,Acute febrile neutrophilic dermatosis 
842,Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant 
843,Renal insufficiency;Abnormality of cardiovascular system morphology;Heart, malformation of 
844,ALG8 congenital disorder of glycosylation 
845,Neuronal ceroid lipofuscinosis 5 
846,APOLIPOPROTEIN C-II (AFRICAN) 
847,Familial apolipoprotein C-II deficiency 
848,APOLIPOPROTEIN C-II (PADOVA) 
849,APOLIPOPROTEIN C-II (PARIS) 
850,APOLIPOPROTEIN C-II (BARI) 
851,Apolipoprotein c-ii variant 
852,APOLIPOPROTEIN C-II (SAN FRANCISCO) 
853,APOLIPOPROTEIN C-II (WAKAYAMA) 
854,APOLIPOPROTEIN C-II (AUCKLAND) 
855,Epilepsy, progressive myoclonic 2b 
856,Lafora disease 
857,Glutaric acidemia IIa 
858,Multiple acyl-CoA dehydrogenase deficiency 
859,Hyaline fibromatosis syndrome 
860,Spongy degeneration of central nervous system 
861,Canavan Disease, Familial Form 
862,Mild Canavan disease 
863,Neuronopathy, distal hereditary motor, type 2A 
864,Charcot-Marie-Tooth disease axonal type 2L 
865,Ezetimibe response 
866,Marinesco-Sj√∂gren syndrome 
867,Nephronophthisis 3 
868,NPHP3-related Meckel-like syndrome 
869,Renal-hepatic-pancreatic dysplasia 1 
870,Neuronal ceroid lipofuscinosis 2 
871,Neuronal ceroid lipofuscinosis 2;Autosomal recessive spinocerebellar ataxia 7 
872,Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2 
873,Geroderma osteodysplastica 
874,Pancreatic insufficiency-anemia-hyperostosis syndrome 
875,Bardet-Biedl syndrome 9 
876,Multiple sulfatase deficiency 
877,Cerebral cavernous malformation 2 
878,Autosomal recessive nonsyndromic hearing loss 31 
879,Usher syndrome type 2D 
880,p phenotype 
881,Congenital disorder of glycosylation type II 
882,Epilepsy, childhood absence, susceptibility to, 6 
883,Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV 
884,Hyperaldosteronism, familial, type IV;Idiopathic generalized epilepsy 
885,Epilepsy, idiopathic generalized 6 
886,Leukocyte adhesion deficiency 3 
887,Kindler syndrome 
888,Hypotrichosis 6 
889,Vitelliform macular dystrophy 2 
890,Autosomal recessive bestrophinopathy 
891,Retinitis Pigmentosa, Recessive 
892,Autosomal dominant vitreoretinochoroidopathy 
893,Stargardt disease 
894,Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 
895,Retinitis pigmentosa 50 
896,Osteopoikilosis 
897,Melorheostosis with osteopoikilosis 
898,Dermatofibrosis lenticularis disseminata 
899,Dermatofibrosis lenticularis disseminata, isolated 
900,Mucolipidosis III alpha/beta, atypical 
901,Pseudo-Hurler polydystrophy 
902,Mucolipidosis type II;Pseudo-Hurler polydystrophy 
903,Mucolipidosis 
904,Mucolipidosis type II 
905,Mucopolysaccharidosis, MPS-III-A 
906,Glycogen storage disease IV, nonprogressive hepatic 
907,Glycogen storage disease, type IV 
908,Adult polyglucosan body neuropathy 
909,GBE1-Related Disorders 
910,Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV 
911,Glycogen storage disease, type IV;Adult polyglucosan body disease 
912,Adult polyglucosan body disease 
913,Glycogen storage disease IV, classic hepatic 
914,Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form 
915,Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic 
916,Glycogen storage disease IV, combined hepatic and myopathic 
917,Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form 
918,Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form 
919,Mucolipidosis type III gamma 
920,Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 
921,Neuronal ceroid lipofuscinosis 8 
922,Neuronal ceroid lipofuscinosis 8 northern epilepsy variant;Neuronal ceroid lipofuscinosis 8 
923,Fraser syndrome 1 
924,Cohen syndrome 
925,History of neurodevelopmental disorder 
926,Deficiency of acetyl-CoA acetyltransferase 
927,Jalili syndrome 
928,Autosomal recessive congenital ichthyosis 4A 
929,Autosomal recessive congenital ichthyosis 4B;Autosomal recessive congenital ichthyosis 4A 
930,Autosomal recessive congenital ichthyosis 4B 
931,Congenital ichthyosis of skin 
932,Factor 5 and Factor VIII, combined deficiency of, 2 
933,Hypercholesterolemia, autosomal dominant, 3 
934,Hypercholesterolemia, familial, 1 
935,Low density lipoprotein cholesterol level quantitative trait locus 1 
936,Familial hypercholesterolemia 
937,Hypocholesterolemia 
938,Hypobetalipoproteinemia 
939,Congenital bile acid synthesis defect 1 
940,Intellectual disability, autosomal dominant 4 
941,BAK PLATELET-SPECIFIC ANTIGEN 
942,Glanzmann thrombasthenia 
943,Glanzmann thrombasthenia 1 
944,Phenylthiocarbamide tasting 
945,Hypercholanemia, familial 1 
946,Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma 
947,Usher syndrome type 1G 
948,Thyroid hormone metabolism, abnormal 1 
949,Chylomicron retention disease 
950,Cold-induced sweating syndrome 2 
951,Mucopolysaccharidosis, MPS-III-D 
952,Cystathioninuria 
953,Homocysteine level elevated 
954,Autosomal recessive osteopetrosis 5 
955,Smith-Magenis syndrome 
956,Hereditary xanthinuria type 1 
957,Xanthinuria type II 
958,Niemann-Pick disease, type C1 
959,Niemann-Pick disease, type C 
960,Niemann-Pick disease, type D 
961,Niemann-Pick disease, type C1, adult form 
962,Niemann-Pick disease, type C1, juvenile form 
963,Niemann-Pick disease, type A 
964,Sphingomyelin/cholesterol lipidosis 
965,Niemann-Pick disease, type A;Niemann-Pick disease, type B 
966,Niemann-Pick disease, type B 
967,Niemann-Pick disease, type B;Niemann-Pick disease, type A 
968,Niemann-pick disease, intermediate, protracted neurovisceral 
969,Epidermolytic palmoplantar keratoderma 
970,Palmoplantar keratoderma, epidermolytic, with knuckle pads 
971,Palmoplantar keratoderma 
972,Cone dystrophy with supernormal rod response 
973,Bardet-Biedl syndrome 7 
974,Bardet-Biedl syndrome 1/7, digenic 
975,Ataxia - telangiectasia variant 
976,Ataxia-telangiectasia syndrome 
977,T-cell prolymphocytic leukemia 
978,Breast neoplasm 
979,Familial cancer of breast;Ataxia-telangiectasia syndrome 
980,B-cell non-Hodgkin lymphoma 
981,Breast and/or ovarian cancer 
982,Hereditary breast ovarian cancer syndrome 
983,Ataxia-telangiectasia without immunodeficiency 
984,Carcinoma of pancreas 
985,Mantle cell lymphoma 
986,Ataxia-telangiectasia syndrome;Familial cancer of breast 
987,Malignant tumor of breast 
988,ARYLSULFATASE A POLYMORPHISM 
989,Metachromatic leukodystrophy, juvenile type 
990,Arylsulfatase a, allele a 
991,Metachromatic leukodystrophy, adult type 
992,Metachromatic leukodystrophy, late infantile form 
993,Pseudoarylsulfatase A deficiency 
994,Metachromatic leukodystrophy, severe 
995,Arylsulfatase A pseudodeficiency 
996,Leukodystrophy 
997,Metachromatic leukodystrophy, mild 
998,Arylsulfatase a pseudodeficiency, severe 
999,Arylsulfatase a pseudodeficiency, intermediate 
1000,Methylmalonic aciduria, cblB type 
1001,Progressive myoclonic epilepsy 
1002,Inflammatory bowel disease 17, protection against 
1003,Psoriasis, protection against 
1004,Autosomal dominant nonsyndromic hearing loss 25 
1005,Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 
1006,Long QT syndrome 1 
1007,Congenital long QT syndrome 
1008,Long QT syndrome 
1009,Cardiac arrhythmia 
1010,Long QT syndrome 1/2, digenic 
1011,Prolonged QT interval 
1012,Jervell and Lange-Nielsen syndrome 1 
1013,Atrial fibrillation, familial, 3 
1014,Short QT syndrome type 2 
1015,Long QT syndrome 1, recessive 
1016,KCNQ1-Related Disorders 
1017,Conduction disorder of the heart 
1018,Long QT syndrome 2 
1019,Beckwith-Wiedemann syndrome 
1020,Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1 
1021,Acquired susceptibility to long QT syndrome 1 
1022,Beckwith-Wiedemann syndrome;Long QT syndrome 1;Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1;Atrial fibrillation, familial, 3 
1023,Atrial fibrillation 
1024,Short QT syndrome 
1025,Weill-Marchesani 4 syndrome, recessive 
1026,Methylmalonic aciduria, cblA type 
1027,Hypotrichosis 1 
1028,Unipolar depression, susceptibility to 
1029,Attention deficit-hyperactivity disorder, susceptibility to, 7 
1030,Bipolar affective disorder, susceptibility to 
1031,Tryptophan 5-monooxygenase deficiency 
1032,Alkaptonuria 
1033,Congenital dyserythropoietic anemia, type I 
1034,Anemia, congenital dyserythropoietic, type 1a 
1035,Dyggve-Melchior-Clausen syndrome 
1036,Smith-McCort dysplasia 1 
1037,Hereditary North American Indian childhood cirrhosis 
1038,Shwachman-Diamond syndrome 1 
1039,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 
1040,Walker-Warburg congenital muscular dystrophy 
1041,Autosomal recessive limb-girdle muscular dystrophy type 2M 
1042,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 
1043,Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 
1044,Dilated cardiomyopathy 1X 
1045,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 
1046,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 
1047,Muscular dystrophy 
1048,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 
1049,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 
1050,Autosomal recessive limb-girdle muscular dystrophy type 2N 
1051,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome 
1052,Abnormality of the musculature 
1053,MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1 
1054,Autosomal recessive limb-girdle muscular dystrophy type 2K 
1055,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 
1056,Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 
1057,Primary ciliary dyskinesia 6 
1058,Glucocorticoid Deficiency 
1059,Hyperparathyroidism 2 with jaw tumors 
1060,Parathyroid carcinoma 
1061,Hyperparathyroidism 1 
1062,Neurofibromatosis, type 2 
1063,Meningioma 
1064,Woolly hair, autosomal recessive 2, with or without hypotrichosis 
1065,Polyglandular autoimmune syndrome, type 1 
1066,Autoimmune polyglandular syndrome type 1, autosomal dominant 
1067,Duane-radial ray syndrome 
1068,Epileptic encephalopathy 
1069,Retinitis pigmentosa 9 
1070,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency 
1071,Abnormality of the genitourinary system 
1072,STEROID 5-ALPHA-REDUCTASE POLYMORPHISM 
1073,Micropenis 
1074,Retinitis pigmentosa 18 
1075,Retinitis pigmentosa 13 
1076,Retinitis pigmentosa 35 
1077,Cone-rod dystrophy 10 
1078,Multiple fibrofolliculomas 
1079,Familial spontaneous pneumothorax 
1080,Ellis-van Creveld syndrome 
1081,Short-rib thoracic dysplasia 6 with or without polydactyly 
1082,Curry-Hall syndrome;Ellis-van Creveld syndrome 
1083,Ellis-van Creveld syndrome;Curry-Hall syndrome 
1084,Autosomal recessive nonsyndromic hearing loss 6 
1085,Sensorineural hearing loss disorder 
1086,Nephronophthisis 4 
1087,Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities);Infertility 
1088,Senior-Loken syndrome 4 
1089,Predisposition to invasive fungal disease due to CARD9 deficiency 
1090,Autosomal recessive congenital ichthyosis 3 
1091,Van der Woude syndrome 1 
1092,Popliteal pterygium syndrome 
1093,Autosomal dominant popliteal pterygium syndrome 
1094,Van der Woude syndrome;Orofacial cleft 6, susceptibility to;Popliteal pterygium syndrome 
1095,Popliteal pterygium syndrome;Van der Woude syndrome;Orofacial cleft 6, susceptibility to 
1096,Van der Woude syndrome 1;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to 
1097,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1 
1098,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome 
1099,Atrioventricular septal defect, susceptibility to, 2 
1100,Atrioventricular septal defect, partial, with heterotaxy syndrome 
1101,Hermansky-Pudlak syndrome 7 
1102,ALG12-congenital disorder of glycosylation 
1103,Fanconi anemia complementation group A 
1104,Hypogonadotropic hypogonadism 3 with or without anosmia 
1105,Infertility 
1106,Amenorrhea 
1107,Hypogonadism with anosmia 
1108,Microcephaly 1, primary, autosomal recessive 
1109,Aniridia 1 
1110,Cataracts, congenital, with late-onset corneal dystrophy 
1111,ANTERIOR SEGMENT DYSGENESIS 5, PETERS ANOMALY SUBTYPE 
1112,Irido-corneo-trabecular dysgenesis;Aniridia 1 
1113,Aniridia 1;Irido-corneo-trabecular dysgenesis 
1114,Foveal hypoplasia 1 
1115,Aniridia, atypical 
1116,Foveal hypoplasia 1 with cataract 
1117,ANTERIOR SEGMENT DYSGENESIS 5, MULTIPLE SUBTYPES 
1118,Foveal hypoplasia 1 with or without anterior segment anomalies 
1119,Hypertelorism;Nystagmus;Visual impairment 
1120,Coloboma of optic nerve 
1121,Optic nerve hypoplasia, bilateral 
1122,Congenital ocular coloboma 
1123,Optic nerve aplasia, bilateral 
1124,Drash syndrome 
1125,Nephrotic syndrome, type 4 
1126,Meacham syndrome 
1127,Frasier syndrome;Drash syndrome;11p partial monosomy syndrome;Wilms tumor 1 
1128,Nephrotic range proteinuria;Steroid-resistant nephrotic syndrome 
1129,Wilms tumor 1 
1130,Frasier syndrome;Drash syndrome;Nephrotic syndrome, type 4;Wilms tumor 1 
1131,Frasier syndrome 
1132,Mesothelioma 
1133,Nephronophthisis 1 
1134,NPHP1-Related Disorders 
1135,Dalmatian hypouricemia 
1136,Familial renal hypouricemia 
1137,Homocystinuria due to MTHFR deficiency 
1138,Homocystinuria due to methylene tetrahydrofolate reductase deficiency 
1139,MTHFR THERMOLABILE POLYMORPHISM 
1140,Gastrointestinal stromal tumor 
1141,Neural tube defects, folate-sensitive 
1142,Neoplasm of stomach 
1143,Thrombophilia due to thrombin defect 
1144,methotrexate response - Metabolism/PK 
1145,methotrexate response - Toxicity 
1146,Stroke 
1147,Schizophrenia, susceptibility to 
1148,Deficiency of hyaluronoglucosaminidase 
1149,Hereditary acrodermatitis enteropathica 
1150,Retinitis pigmentosa 56 
1151,Macular dystrophy 
1152,Vitelliform macular dystrophy 5 
1153,Ceroid lipofuscinosis, neuronal, 3, protracted 
1154,Neuronal ceroid lipofuscinosis 3 
1155,early onset and severe retinal dystrophy 
1156,Apocrine gland secretion, variation in 
1157,Axillary odor 
1158,Colostrum secretion 
1159,Isovaleric acidemia, type I 
1160,Isovaleryl-CoA dehydrogenase deficiency 
1161,Medulloblastoma 
1162,Intestinal hypomagnesemia 1 
1163,Medium-chain acyl-coenzyme A dehydrogenase deficiency 
1164,Epileptic spasm 
1165,Abnormal circulating lipid concentration 
1166,Medium chain dicarboxylic aciduria 
1167,Hypogonadotropic hypogonadism 4 with or without anosmia 
1168,Kleefstra syndrome 1 
1169,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 
1170,Galactosemia 
1171,GALT POLYMORPHISM 
1172,GALT POLYMORPHISM (DUARTE, D2) 
1173,Myeloperoxidase deficiency 
1174,Autosomal recessive ataxia due to ubiquinone deficiency 
1175,Joubert syndrome 17 
1176,COG8-CDG 
1177,COG4-CDG 
1178,LCAT deficiency 
1179,Fish-eye disease 
1180,UDPglucose-4-epimerase deficiency 
1181,Galactose epimerase deficiency, severe 
1182,Homozygous familial hypercholesterolemia 
1183,Aortic dissection;Carotid artery occlusion;Stroke;Carotid artery dissection;Internal carotid artery dissection 
1184,Hypercholesterolemia 
1185,ALG9 congenital disorder of glycosylation 
1186,Cutaneous porphyria 
1187,Progressive familial heart block type IB 
1188,Tyrosinase-negative oculocutaneous albinism 
1189,Albinism 
1190,Oculocutaneous albinism 
1191,Oculocutaneous albinism type 1B 
1192,Skin/hair/eye pigmentation, variation in, 3;Ocular albinism with congenital sensorineural hearing loss;Tyrosinase-negative oculocutaneous albinism;Oculocutaneous albinism type 1B 
1193,Skin/hair/eye pigmentation, variation in, 3 
1194,Tyrosinase-negative oculocutaneous albinism;Oculocutaneous albinism type 1B 
1195,Temperature-sensitive oculocutaneous albinism type 1 
1196,Melanoma, cutaneous malignant, susceptibility to, 8 
1197,Skin/hair/eye pigmentation 3, blue/green eyes 
1198,Autosomal recessive ocular albinism 
1199,Oculocutaneous albinism type 1 
1200,Horizontal nystagmus;Iris transillumination defect;Hypopigmentation of the skin;Hypopigmentation of hair 
1201,Myopia;Nystagmus;Albinism 
1202,Chediak-Higashi syndrome, adult type 
1203,Ch√©diak-Higashi syndrome 
1204,Chediak-Higashi syndrome, childhood type 
1205,Galactosylceramide beta-galactosidase deficiency 
1206,Sulfite oxidase deficiency 
1207,Deficiency of butyryl-CoA dehydrogenase 
1208,Immunodeficiency 67 
1209,Wilson disease 
1210,PHGDH deficiency 
1211,Neu-Laxova syndrome 1 
1212,Neu-Laxova syndrome 1;PHGDH deficiency 
1213,HEXB POLYMORPHISM 
1214,Sandhoff disease 
1215,Sandhoff disease, juvenile form 
1216,Sandhoff disease, adult form 
1217,HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM 
1218,Sandhoff disease, infantile form 
1219,Sandhoff disease, chronic 
1220,Tay-Sachs disease 
1221,Gm2-gangliosidosis, juvenile 
1222,Tay-Sachs disease, B1 variant 
1223,Hexa, dn allele 
1224,Global developmental delay 
1225,HEXA, Czechoslovakian allele 
1226,Gm2-gangliosidosis, adult 
1227,Gm2-gangliosidosis, late onset 
1228,Tay-sachs disease, juvenile 
1229,Gm2-gangliosidosis, chronic 
1230,Gm2-gangliosidosis, adult-onset 
1231,Gm2-gangliosidosis, variant b1 
1232,Beta-hexosaminidase a, pseudodeficiency of 
1233,Tay-Sachs disease, variant AB;Tay-Sachs disease 
1234,Gm2-gangliosidosis, subacute 
1235,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor 
1236,Hereditary angioedema type 1 
1237,Complement component 4, partial deficiency of, due to dysfunctional c1 inhibitor 
1238,Gamma-glutamylcysteine synthetase deficiency 
1239,Treacher Collins syndrome 1 
1240,Alstrom syndrome 
1241,Friedreich ataxia 
1242,Muscle eye brain disease 
1243,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 
1244,Autosomal recessive limb-girdle muscular dystrophy type 2O 
1245,Retinitis pigmentosa 76 
1246,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 
1247,Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 
1248,Autosomal recessive limb-girdle muscular dystrophy 
1249,Congenital Muscular Dystrophy, alpha-dystroglycan related 
1250,Muscle eye brain disease;Retinitis pigmentosa 76;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 
1251,Deficiency of pyrroline-5-carboxylate reductase 
1252,Proline dehydrogenase deficiency 
1253,Schizophrenia 4 
1254,Autosomal recessive nonsyndromic hearing loss 30 
1255,Glutamate formiminotransferase deficiency 
1256,Acid alpha-glucosidase, allele 2 
1257,Glycogen storage disease, type II 
1258,Glycogen storage disease type II, infantile 
1259,Glycogen storage disease II, adult form 
1260,Acid alpha-glucosidase, allele 4 
1261,Autosomal recessive congenital ichthyosis 11 
1262,Deficiency of iodide peroxidase 
1263,Deficiency of malonyl-CoA decarboxylase 
1264,Thyroid dyshormonogenesis 6 
1265,Aicardi-Goutieres syndrome 5 
1266,Atrial septal defect 6 
1267,Ceroid lipofuscinosis, neuronal, 6A 
1268,Atelosteogenesis type II 
1269,Diastrophic dysplasia 
1270,Multiple epiphyseal dysplasia type 4 
1271,SLC26A2-Related Disorders 
1272,Osteochondrodysplasia 
1273,Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB 
1274,Achondrogenesis, type IB 
1275,3MC syndrome 2 
1276,Diastrophic dysplasia;Multiple epiphyseal dysplasia type 4;Achondrogenesis, type IB;Atelosteogenesis type II 
1277,Atelosteogenesis type II;Diastrophic dysplasia;Multiple epiphyseal dysplasia type 4;Achondrogenesis, type IB 
1278,Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II 
1279,Diastrophic dysplasia;Atelosteogenesis type II;Multiple epiphyseal dysplasia type 4;Achondrogenesis, type IB 
1280,Diastrophic dysplasia, broad bone-platyspondylic variant 
1281,Multiple epiphyseal dysplasia type 4;Diastrophic dysplasia;Atelosteogenesis type II;Achondrogenesis, type IB 
1282,de la Chapelle dysplasia 
1283,Autosomal dominant nonsyndromic hearing loss 36 
1284,Autosomal recessive nonsyndromic hearing loss 7 
1285,Autosomal recessive polycystic kidney disease 
1286,Colorectal cancer, protection against 
1287,Periportal fibrosis;Polycystic kidney disease;Oligohydramnios 
1288,Polycystic kidney disease 
1289,Autosomal dominant polycystic liver disease 
1290,Polycystic kidney disease 4 
1291,Vanishing white matter disease 
1292,Ovarioleukodystrophy 
1293,Hermansky-Pudlak syndrome 4 
1294,Sotos syndrome 
1295,Sotos syndrome 1 
1296,Deficiency of beta-ureidopropionase 
1297,Bernard-Soulier syndrome, type A1 
1298,Pseudo von Willebrand disease 
1299,Bernard-Soulier syndrome, type A2, autosomal dominant 
1300,Thrombocytopenia 
1301,Impaired ristocetin-induced platelet aggregation 
1302,Cryptorchidism 
1303,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 
1304,Vitiligo-associated multiple autoimmune disease susceptibility 1 
1305,Respiratory papillomatosis, juvenile recurrent, congenital 
1306,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome 
1307,Autoinflammation with arthritis and dyskeratosis 
1308,Enterokinase deficiency 
1309,Cone-rod dystrophy 7 
1310,Glycine N-methyltransferase deficiency 
1311,Schimke immuno-osseous dysplasia 
1312,Aicardi-Goutieres syndrome 1 
1313,Systemic lupus erythematosus, susceptibility to 
1314,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations 
1315,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Chilblain lupus 1;Aicardi-Goutieres syndrome 1 
1316,Chilblain lupus 1;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1 
1317,Aicardi Goutieres syndrome 1, autosomal dominant 
1318,Chilblain lupus 
1319,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive 
1320,Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant 
1321,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant 
1322,Charcot-Marie-Tooth disease type 4A 
1323,Charcot-Marie-Tooth disease axonal type 2K 
1324,Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive 
1325,Neuropathy, axonal, with vocal cord paresis, autosomal recessive 
1326,Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive 
1327,Charcot-Marie-Tooth disease recessive intermediate A 
1328,Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A 
1329,Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A 
1330,Polyneuropathy;Sensory neuropathy;Peripheral axonal neuropathy;Elevated circulating creatine kinase concentration;Elevated circulating alkaline phosphatase concentration 
1331,GDAP1-Related Disorders 
1332,Waardenburg syndrome type 1 
1333,Waardenburg syndrome type 3 
1334,Craniofacial-deafness-hand syndrome 
1335,Waardenburg syndrome 
1336,Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5 
1337,Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 
1338,Autosomal recessive limb-girdle muscular dystrophy type 2I 
1339,Muscular dystrophy-dystroglycanopathy 
1340,Limb-girdle muscular dystrophy 
1341,Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 
1342,Muscular dystrophy-dystroglycanopathy type B5 
1343,Myopathy 
1344,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 
1345,FKRP-Related Disorder 
1346,Amelogenesis imperfecta - hypoplastic autosomal dominant - local 
1347,Optic atrophy 3 
1348,3-Methylglutaconic aciduria type 3;Optic atrophy 3 
1349,Cardiomyopathy, hypertrophic, midventricular, digenic 
1350,Hypertrophic cardiomyopathy 1 
1351,Esophageal squamous cell carcinoma, somatic 
1352,Congenital microvillous atrophy 
1353,Cholestanol storage disease 
1354,Griscelli syndrome type 3 
1355,Amish lethal microcephaly 
1356,Mandibuloacral dysplasia with type B lipodystrophy 
1357,Lethal tight skin contracture syndrome 
1358,Dyskeratosis congenita, autosomal recessive 1 
1359,Dyskeratosis congenita, autosomal recessive 2 
1360,Hemochromatosis type 2B 
1361,Hemochromatosis, type 2a, modifier of 
1362,Gaucher disease type III 
1363,Dementia, Lewy body, susceptibility to 
1364,Gaucher disease type II 
1365,Gaucher disease type I 
1366,Gaucher disease 
1367,Parkinsonism;Thoracolumbar scoliosis;Resting tremor;Movement disorder;Hypomimic face 
1368,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III 
1369,Gaucher disease perinatal lethal 
1370,Rigidity;Akinesia 
1371,Lewy body dementia 
1372,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome 
1373,Thrombocytopenia;Abnormal bleeding 
1374,Parkinson disease 13, autosomal dominant, susceptibility to 
1375,Hereditary spastic paraplegia 3A 
1376,Neuropathy, hereditary sensory, type 1D;Hereditary spastic paraplegia 3A 
1377,Erythrocytosis, familial, 3 
1378,Retinitis pigmentosa 11 
1379,Desmosterolosis 
1380,Familial cold autoinflammatory syndrome 1 
1381,Cryopyrin associated periodic syndrome 
1382,Familial cold autoinflammatory syndrome 
1383,Familial cold autoinflammatory syndrome 1;Chronic infantile neurological, cutaneous and articular syndrome;Familial amyloid nephropathy with urticaria AND deafness 
1384,Hearing loss, autosomal dominant 34, with or without inflammation 
1385,Familial amyloid nephropathy with urticaria AND deafness 
1386,Chronic infantile neurological, cutaneous and articular syndrome 
1387,Familial cold autoinflammatory syndrome 1;Chronic infantile neurological, cutaneous and articular syndrome;Hearing loss, autosomal dominant 34, with or without inflammation;Familial amyloid nephropathy with urticaria AND deafness;Keratitis fugax hereditaria 
1388,Bartter disease type 4a 
1389,Bartter syndrome 
1390,Sensorineural deafness with mild renal dysfunction 
1391,Capillary infantile hemangioma 
1392,Usher syndrome type 3 
1393,Usher syndrome type 3A 
1394,Retinitis pigmentosa;Usher syndrome type 3A 
1395,Familial type 5 hyperlipoproteinemia 
1396,Infantile-onset ascending hereditary spastic paralysis 
1397,Deafness, without vestibular involvement, autosomal dominant 
1398,Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 
1399,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 
1400,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 
1401,Nephropathic cystinosis 
1402,Ocular cystinosis;Juvenile nephropathic cystinosis;Nephropathic cystinosis 
1403,Cystinosis 
1404,Cystinosis, atypical nephropathic 
1405,Ocular cystinosis 
1406,Juvenile nephropathic cystinosis 
1407,Odonto-onycho-dermal dysplasia 
1408,Odonto-onycho-dermal dysplasia;Tooth agenesis, selective, 4 
1409,SchC6pf-Schulz-Passarge syndrome 
1410,Tooth agenesis, selective, 4 
1411,Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia 
1412,Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia 
1413,WNT10A-Related Disorders 
1414,Ectodermal dysplasia 
1415,Hypohidrotic ectodermal dysplasia 
1416,Tooth agenesis 
1417,Odonto-onycho-dermal dysplasia;Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome 
1418,Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome 
1419,Oligodontia 
1420,Familial chronic mucocutaneous candidiasis 
1421,Aspergillosis, susceptibility to 
1422,Invasive pneumococcal disease, protection against 
1423,Malaria, resistance to 
1424,Mycobacterium tuberculosis, protection against 
1425,Bacteremia, susceptibility 
1426,Pleuropulmonary blastoma 
1427,DICER1 syndrome 
1428,Nanophthalmos 2 
1429,Isolated microphthalmia 5 
1430,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency 
1431,Eichsfeld type congenital muscular dystrophy 
1432,SEPN1-Related Disorders 
1433,Congenital myopathy with fiber type disproportion 
1434,Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy 
1435,Oculocutaneous albinism type 4 
1436,Skin/hair/eye pigmentation, variation in, 5 
1437,Wolfram syndrome 1 
1438,Wolfram syndrome 1;Wolfram-like syndrome 
1439,Autosomal dominant nonsyndromic hearing loss 6 
1440,Wolfram-like syndrome 
1441,Nonsyndromic genetic hearing loss 
1442,WFS1-Related Spectrum Disorders 
1443,Short sleep, familial natural, 1 
1444,Congenital generalized lipodystrophy type 2 
1445,Hereditary spastic paraplegia 17 
1446,Neuronopathy, distal hereditary motor, type 5A 
1447,Neuronopathy, distal hereditary motor, type 5C 
1448,Neuronopathy, distal hereditary motor, type 5A;Hereditary spastic paraplegia 17 
1449,Abnormal central motor function 
1450,Pigmentary pallidal degeneration 
1451,Neurodegeneration with brain iron accumulation 1, atypical 
1452,Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 
1453,Dystonic disorder 
1454,Biotin-responsive basal ganglia disease 
1455,Bardet-Biedl syndrome 2 
1456,Bardet-biedl syndrome 2/6, digenic 
1457,Bardet-Biedl syndrome 2;Retinitis pigmentosa 74 
1458,Bardet-biedl syndrome 2/4, digenic 
1459,Bardet-biedl syndrome 1/2, digenic 
1460,Retinitis pigmentosa 74 
1461,BBS2-Related Disorders 
1462,Arterial tortuosity syndrome 
1463,Familial thoracic aortic aneurysm and aortic dissection 
1464,RAB23-related Carpenter syndrome 
1465,Carpenter syndrome 
1466,Hypouricemia, renal, 2 
1467,Acroerythrokeratoderma 
1468,Hermansky-Pudlak syndrome 3 
1469,Hermansky-Pudlak syndrome 
1470,Lethal congenital contracture syndrome 3 
1471,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 
1472,Mitochondrial disease 
1473,Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic 
1474,Infantile onset spinocerebellar ataxia 
1475,Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 
1476,Atrial septal defect 4 
1477,Cranioectodermal dysplasia 1 
1478,C syndrome 
1479,Aicardi-Goutieres syndrome 4 
1480,Frontorhiny 
1481,Kostmann syndrome 
1482,Charcot-Marie-Tooth disease type 2A1 
1483,Neuroblastoma, susceptibility to, 1 
1484,Neuroblastoma 
1485,Pyruvate dehydrogenase phosphatase deficiency 
1486,Severe combined immunodeficiency due to DCLRE1C deficiency 
1487,Severe combined immunodeficiency due to DCLRE1C deficiency;Histiocytic medullary reticulosis 
1488,Histiocytic medullary reticulosis 
1489,Severe combined immunodeficiency, athabascan-type 
1490,Johanson-Blizzard syndrome 
1491,Chorea-acanthocytosis 
1492,Blau syndrome 
1493,Susceptibility to Yao syndrome 
1494,Inflammatory bowel disease 1;Blau syndrome 
1495,Inflammatory bowel disease 1 
1496,Inflammatory bowel disease 1;Blau syndrome;Susceptibility to Yao syndrome;Psoriatic arthritis, susceptibility to 
1497,Crohn disease 
1498,Blau syndrome;Inflammatory bowel disease 1 
1499,DPM3-CDG 
1500,Microcephalic osteodysplastic primordial dwarfism type II 
1501,Plasma triglyceride level quantitative trait locus 
1502,Megalencephalic leukoencephalopathy with subcortical cysts 1 
1503,Megalencephalic leukoencephalopathy with subcortical cysts 
1504,ALG1-CDG 
1505,Congenital disorder of glycosylation 
1506,Finnish congenital nephrotic syndrome 
1507,Encephalopathy 
1508,Dilated cardiomyopathy 1C 
1509,Familial hypertrophic cardiomyopathy 24 
1510,Myofibrillar myopathy 4 
1511,Left ventricular noncompaction 3 
1512,Breast cancer, early-onset 
1513,Fanconi anemia complementation group J;Familial cancer of breast 
1514,Fanconi anemia complementation group J 
1515,Neoplasm of ovary 
1516,BRIP1-Related Disorders 
1517,Tracheoesophageal fistula;Fanconi anemia complementation group J;Familial cancer of breast 
1518,Fanconi anemia complementation group J;BRIP1-Related Disorders 
1519,Leukocyte adhesion deficiency type II 
1520,Birk-Barel syndrome 
1521,Dimethylglycine dehydrogenase deficiency 
1522,Epidermodysplasia verruciformis, susceptibility to, 2 
1523,Epidermodysplasia verruciformis 
1524,EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1 
1525,Infantile bilateral striatal necrosis 
1526,Hypotonia with lactic acidemia and hyperammonemia 
1527,Mowat-Wilson syndrome 
1528,Imerslund-Grasbeck syndrome type 2 
1529,Imerslund-Grasbeck syndrome 
1530,Hereditary hypercarotenemia and vitamin A deficiency 
1531,Hypercholesterolemia, familial, 4 
1532,Sclerosteosis 1 
1533,Autosomal recessive Dejerine-Sottas syndrome 
1534,Charcot-Marie-Tooth disease type 4F 
1535,Dejerine-Sottas disease 
1536,Neuropathy, hereditary sensory and autonomic, type 1C 
1537,NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE 
1538,Hereditary sensory and autonomic neuropathy type 1 
1539,Neuropathy, hereditary sensory and autonomic, type 1A 
1540,Sensorimotor neuropathy 
1541,Neuropathy, hereditary sensory and autonomic, type IA, severe 
1542,Amyotrophic lateral sclerosis type 8 
1543,Adult-onset proximal spinal muscular atrophy, autosomal dominant 
1544,Adult-onset proximal spinal muscular atrophy, autosomal dominant;Amyotrophic lateral sclerosis type 8 
1545,Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to 
1546,Juvenile amyotrophic lateral sclerosis 
1547,Parkinsonian-pyramidal syndrome 
1548,Pendred syndrome 
1549,Autosomal recessive nonsyndromic hearing loss 4 
1550,Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4 
1551,SLC26A4-Related Disorders 
1552,Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome 
1553,Wolff-Parkinson-White pattern 
1554,Microcephaly, seizures, and developmental delay 
1555,Autosomal recessive nonsyndromic hearing loss 29 
1556,Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1 
1557,Blepharophimosis, ptosis, and epicanthus inversus syndrome 
1558,Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2 
1559,Premature ovarian failure 3 
1560,Testosterone 17-beta-dehydrogenase deficiency 
1561,Pseudohermaphroditism 
1562,Pituitary adenoma predisposition 
1563,Somatotroph adenoma 
1564,Pituitary dependent hypercortisolism 
1565,Dopamine agonists response 
1566,Majeed syndrome 
1567,Myoglobinuria, acute recurrent, autosomal recessive 
1568,Usher syndrome type 1D 
1569,Usher syndrome type 1 
1570,CDH23-Related Disorders 
1571,Pituitary adenoma 5, multiple types;Autosomal recessive nonsyndromic hearing loss 12;Usher syndrome type 1D 
1572,Childhood onset hearing loss 
1573,Autosomal recessive nonsyndromic hearing loss 12 
1574,Usher syndrome type 2A;Autosomal recessive nonsyndromic hearing loss 12 
1575,USHER SYNDROME, TYPE ID/F, DIGENIC 
1576,Usher syndrome type 1F 
1577,Autosomal recessive nonsyndromic hearing loss 23 
1578,Autosomal recessive nonsyndromic hearing loss 23;Usher syndrome type 1D;Usher syndrome type 1F 
1579,Stargardt disease 3 
1580,Autosomal recessive nonsyndromic hearing loss 8 
1581,Osteogenesis imperfecta type 7 
1582,Primary ciliary dyskinesia 9 
1583,Microcephaly 5, primary, autosomal recessive 
1584,Sitosterolemia 
1585,Sitosterolemia 1 
1586,Gallbladder disease 4 
1587,Sitosterolemia 2 
1588,Leber congenital amaurosis 6 
1589,Cone-rod dystrophy 13 
1590,Leber congenital amaurosis 1 
1591,Cone-rod dystrophy 13;Leber congenital amaurosis 6 
1592,Hypoadiponectinemia 
1593,Cerebral infarction, susceptibility to 
1594,Brachyrachia (short spine dysplasia) 
1595,Skeletal dysplasia 
1596,Skeletal dysplasia;Neuromuscular disease 
1597,Charcot-Marie-Tooth disease axonal type 2C 
1598,Spondylometaphyseal dysplasia, Kozlowski type 
1599,Parastremmatic dwarfism 
1600,Metatropic dysplasia 
1601,Autosomal dominant congenital benign spinal muscular atrophy 
1602,Spondyloepimetaphyseal dysplasia, Maroteaux type 
1603,Scapuloperoneal spinal muscular atrophy 
1604,Neuromuscular disease 
1605,Autosomal dominant distal hereditary motor neuropathy 
1606,11 conditions 
1607,TRPV4-related disorders 
1608,Sodium serum level quantitative trait locus 1 
1609,Erythrokeratodermia variabilis et progressiva 2 
1610,46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome 
1611,46,XY sex reversal 7 
1612,Parietal foramina 2 
1613,Frontonasal dysplasia with alopecia and genital anomaly 
1614,Thyroid cancer, nonmedullary, 2 
1615,Autosomal dominant hypophosphatemic rickets 
1616,Tumoral calcinosis, hyperphosphatemic, familial, 1 
1617,Tumoral calcinosis, hyperphosphatemic, familial, 2 
1618,Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 
1619,Giant axonal neuropathy 1 
1620,Glucocorticoid deficiency with achalasia 
1621,Neurodevelopmental disorder 
1622,Spastic paraparesis;Babinski sign;Hyperreflexia 
1623,Periventricular heterotopia with microcephaly, autosomal recessive 
1624,Prostate cancer, hereditary, 2 
1625,Combined oxidative phosphorylation defect type 17 
1626,Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities 
1627,Metabolic syndrome, susceptibility to 
1628,Obesity 
1629,Obesity, age at onset of 
1630,Childhood apraxia of speech 
1631,Macular corneal dystrophy 
1632,Macular corneal dystrophy, type II 
1633,Autosomal dominant optic atrophy classic form 
1634,Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 
1635,Tuberous sclerosis 1 
1636,Tuberous sclerosis syndrome 
1637,Isolated focal cortical dysplasia type II 
1638,Lymphangiomyomatosis 
1639,Focal cortical dysplasia of Taylor type 2B 
1640,Venous thrombosis, susceptibility to 
1641,Sanfilippo syndrome 
1642,Neurodegeneration 
1643,Abnormal circulating carbohydrate concentration 
1644,Charcot-Marie-Tooth disease type 4D 
1645,Hyper-IgM syndrome type 2 
1646,Mucolipidosis type IV 
1647,Usher syndrome type 1C 
1648,Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C 
1649,Autosomal recessive nonsyndromic hearing loss 18A 
1650,Meniere disease 
1651,Autosomal recessive distal renal tubular acidosis 
1652,Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss 
1653,Inherited susceptibility to asthma 
1654,Sick sinus syndrome 2, autosomal dominant 
1655,Brugada syndrome 8 
1656,Dystonia 1, torsion, modifier of 
1657,Early-onset generalized limb-onset dystonia 
1658,Spondylocostal dysostosis 2, autosomal recessive 
1659,Heterotaxy, visceral, 2, autosomal 
1660,Craniometaphyseal dysplasia, autosomal dominant 
1661,Chondrocalcinosis 2 
1662,Diarrhea 3, secretory sodium, congenital, syndromic 
1663,Immunodeficiency due to MASP-2 deficiency 
1664,Congenital heart defects, multiple types, 2 
1665,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 
1666,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 
1667,Osteoarthritis 
1668,Achromatopsia 3 
1669,Achromatopsia 
1670,Severe early-childhood-onset retinal dystrophy 
1671,Amyotrophic lateral sclerosis type 10 
1672,Amyotrophic lateral sclerosis type 10;TARDBP-related frontotemporal dementia 
1673,TARDBP-related frontotemporal dementia;Amyotrophic lateral sclerosis type 10 
1674,FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED 
1675,Mulibrey nanism syndrome 
1676,Keratoconus 1 
1677,Polymorphous corneal dystrophy 
1678,Posterior polymorphous corneal dystrophy 1 
1679,Craniofacial anomalies and anterior segment dysgenesis syndrome 
1680,Familial cylindromatosis 
1681,Familial multiple trichoepitheliomata 
1682,Brooke-Spiegler syndrome 
1683,Familial hemophagocytic lymphohistiocytosis 4 
1684,Netherton syndrome 
1685,SPINK5 POLYMORPHISM 
1686,Hypophosphatemic nephrolithiasis/osteoporosis 2 
1687,Chronic kidney disease 
1688,Hypophosphatemia;Nephrolithiasis 
1689,Spinocerebellar ataxia type 5 
1690,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 
1691,Hermansky-Pudlak syndrome 1 
1692,SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS 
1693,Pigmented nodular adrenocortical disease, primary, 2 
1694,Hypoparathyroidism-retardation-dysmorphism syndrome 
1695,MUTYH-related attenuated familial adenomatous polyposis 
1696,Endometrial carcinoma 
1697,Pilomatrixoma;MUTYH-related attenuated familial adenomatous polyposis;Neoplasm of stomach 
1698,Endometrial cancer 
1699,MUTYH-related attenuated familial adenomatous polyposis;Neoplasm of stomach 
1700,Small intestine carcinoid 
1701,Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 
1702,Ovarian carcinoma 
1703,Colon cancer 
1704,Immunodeficiency, common variable, 2 
1705,Immunoglobulin A deficiency 2 
1706,Common Variable Immune Deficiency, Dominant 
1707,Immunodeficiency, common variable, 1;Immunodeficiency, common variable, 2 
1708,Severe SARS-CoV-2 infection, susceptibility to 
1709,Common variable agammaglobulinemia 
1710,Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2 
1711,Bardet-Biedl syndrome;McKusick-Kaufman syndrome 
1712,McKusick-Kaufman syndrome 
1713,Bardet-Biedl syndrome 6 
1714,Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome 
1715,McKusick-Kaufman syndrome;Bardet-Biedl syndrome 
1716,Congenital malabsorptive diarrhea 4 
1717,Agenesis of the corpus callosum with peripheral neuropathy 
1718,BETA-GLUCOPYRANOSIDE TASTING 
1719,Alcohol dependence, susceptibility to 
1720,RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED 
1721,Birbeck granule deficiency 
1722,Curry-Hall syndrome 
1723,Tumoral calcinosis, hyperphosphatemic, familial, 3 
1724,Triglyceride storage disease with ichthyosis 
1725,Deficiency of isobutyryl-CoA dehydrogenase 
1726,Nephrotic syndrome, type 2 
1727,Nephrotic range proteinuria 
1728,Steroid-resistant nephrotic syndrome 
1729,Idiopathic nephrotic syndrome 
1730,Nephrotic syndrome, type 2, susceptibility to 
1731,Proteinuria 
1732,Spermatogenic failure 4 
1733,Congenital bile acid synthesis defect 2 
1734,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 
1735,Hemochromatosis type 3 
1736,Hemochromatosis, type 1, modifier of 
1737,Mitochondrial DNA depletion syndrome 8a 
1738,RRM2B-related mitochondrial disease 
1739,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 
1740,Mitochondrial DNA depletion syndrome 8B (MNGIE type) 
1741,Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 
1742,Retinitis pigmentosa 38 
1743,Cardiac conduction defect, susceptibility to 
1744,Bilateral microtia-deafness-cleft palate syndrome 
1745,Hemochromatosis type 4 
1746,Focal segmental glomerulosclerosis 1 
1747,Cutis laxa, autosomal recessive, type 1B 
1748,Cutis laxa, autosomal recessive, type 1A 
1749,Obesity, mild, early-onset 
1750,Neuronopathy, distal hereditary motor, type 2C 
1751,Epilepsy, familial temporal lobe, 1 
1752,Autosomal dominant epilepsy with auditory features 
1753,Congenital isolated adrenocorticotropic hormone deficiency 
1754,Werner syndrome 
1755,Bloom syndrome 
1756,Autosomal recessive osteopetrosis 1 
1757,Spinocerebellar ataxia type 28 
1758,Macular degeneration, age-related, 3 
1759,Cutis laxa 
1760,Exudative vitreoretinopathy, digenic 
1761,Exudative vitreoretinopathy 1 
1762,Retinopathy of prematurity 
1763,Autism, susceptibility to, 15 
1764,Cortical dysplasia-focal epilepsy syndrome 
1765,Congenital disorder of glycosylation type 1C 
1766,Ehlers-Danlos syndrome, dermatosparaxis type 
1767,Retinitis pigmentosa 46 
1768,Achondrogenesis, type IA 
1769,Goldblatt syndrome 
1770,Charlevoix-Saguenay spastic ataxia 
1771,Alpha-methylacyl-CoA racemase deficiency 
1772,Congenital bile acid synthesis defect 4 
1773,Autosomal recessive limb-girdle muscular dystrophy type 2G 
1774,Hypertrophic cardiomyopathy 25 
1775,Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy 
1776,Hypertrophic cardiomyopathy 4 
1777,Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25 
1778,Enhanced S-cone syndrome 
1779,NR2E3-Related Disorders 
1780,Retinitis pigmentosa 37;Enhanced S-cone syndrome 
1781,Goldmann-Favre syndrome 
1782,NR2E3-Related Disorders;Enhanced S-cone syndrome 
1783,Retinitis pigmentosa 37 
1784,Asthma-related traits, susceptibility to, 5 
1785,Mycobacterium tuberculosis, susceptibility to 
1786,Hepatic veno-occlusive disease-immunodeficiency syndrome 
1787,Periodic paralysis 
1788,Ventricular fibrillation;Syncope 
1789,Brugada syndrome 6 
1790,Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 
1791,Autosomal dominant nonsyndromic hearing loss 3B 
1792,Hidrotic ectodermal dysplasia syndrome 
1793,Autosomal recessive nonsyndromic hearing loss 1B;Hidrotic ectodermal dysplasia syndrome;Autosomal dominant nonsyndromic hearing loss 3B;Autosomal recessive nonsyndromic hearing loss 1A 
1794,Autosomal recessive nonsyndromic hearing loss 1B;Hidrotic ectodermal dysplasia syndrome;Autosomal dominant nonsyndromic hearing loss 3B;X-linked mixed hearing loss with perilymphatic gusher;Autosomal recessive nonsyndromic hearing loss 1A 
1795,Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1A;Autosomal dominant nonsyndromic hearing loss 3B;Autosomal recessive nonsyndromic hearing loss 1B 
1796,Autosomal recessive omodysplasia 
1797,GM3 synthase deficiency 
1798,Colorectal cancer, hereditary nonpolyposis, type 7 
1799,Leber congenital amaurosis 4 
1800,AIPL1-Related Disorders 
1801,Trichorhinophalangeal dysplasia type I 
1802,Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III 
1803,Trichorhinophalangeal syndrome, type III 
1804,Familial benign pemphigus 
1805,Prostate cancer, susceptibility to 
1806,Li-Fraumeni syndrome 2 
1807,Cancer of multiple types, susceptibility to 
1808,Breast and colorectal cancer, susceptibility to 
1809,Gastrointestinal carcinoma;Adrenal cortex carcinoma 
1810,Colon cancer, susceptibility to;Breast cancer, susceptibility to 
1811,CHEK2-Related Cancer Susceptibility 
1812,Familial cancer of breast;Li-Fraumeni syndrome 2;Malignant tumor of prostate;Bone osteosarcoma 
1813,Predisposition to cancer 
1814,Li-Fraumeni syndrome 
1815,Bone osteosarcoma 
1816,Prostate cancer, somatic 
1817,Malignant tumor of prostate;Bone osteosarcoma;Li-Fraumeni syndrome 2;Familial cancer of breast 
1818,CHEK2-related cancer risk 
1819,Retinitis pigmentosa 41 
1820,Stargardt disease 4 
1821,Retinal macular dystrophy type 2 
1822,Cone-rod dystrophy 12 
1823,Ehlers-Danlos syndrome progeroid type 
1824,Larsen-like syndrome, B3GAT3 type 
1825,Lethal skeletal dysplasia 
1826,Salla disease 
1827,Sialic acid storage disease, severe infantile type;Salla disease 
1828,Sialic acid storage disease, severe infantile type 
1829,Dyskeratosis congenita, autosomal dominant 3 
1830,Dyskeratosis congenita, autosomal dominant 1 
1831,Revesz syndrome 
1832,Dyskeratosis congenita 
1833,Deficiency of galactokinase 
1834,Hereditary cerebral amyloid angiopathy, Icelandic type 
1835,Age related macular degeneration 11 
1836,Primary hyperoxaluria, type II 
1837,Primary hyperoxaluria 
1838,Non-Hodgkin lymphoma 
1839,Primary hyperoxaluria, type I 
1840,Nephrolithiasis;Nephrocalcinosis 
1841,Hereditary spastic paraplegia 4 
1842,Spastic paraparesis 
1843,Tics 
1844,Spastic paraplegia 4, modifier of 
1845,Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 
1846,Myopia 6 
1847,Severe global developmental delay;Seizure 
1848,Cenani-Lenz syndactyly syndrome 
1849,Growth hormone insensitivity with immune dysregulation 1, autosomal recessive 
1850,Focal segmental glomerulosclerosis 3 
1851,Cold-induced sweating syndrome 1 
1852,PULMONARY ALVEOLAR MICROLITHIASIS 
1853,Cerebral cavernous malformation 1 
1854,Cerebral cavernous malformation 
1855,Retinitis pigmentosa 12 
1856,CRB1-Related Disorders 
1857,Retinitis pigmentosa 12;Leber congenital amaurosis 8 
1858,Leber congenital amaurosis 8 
1859,CRB1-related maculopathy 
1860,Pigmented paravenous retinochoroidal atrophy 
1861,Early-onset retinal dystrophy 
1862,Ichthyosis prematurity syndrome 
1863,SLC22A4 POLYMORPHISM 
1864,Diamond-Blackfan anemia 7 
1865,Diamond-Blackfan anemia 
1866,Hypogonadotropic hypogonadism 8 without anosmia 
1867,Centra precocious puberty 1 
1868,Hyperekplexia 3 
1869,Myoclonic dystonia 11 
1870,Cystinuria 
1871,Upshaw-Schulman syndrome 
1872,Bilateral frontoparietal polymicrogyria 
1873,Myofibrillar myopathy 3 
1874,Progressive proximal muscle weakness;Progressive distal muscle weakness 
1875,Myofibrillar myopathy 
1876,Spheroid body myopathy 
1877,Congenital stationary night blindness 1B 
1878,Congenital stationary night blindness 
1879,Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive 
1880,Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant 
1881,Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b 
1882,Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant 
1883,Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive 
1884,Non-syndromic oligodontia 
1885,Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome 
1886,Hair morphology 1, hair thickness 
1887,Hypohidrotic Ectodermal Dysplasia, Dominant 
1888,Bradyopsia 
1889,Amyotrophic neuralgia 
1890,MPDU1-CDG 
1891,Nijmegen breakage syndrome-like disorder 
1892,Wolcott-Rallison dysplasia 
1893,Oligodontia-cancer predisposition syndrome 
1894,Long QT syndrome 11 
1895,Xeroderma pigmentosum variant type 
1896,Hyperkalemic periodic paralysis 
1897,Paramyotonia congenita/hyperkalemic periodic paralysis 
1898,Paramyotonia congenita of Von Eulenburg 
1899,Hypokalemic periodic paralysis, type 1 
1900,Rhabdomyolysis 
1901,Delayed gross motor development 
1902,SCN4A-related non-dystrophic myotonia 
1903,Focal-onset seizure 
1904,Paramyotonia congenita/myotonia congenita 
1905,Myotonia fluctuans 
1906,Normokalemic periodic paralysis, potassium-sensitive 
1907,Potassium-aggravated myotonia 
1908,Hypokalemic periodic paralysis, type 2 
1909,Myotonia congenita, atypical, acetazolamide-responsive 
1910,Hyperkalemic periodic paralysis;Potassium-aggravated myotonia;Paramyotonia congenita of Von Eulenburg;Hypokalemic periodic paralysis, type 2 
1911,SCN4A-related disorder 
1912,Congenital myasthenic syndrome 16 
1913,Congenital myasthenic syndrome 
1914,Myotonia permanens 
1915,Primary hypomagnesemia 
1916,Hypercalciuria, childhood, self-limiting 
1917,Hypertension, diastolic, resistance to 
1918,Glycogen storage disease XV 
1919,Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness 
1920,Retinitis pigmentosa 1 
1921,Hyperekplexia 
1922,Hyperekplexia 1 
1923,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C 
1924,Venous thromboembolism, susceptibility to 
1925,FACTOR VII-ACTIVATING PROTEASE MARBURG I POLYMORPHISM 
1926,THYROID CANCER, NONMEDULLARY, 5, SUSCEPTIBILITY TO 
1927,Factor VII Marburg I Variant Thrombophilia 
1928,Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 
1929,ABri amyloidosis 
1930,Myofibrillar myopathy 6 
1931,Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6 
1932,Griscelli syndrome type 2 
1933,Multisystem inflammatory syndrome in children 
1934,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome 
1935,Citrullinemia type II 
1936,Neonatal intrahepatic cholestasis due to citrin deficiency 
1937,Citrin deficiency 
1938,Citrullinemia 
1939,Neuroblastoma, susceptibility to, 2 
1940,Haddad syndrome 
1941,Hirschsprung disease-ganglioneuroblastoma syndrome 
1942,Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 
1943,Mitochondrial complex 1 deficiency, nuclear type 9 
1944,Mitochondrial complex 1 deficiency, nuclear type 8 
1945,Sialuria 
1946,Sialuria;GNE myopathy 
1947,GNE myopathy 
1948,GNE myopathy;Sialuria 
1949,Acral peeling skin syndrome 
1950,Spondyloepiphyseal dysplasia with congenital joint dislocations 
1951,Long QT syndrome 6, acquired, susceptibility to 
1952,Long QT syndrome 6 
1953,Atrial fibrillation, familial, 4 
1954,KCNE2-Related Disorders 
1955,Atrial fibrillation, familial, 4;Long QT syndrome 6 
1956,Long QT syndrome 3/6, digenic 
1957,Charcot-Marie-Tooth disease type 1C 
1958,Rothmund-Thomson syndrome 
1959,Baller-Gerold syndrome 
1960,Baller-Gerold syndrome;Rothmund-Thomson syndrome;Rapadilino syndrome 
1961,Rothmund-Thomson syndrome type 2 
1962,Baller-Gerold syndrome;Rothmund-Thomson syndrome type 2;Rapadilino syndrome 
1963,Rapadilino syndrome 
1964,Parkinson Disease, Dominant/Recessive 
1965,Amelogenesis imperfecta type 2A1 
1966,Hyalinosis, Segmental Glomerular 
1967,Steroid-resistant nephrotic syndrome;Focal segmental glomerulosclerosis 
1968,Glomerulonephritis 
1969,Sickled erythrocytes;Focal segmental glomerulosclerosis 
1970,Focal segmental glomerulosclerosis 
1971,Autosomal recessive congenital ichthyosis 2 
1972,Familial dysautonomia 
1973,Hypoparathyroidism, familial isolated, 2 
1974,Holoprosencephaly 2 
1975,Hereditary spastic paraplegia 5A 
1976,Congenital bile acid synthesis defect 3 
1977,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 
1978,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A 
1979,Diamond-Blackfan anemia 10 
1980,Tetralogy of Fallot 
1981,46,XY sex reversal 9 
1982,Double outlet right ventricle 
1983,Diaphragmatic hernia 3 
1984,46,XY sex reversal 3 
1985,Hereditary spastic paraplegia 42 
1986,Autosomal recessive nonsyndromic hearing loss 9 
1987,Auditory neuropathy, autosomal recessive, 1 
1988,Gorlin syndrome 
1989,Developmental and epileptic encephalopathy, 39 
1990,Focal segmental glomerulosclerosis 2 
1991,Bardet-Biedl syndrome 5 
1992,Mitochondrial complex III deficiency nuclear type 1 
1993,GRACILE syndrome 
1994,GRACILE syndrome;Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;Leigh syndrome 
1995,BCS1L-Related Disorders 
1996,Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome;Leigh syndrome 
1997,Pili torti-deafness syndrome 
1998,Bjornstad syndrome with mild mitochondrial complex III deficiency 
1999,Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 
2000,Mitochondrial complex 4 deficiency, nuclear type 4 
2001,Diamond-Blackfan anemia 6 
2002,Diamond-Blackfan anemia 9 
2003,Charcot-Marie-Tooth disease dominant intermediate C 
2004,Colon adenocarcinoma 
2005,Ductal breast carcinoma 
2006,Infantile neuroaxonal dystrophy 
2007,Iron accumulation in brain 
2008,Autosomal recessive Parkinson disease 14;Neurodegeneration with brain iron accumulation 2B;Infantile neuroaxonal dystrophy 
2009,PLA2G6-associated neurodegeneration 
2010,Autism;Seizure 
2011,Neurodegeneration with brain iron accumulation 2B 
2012,Neurodegeneration with brain iron accumulation 
2013,Developmental regression;Congenital cerebellar hypoplasia;Cerebellar ataxia;Global developmental delay;Microcephaly 
2014,Autosomal recessive Parkinson disease 14 
2015,Karak syndrome 
2016,Infantile neuroaxonal dystrophy;Autosomal recessive Parkinson disease 14;Neurodegeneration with brain iron accumulation 2B 
2017,Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B 
2018,Lysinuric protein intolerance 
2019,Muscular dystrophy-dystroglycanopathy type B6 
2020,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 
2021,Congenital stationary night blindness 1C 
2022,Charcot-Marie-Tooth disease type 4B1 
2023,Autosomal dominant nonsyndromic hearing loss 2A 
2024,Male germ cell tumor, somatic 
2025,Coronary artery disease, autosomal dominant 2 
2026,Osteoporosis with pseudoglioma 
2027,Increased bone mineral density 
2028,High bone mass 
2029,Autosomal dominant osteopetrosis 1 
2030,Worth disease 
2031,Exudative vitreoretinopathy 4, autosomal recessive 
2032,Exudative vitreoretinopathy 4, autosomal dominant 
2033,Exudative vitreoretinopathy 4, digenic 
2034,Congenital disorder of glycosylation type 1E 
2035,Autosomal recessive osteopetrosis 7 
2036,Infertility associated with multi-tailed spermatozoa and excessive DNA 
2037,Mullerian aplasia and hyperandrogenism 
2038,SERKAL syndrome 
2039,Lumbar disc disease, susceptibility to 
2040,Diamond-Blackfan anemia 1 
2041,Citrullinemia type I 
2042,Citrullinemia, mild 
2043,Fanconi anemia complementation group F 
2044,Advanced sleep phase syndrome 1 
2045,Dystonia 16 
2046,Primary erythromelalgia 
2047,Abnormality of pain sensation;Acute episodes of neuropathic symptoms 
2048,Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A 
2049,SCN9A-related peripheral neuropathies associated with increased pain 
2050,Channelopathy-associated congenital insensitivity to pain, autosomal recessive 
2051,Paroxysmal extreme pain disorder 
2052,Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7 
2053,Generalized epilepsy with febrile seizures plus, type 7 
2054,Channelopathy-associated congenital insensitivity to pain, autosomal recessive;Neuropathy, hereditary sensory and autonomic, type 2A;Paroxysmal extreme pain disorder;Primary erythromelalgia 
2055,Hypoglycemia;Seizure;Global developmental delay 
2056,Febrile seizures, familial, 3b 
2057,Inherited Erythromelalgia 
2058,Hermansky-Pudlak syndrome 2 
2059,Progressive pseudorheumatoid dysplasia 
2060,Pigmented nodular adrenocortical disease, primary, 3 
2061,Intellectual disability, autosomal dominant 5 
2062,Spondylocarpotarsal synostosis syndrome 
2063,Larsen syndrome 
2064,Atelosteogenesis type I 
2065,Atelosteogenesis type III 
2066,Boomerang dysplasia 
2067,Renal carnitine transport defect 
2068,Decreased plasma carnitine 
2069,THYROTROPIN RECEPTOR POLYMORPHISM 
2070,Hypothyroidism due to TSH receptor mutations 
2071,Familial hyperthyroidism due to mutations in TSH receptor 
2072,Thyroid adenoma, hyperfunctioning 
2073,THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC 
2074,autistic features;Developmental delay;Epilepsy 
2075,Familial gestational hyperthyroidism 
2076,Lethal congenital contracture syndrome 1 
2077,Lethal arthrogryposis-anterior horn cell disease syndrome 
2078,Lethal congenital contractural syndrome Finnish type 
2079,Peroxisome biogenesis disorder 8A (Zellweger) 
2080,Erythrocytosis, familial, 4 
2081,Autosomal recessive proximal renal tubular acidosis 
2082,Primary ciliary dyskinesia 7 
2083,CILIARY DYSKINESIA, PRIMARY, 7, WITH SITUS INVERSUS 
2084,Primary ciliary dyskinesia 3 
2085,Erythrokeratodermia variabilis et progressiva 1 
2086,Autosomal dominant nonsyndromic hearing loss 2B 
2087,Deafness, digenic, GJB2/GJB3 
2088,Maturity-onset diabetes of the young type 7 
2089,Monogenic diabetes 
2090,Asphyxiating thoracic dystrophy 3 
2091,Jeune thoracic dystrophy 
2092,Short rib-polydactyly syndrome 
2093,Bowing of the long bones;Fetal growth restriction;Narrow chest 
2094,DYNC2H1-Related Disorders 
2095,Pulmonary hypertension, primary, 2 
2096,Cornea plana 2 
2097,Pyridoxal phosphate-responsive seizures 
2098,Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 
2099,TP63-Related Spectrum Disorders 
2100,Split hand-foot malformation 4 
2101,Rapp-Hodgkin ectodermal dysplasia syndrome 
2102,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome 
2103,ADULT syndrome 
2104,Orofacial cleft 8 
2105,Rhabdoid tumor predisposition syndrome 2 
2106,Brachydactyly type A2 
2107,Pseudoxanthoma elasticum 
2108,Arterial calcification, generalized, of infancy, 2 
2109,Papule;Cutis laxa 
2110,Arterial calcification, generalized, of infancy, 2;Pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste 
2111,Pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2 
2112,Abnormality of the eye 
2113,Pseudoxanthoma elasticum, forme fruste 
2114,Cataract 12 multiple types 
2115,Snowflake vitreoretinal degeneration 
2116,Congenital lactase deficiency 
2117,Progressive familial intrahepatic cholestasis type 2 
2118,Benign recurrent intrahepatic cholestasis type 2 
2119,Progressive familial intrahepatic cholestasis 
2120,Cholestasis, intrahepatic, of pregnancy, 3 
2121,Bare lymphocyte syndrome, type II, complementation group B 
2122,MHC class II deficiency 
2123,Hereditary spastic paraplegia 39 
2124,Ataxia-hypogonadism-choroidal dystrophy syndrome 
2125,Autosomal dominant nonsyndromic hearing loss 9 
2126,Methylmalonate semialdehyde dehydrogenase deficiency 
2127,Lung carcinoma 
2128,Anaphylotoxin inactivator deficiency 
2129,Congenital generalized lipodystrophy type 1 
2130,Colon cancer, susceptibility to 
2131,Bone fragility with contractures, arterial rupture, and deafness 
2132,Rhizomelic chondrodysplasia punctata type 3 
2133,Congenital myasthenic syndrome 5 
2134,Myasthenic syndrome, slow-channel congenital 
2135,Legionnaire disease, susceptibility to 
2136,Systemic lupus erythematosus, resistance to, 1 
2137,Melioidosis, resistance to 
2138,TLR4 POLYMORPHISM 
2139,Pericementitis 
2140,Herpes simplex encephalitis, susceptibility to, 2 
2141,Leprosy, susceptibility to, 3 
2142,Miyoshi muscular dystrophy 1 
2143,Qualitative or quantitative defects of dysferlin 
2144,Autosomal recessive limb-girdle muscular dystrophy type 2B 
2145,DYSF-Related Disorders 
2146,Distal myopathy with anterior tibial onset 
2147,Distal myopathy with anterior tibial onset;Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1 
2148,Spondyloepimetaphyseal dysplasia, PAPSS2 type 
2149,Autosomal recessive brachyolmia 
2150,Imerslund-Grasbeck syndrome type 1 
2151,Tarsal-carpal coalition syndrome 
2152,Proximal symphalangism 1A 
2153,Symphalangism-brachydactyly syndrome 
2154,Brachydactyly type B2 
2155,Stapes ankylosis with broad thumbs and toes 
2156,Mitochondrial complex 1 deficiency, nuclear type 6 
2157,Fanconi anemia complementation group G 
2158,Bile acid conjugation defect 1 
2159,FAAH POLYMORPHISM 
2160,Developmental and epileptic encephalopathy, 4 
2161,Infantile epilepsy syndrome 
2162,Glycerol release during exercise, defective 
2163,Immunodeficiency-centromeric instability-facial anomalies syndrome 1 
2164,Non-obstructive azoospermia 
2165,Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency 
2166,Congenital heart defects, multiple types, 6 
2167,Right atrial isomerism 
2168,Progressive myoclonic epilepsy type 8 
2169,Pseudo-TORCH syndrome 1 
2170,Arrhythmogenic right ventricular dysplasia 9 
2171,Mosaic variegated aneuploidy syndrome 1 
2172,Premature chromatid separation trait 
2173,Peroxisome biogenesis disorder 6B 
2174,Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B 
2175,Peroxisome biogenesis disorder, complementation group 7 
2176,Smith-Lemli-Opitz syndrome 
2177,Abnormality of brain morphology 
2178,Microcephaly 
2179,Febrile seizures, familial, 4 
2180,Usher syndrome type 2C;Febrile seizures, familial, 4 
2181,Hereditary spastic paraplegia 10 
2182,Hereditary spastic paraplegia 7 
2183,Proximal spinal muscular atrophy 
2184,Noonan syndrome-like disorder with loose anagen hair 1 
2185,RASopathy 
2186,Noonan syndrome 
2187,Noonan syndrome-like disorder with loose anagen hair 
2188,Fanconi anemia complementation group O 
2189,Breast-ovarian cancer, familial, susceptibility to, 3 
2190,Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3 
2191,46,XY sex reversal 5 
2192,Spondylocostal dysostosis 1, autosomal recessive 
2193,Ectodermal dysplasia 4, hair/nail type 
2194,Beaded hair 
2195,Fibrosis of extraocular muscles, congenital, 2 
2196,Rhizomelic chondrodysplasia punctata type 2 
2197,Hypertrophic cardiomyopathy 6 
2198,Primary familial hypertrophic cardiomyopathy 
2199,Lethal congenital glycogen storage disease of heart 
2200,Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome 
2201,Wolff-Parkinson-White syndrome, childhood-onset 
2202,ALDH9A1*2 POLYMORPHISM 
2203,Heterotaxy, visceral, 4, autosomal 
2204,Autosomal recessive osteopetrosis 4 
2205,Autosomal dominant osteopetrosis 2 
2206,Congenital nephrotic syndrome 
2207,Cone-rod dystrophy 9 
2208,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 
2209,Paragangliomas 1 
2210,Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss 
2211,Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome 
2212,Cowden syndrome 3 
2213,Carney-Stratakis syndrome 
2214,Mitochondrial complex 2 deficiency, nuclear type 3 
2215,Paragangliomas 1 with sensorineural hearing loss 
2216,Paragangliomas 1;Mitochondrial complex II deficiency, nuclear type 1;Pheochromocytoma;Carney-Stratakis syndrome 
2217,Mitochondrial complex II deficiency, nuclear type 1 
2218,Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas 1 
2219,Carcinoid tumor of intestine 
2220,Carotid body paraganglioma 
2221,Paragangliomas 1;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome 
2222,Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss 
2223,Lymphoma, somatic 
2224,Glucose-6-phosphate transport defect 
2225,Phosphate transport defect 
2226,Glycogen storage disease, type I 
2227,Cataract 11 multiple types 
2228,Microcephaly, normal intelligence and immunodeficiency 
2229,Leukemia, acute lymphoblastic, susceptibility to 
2230,Aplastic anemia 
2231,Acute lymphoid leukemia 
2232,Autosomal recessive nonsyndromic hearing loss 3 
2233,Deafness, with smith-magenis syndrome 
2234,Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement 
2235,Complex cortical dysplasia with other brain malformations 1 
2236,TUBB3-Releated Disorders 
2237,Hyperphosphatasemia with bone disease 
2238,Autosomal recessive osteopetrosis 2 
2239,Rhabdomyosarcoma, somatic 
2240,Holoprosencephaly 4 
2241,Bamforth-Lazarus syndrome 
2242,Hypothyroidism, thyroidal, with spiky hair and cleft palate 
2243,MGAT2-CDG 
2244,Myocardial infarction, susceptibility to 
2245,Myocardial infarction 1 
2246,Hypotrichosis 2 
2247,Spondylocostal dysostosis 3, autosomal recessive 
2248,Nail-patella syndrome 
2249,Autosomal dominant nonsyndromic hearing loss 12 
2250,Down syndrome, susceptibility to 
2251,Neural tube defects, folate-sensitive, susceptibility to 
2252,Disorders of Intracellular Cobalamin Metabolism 
2253,Methylcobalamin deficiency type cblE 
2254,Autosomal recessive juvenile Parkinson disease 2 
2255,Autosomal recessive juvenile Parkinson disease 2;Lung carcinoma;Neoplasm of ovary;Leprosy, susceptibility to, 2 
2256,Warburg micro syndrome 1 
2257,Autosomal recessive early-onset Parkinson disease 7 
2258,Lissencephaly due to TUBA1A mutation 
2259,Tubulinopathies 
2260,Lissencephaly 
2261,Tubulinopathy-associated dysgyria 
2262,Autosomal dominant nonsyndromic hearing loss 15 
2263,Colorectal cancer with chromosomal instability, somatic 
2264,PARAOXONASE 2 POLYMORPHISM 
2265,Familial encephalopathy with neuroserpin inclusion bodies 
2266,Cataract 5 multiple types 
2267,Glaucoma 1, open angle, E 
2268,Amyotrophic lateral sclerosis type 12 
2269,Primary open angle glaucoma 
2270,Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma;Glaucoma 1, open angle, E 
2271,Glaucoma, normal tension, susceptibility to 
2272,Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma 
2273,Vesicoureteral reflux 2 
2274,Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation 
2275,CFTR-related disorders 
2276,ivacaftor response - Efficacy 
2277,Cystic fibrosis;CFTR-related disorders 
2278,Hereditary pancreatitis 
2279,Congenital bilateral aplasia of vas deferens from CFTR mutation 
2280,Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis 
2281,Obstructive azoospermia 
2282,Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation 
2283,CFTR-related disorders;Cystic fibrosis 
2284,Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis 
2285,Bronchiectasis with or without elevated sweat chloride 1;Hereditary pancreatitis;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation 
2286,Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1 
2287,Chronic sinusitis 
2288,Lung disease, non-specific 
2289,Sweat chloride elevation without cystic fibrosis 
2290,Pancreatitis, idiopathic, susceptibility to 
2291,Hypertrypsinemia, neonatal, susceptibility to 
2292,Pancreatitis 
2293,Paragangliomas 3 
2294,Paragangliomas 3;Gastrointestinal stromal tumor 
2295,Diamond-Blackfan anemia 3 
2296,BLEOMYCIN HYDROLASE POLYMORPHISM 
2297,Distichiasis-lymphedema syndrome 
2298,Progressive familial intrahepatic cholestasis type 1 
2299,Benign recurrent intrahepatic cholestasis type 1 
2300,Cholestasis, intrahepatic, of pregnancy, 1 
2301,Familial intrahepatic cholestasis type 1 
2302,Combined oxidative phosphorylation defect type 4 
2303,Charcot-Marie-Tooth disease, dominant intermediate b, with neutropenia 
2304,Autosomal dominant centronuclear myopathy 
2305,Centronuclear myopathy 
2306,Charcot-Marie-Tooth disease dominant intermediate B 
2307,Autosomal dominant Charcot-Marie-Tooth disease type 2M 
2308,Severe X-linked myotubular myopathy 
2309,Hepatitis B virus, susceptibility to 
2310,Immunodeficiency 45 
2311,Papillon-Lef√®vre syndrome 
2312,Haim-Munk syndrome;Papillon-Lef√®vre syndrome;Periodontitis, aggressive 1 
2313,Haim-Munk syndrome 
2314,Periodontitis, aggressive 1 
2315,Arginine:glycine amidinotransferase deficiency 
2316,Narcolepsy 1 
2317,Brachydactyly type B1 
2318,Autosomal recessive Robinow syndrome 
2319,Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly 
2320,Leanness, inherited 
2321,Obesity, late-onset 
2322,Alopecia universalis congenita 
2323,Atrichia with papular lesions 
2324,Charcot-Marie-Tooth disease type 2B 
2325,Sarcotubular myopathy 
2326,Bardet-Biedl syndrome 11 
2327,Lathosterolosis 
2328,Retinitis pigmentosa 14 
2329,Oculopharyngeal muscular dystrophy 
2330,Retinitis pigmentosa 48 
2331,Pitt-Hopkins syndrome 
2332,Severe intellectual deficiency 
2333,Corneal dystrophy, Fuchs endothelial, 3;Pitt-Hopkins syndrome 
2334,Action myoclonus-renal failure syndrome 
2335,Seizures, benign familial neonatal, 1 
2336,Developmental and epileptic encephalopathy, 7 
2337,Seizures, benign familial neonatal, 1, and/or myokymia 
2338,Seizures, benign familial neonatal, 2 
2339,Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1 
2340,Waardenburg syndrome type 4C 
2341,Waardenburg syndrome type 2E, without neurologic involvement 
2342,PCWH syndrome 
2343,Waardenburg syndrome type 2E, with neurologic involvement 
2344,Cone-rod dystrophy 2 
2345,Cone-rod dystrophy 2;Leber congenital amaurosis 7 
2346,Leber congenital amaurosis 7;Cone-rod dystrophy 2 
2347,Leber congenital amaurosis 7 
2348,Townes-Brocks syndrome 1 
2349,Townes syndrome 
2350,Townes-Brocks-branchiootorenal-like syndrome 
2351,Peutz-Jeghers syndrome 
2352,Malignant tumor of testis 
2353,Melanoma, cutaneous malignant, susceptibility to, 1 
2354,Melanoma 
2355,EAST syndrome 
2356,Bilateral sensorineural hearing impairment;Renal tubular dysfunction;Spastic diplegia;Microcephaly;Cerebellar ataxia 
2357,Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4;EAST syndrome 
2358,KCNJ10-Related Disorders 
2359,Lipid proteinosis 
2360,Neuronopathy, distal hereditary motor, type 2B 
2361,Charcot-Marie-Tooth disease axonal type 2F 
2362,HSPB1-related axonal neuropathies 
2363,CARASIL syndrome 
2364,HTRA1-related cerebral small vessel disease 
2365,Personality changes;Cognitive impairment;Seizure 
2366,Small vessel cerebrovascular disease 
2367,Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 
2368,Pyogenic bacterial infections due to MyD88 deficiency 
2369,Pontocerebellar hypoplasia type 1A 
2370,Multiple congenital anomalies 
2371,Congenital pontocerebellar hypoplasia type 1 
2372,Autosomal recessive nonsyndromic hearing loss 35 
2373,Clubfoot 
2374,Short stature-pituitary and cerebellar defects-small sella turcica syndrome 
2375,Mitochondrial complex 1 deficiency, nuclear type 2 
2376,Peroxisome biogenesis disorder 1A (Zellweger) 
2377,Peroxisome biogenesis disorder 1B 
2378,Heimler syndrome 1 
2379,Peroxisome biogenesis disorder 1A (Zellweger);Peroxisome biogenesis disorder 1B;Heimler syndrome 1 
2380,Peroxisomal disorder 
2381,Peroxisome biogenesis disorder 1A (Zellweger);Peroxisome biogenesis disorder 1B 
2382,Zellweger spectrum disorders 
2383,Heimler syndrome 1;Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger) 
2384,Mitochondrial complex 4 deficiency, nuclear type 3 
2385,Congenital absence of salivary gland 
2386,Levy-Hollister syndrome 
2387,Kabuki syndrome 1 
2388,Kabuki syndrome 
2389,Multiple epiphyseal dysplasia type 5 
2390,Multiple epiphyseal dysplasia 
2391,Osteoarthritis susceptibility 2 
2392,Spondyloepimetaphyseal dysplasia, matrilin-3 type 
2393,Fibrous dysplasia of jaw 
2394,Glaucoma 3, primary congenital, D 
2395,Microspherophakia 
2396,Brachyolmia-amelogenesis imperfecta syndrome 
2397,Conotruncal anomaly face syndrome 
2398,DiGeorge syndrome 
2399,Velocardiofacial syndrome 
2400,Neutrophil immunodeficiency syndrome 
2401,Obesity, severe, and type II diabetes 
2402,UCP3 POLYMORPHISM G/A 
2403,Refsum disease, adult, 1 
2404,Phytanic acid storage disease 
2405,Bartter disease type 4B 
2406,Bartter disease type 3 
2407,Bartter disease type 3;Bartter disease type 4B 
2408,Bartter syndrome, type 3, with hypocalciuria 
2409,Clear cell carcinoma of kidney 
2410,Epidermolysis bullosa simplex due to plakophilin deficiency 
2411,Epilepsy, juvenile myoclonic 6 
2412,Episodic ataxia type 5 
2413,Epilepsy, idiopathic generalized, susceptibility to, 9 
2414,Idiopathic generalized epilepsy 
2415,Alagille syndrome due to a JAG1 point mutation 
2416,Tetralogy of Fallot;Deafness, congenital heart defects, and posterior embryotoxon;Alagille syndrome due to a JAG1 point mutation 
2417,Deafness, congenital heart defects, and posterior embryotoxon 
2418,Split hand-foot malformation 6 
2419,Short stature due to growth hormone secretagogue receptor deficiency 
2420,Isolated microphthalmia 3 
2421,Left-right axis malformations 
2422,Bruck syndrome 2 
2423,Bare lymphocyte syndrome, type II, complementation group c 
2424,Bare lymphocyte syndrome type 2, complementation group E 
2425,Bare Lymphocyte Syndrome, Type II, Complementation Group D 
2426,Bifunctional peroxisomal enzyme deficiency 
2427,Perrault syndrome;Bifunctional peroxisomal enzyme deficiency 
2428,HSD17B4-Related Disorders 
2429,Perrault syndrome 1 
2430,Bifunctional peroxisomal enzyme deficiency;Perrault syndrome 1 
2431,Bifunctional peroxisomal enzyme deficiency;Perrault syndrome 
2432,Pseudohypoaldosteronism type 2B 
2433,Familial thyroid dyshormonogenesis 1 
2434,Congenital hypothyroidism 
2435,DNA ligase IV deficiency 
2436,DNA ligase IV deficiency;Multiple myeloma 
2437,Multiple myeloma, resistance to 
2438,Mitochondrial complex 1 deficiency, nuclear type 3 
2439,Renal hypomagnesemia 2 
2440,Septo-optic dysplasia sequence 
2441,Septooptic dysplasia, mild 
2442,Growth hormone deficiency with pituitary anomalies 
2443,Septo-optic dysplasia sequence;Growth hormone deficiency with pituitary anomalies 
2444,Pituitary hormone deficiency, combined 5 
2445,Peroxisome biogenesis disorder 13A (Zellweger) 
2446,Peroxisome biogenesis disorder 11A (Zellweger) 
2447,Peroxisome biogenesis disorder 11B 
2448,PMM2-CDG 
2449,Muscular dystrophy;Cerebellar ataxia;Congenital cerebellar hypoplasia;Diabetes mellitus 
2450,Cerebellar ataxia 
2451,Congenital disorder of glycosylation type I 
2452,Glaucoma 3A 
2453,Glaucoma 3, primary infantile, B;Glaucoma 3A;Anterior segment dysgenesis 6 
2454,Congenital glaucoma 
2455,Anterior segment dysgenesis 6 
2456,Glaucoma of childhood 
2457,Primary congenital glaucoma 
2458,Irido-corneo-trabecular dysgenesis 
2459,CYP1B1-Related Disorders 
2460,Anterior segment dysgenesis 
2461,Glaucoma, early-onset, digenic 
2462,Irido-corneo-trabecular dysgenesis;Glaucoma 3A 
2463,Myopathy, centronuclear, 5 
2464,Glaucoma, primary open angle, juvenile-onset 
2465,Vitamin D-dependent rickets type II with alopecia 
2466,Autoimmune lymphoproliferative syndrome type 2B 
2467,Breast cancer, protection against 
2468,Autoimmune lymphoproliferative syndrome type 2A 
2469,Autoimmune lymphoproliferative syndrome type 1 
2470,Peroxisome biogenesis disorder 3A (Zellweger) 
2471,Peroxisomal biogenesis disorder 3b 
2472,Peroxisome biogenesis disorder type 3B;Peroxisome biogenesis disorder 3A (Zellweger) 
2473,Rhizomelic chondrodysplasia punctata type 1 
2474,PEX7-Related Disorders 
2475,Peroxisome biogenesis disorder 9B 
2476,Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1 
2477,Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease 
2478,Rhizomelic chondrodysplasia punctata 
2479,Amyloidosis, primary localized cutaneous, 1 
2480,AICA-ribosiduria 
2481,Cowden syndrome 1 
2482,PTEN hamartoma tumor syndrome 
2483,Glioblastoma 
2484,Non-small cell lung carcinoma 
2485,Macrocephaly-autism syndrome 
2486,Cowden syndrome 
2487,Abnormality of cardiovascular system morphology 
2488,Lhermitte-Duclos disease 
2489,Neoplasm of brain 
2490,Glioma susceptibility 2 
2491,Prostate adenocarcinoma 
2492,Malignant melanoma of skin 
2493,Gastric adenocarcinoma 
2494,Neoplasm of uterine cervix 
2495,Uterine carcinosarcoma 
2496,Squamous cell lung carcinoma 
2497,Small cell lung carcinoma 
2498,Squamous cell carcinoma of the head and neck 
2499,Malignant neoplasm of body of uterus 
2500,Proteus-like syndrome 
2501,Cowden syndrome 1;Macrocephaly-autism syndrome 
2502,PTEN-related disorder 
2503,Cowden syndrome;Macrocephaly-autism syndrome 
2504,Vater association with macrocephaly and ventriculomegaly 
2505,Type 2 diabetes mellitus 
2506,Coxopodopatellar syndrome 
2507,Familial hemophagocytic lymphohistiocytosis 5 
2508,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE 
2509,Groenouw corneal dystrophy type I 
2510,Thiel-Behnke corneal dystrophy 
2511,Lattice corneal dystrophy Type I 
2512,Avellino corneal dystrophy 
2513,Corneal dystrophy, lattice type 3A 
2514,Corneal dystrophy 
2515,Reis-Bucklers' corneal dystrophy 
2516,Epithelial basement membrane dystrophy 
2517,Cone-rod dystrophy 3 
2518,Abnormal macular morphology;Peripheral neuropathy 
2519,Age related macular degeneration 2 
2520,Retinitis pigmentosa 19;Age-related macular degeneration;Cone-rod dystrophy 3 
2521,Macular degeneration 
2522,Stargardt Disease, Recessive 
2523,Cone-Rod Dystrophy, Recessive 
2524,ABCA4-Related Disorders 
2525,Retinitis pigmentosa 19 
2526,Retinitis pigmentosa 19;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Age related macular degeneration 2 
2527,Cone dystrophy 
2528,MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO 
2529,Retinitis pigmentosa 19;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3 
2530,Vitreoretinopathy 
2531,Mandibulofacial dysostosis with mental deficiency 
2532,Retinitis pigmentosa 19;Severe early-childhood-onset retinal dystrophy;Age related macular degeneration 2;Cone-rod dystrophy 3 
2533,Retinal dystrophy, early-onset severe 
2534,Retinitis pigmentosa 19;Cone-rod dystrophy 3;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy 
2535,Platelet-activating factor acetylhydrolase deficiency 
2536,Asthma and atopy, susceptibility to 
2537,Cranioosteoarthropathy 
2538,Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 
2539,Isolated congenital digital clubbing 
2540,Corneal dystrophy, Meesmann, 1 
2541,Retinitis pigmentosa 33 
2542,Branchiootorenal syndrome 1 
2543,Melnick-Fraser syndrome 
2544,Branchiooculofacial syndrome 
2545,Anterior segment anomalies and cataract 
2546,Abnormal anterior chamber morphology 
2547,Branchiootorenal syndrome with cataract 
2548,Otofaciocervical syndrome 1 
2549,Branchiootic syndrome 1 
2550,Glaucoma 1, open angle, A 
2551,Glaucoma 1, open angle, a, autosomal recessive 
2552,Glaucoma 
2553,Glaucoma 1, open angle, a, digenic 
2554,Glaucoma 3, primary congenital, a, digenic 
2555,MYOC-Related Disorders 
2556,Spinal muscular atrophy, modifier of 
2557,Kugelberg-Welander disease 
2558,Spinal muscular atrophy 
2559,Angelman syndrome 
2560,Saethre-Chotzen syndrome 
2561,TWIST1-related craniosynostosis;Saethre-Chotzen syndrome 
2562,Saethre-Chotzen syndrome with eyelid anomalies 
2563,Robinow-Sorauf syndrome 
2564,TWIST1-related craniosynostosis 
2565,Ulnar-mammary syndrome 
2566,Holt-Oram syndrome 
2567,Aortic valve disease 2 
2568,Heart, malformation of 
2569,Hypotrichosis-lymphedema-telangiectasia syndrome 
2570,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 
2571,Fundus albipunctatus, autosomal recessive 
2572,Pigmentary retinal dystrophy 
2573,Interstitial lung disease due to ABCA3 deficiency 
2574,Deficiency of 3-hydroxyacyl-CoA dehydrogenase 
2575,Hyperinsulinemic hypoglycemia, familial, 4 
2576,Schwannomatosis 1 
2577,Schwannomatosis 1, somatic 
2578,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency 
2579,Char syndrome 
2580,Congenital myasthenic syndrome 4C 
2581,Congenital myasthenic syndrome 11 
2582,Fetal akinesia deformation sequence 1 
2583,Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1 
2584,Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 11 
2585,RAPSN-Related Disorders 
2586,Fetal akinesia deformation sequence 2 
2587,Schinzel phocomelia syndrome 
2588,Fuhrmann syndrome 
2589,Factor V and factor VIII, combined deficiency of, type 1 
2590,Pancreatitis, chronic, protection against 
2591,Malattia leventinese 
2592,Doyne honeycomb retinal dystrophy 
2593,Lissencephaly due to LIS1 mutation 
2594,Subcortical band heterotopia 
2595,Axenfeld-Rieger syndrome type 1 
2596,Anterior segment dysgenesis 4 
2597,Ring dermoid of cornea 
2598,Pituitary hormone deficiency, combined, 2 
2599,Paget disease of bone 3 
2600,Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 
2601,Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;Paget disease of bone 3 
2602,Spastic paraplegia-Paget disease of bone syndrome 
2603,Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset 
2604,Spinocerebellar ataxia type 27 
2605,Basal cell carcinoma, somatic 
2606,Peroxisome biogenesis disorder 4B 
2607,Short stature due to primary acid-labile subunit deficiency 
2608,Morbid obesity 
2609,Diabetes mellitus, noninsulin-dependent, modifier of 
2610,Body mass index, modifier of 
2611,Obesity, modifier of 
2612,Intimal medial thickness of internal carotid artery, modifier of 
2613,PPARG-related familial partial lipodystrophy 
2614,Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension 
2615,Lipodystrophy 
2616,Glioma susceptibility 1 
2617,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA POLYMORPHISM 
2618,Spermatogenic failure, susceptibility to 
2619,Autosomal dominant nonsyndromic hearing loss 48 
2620,Mitochondrial DNA depletion syndrome 3 
2621,Nemaline myopathy 7 
2622,Dilated cardiomyopathy 1O 
2623,Succinyl-CoA acetoacetate transferase deficiency 
2624,Charcot-Marie-Tooth disease recessive intermediate B 
2625,Autosomal recessive limb-girdle muscular dystrophy type 2F 
2626,Dilated cardiomyopathy 1L;Autosomal recessive limb-girdle muscular dystrophy type 2F 
2627,Dilated cardiomyopathy 1L 
2628,MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6, DIGENIC 
2629,Pancreatitis, chronic, susceptibility to 
2630,CCR5 POLYMORPHISM, ORIENTAL 2 
2631,CCR5 POLYMORPHISM, AFRICAN-AMERICAN 
2632,Susceptibility to HIV infection 
2633,MOGS-CDG 
2634,Polycystic kidney disease, adult type 
2635,Polycystic kidney disease 3 with or without polycystic liver disease 
2636,Holoprosencephaly 7 
2637,Holoprosencephaly sequence 
2638,Juvenile polyposis syndrome 
2639,Congenital myasthenic syndrome 9 
2640,Congenital myasthenic syndrome 9;Fetal akinesia deformation sequence 1 
2641,Telangiectasia, hereditary hemorrhagic, type 2 
2642,Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia 
2643,Pulmonary arterial hypertension 
2644,Epidermolysis bullosa simplex, Ogna type 
2645,Epidermolysis bullosa simplex, Ogna type;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex 5B, with muscular dystrophy 
2646,Simplex epidermolysis bullosa_Ogna type 
2647,Epidermolysis bullosa simplex 5C, with pyloric atresia 
2648,Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex, Ogna type 
2649,Visceral heterotaxy 5, autosomal 
2650,Visceral heterotaxy 
2651,Cardiofaciocutaneous syndrome 4 
2652,Cardio-facio-cutaneous syndrome 
2653,Pancreatic adenocarcinoma 
2654,Rippling muscle disease 2 
2655,Limb-Girdle Muscular Dystrophy, Dominant 
2656,Caveolinopathy 
2657,Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Rippling muscle disease 2;Long QT syndrome 9;Hypertrophic cardiomyopathy 1 
2658,Elevated circulating creatine kinase concentration 
2659,Distal myopathy, Tateyama type 
2660,Rippling muscle disease 2, autosomal recessive 
2661,Long QT syndrome 9 
2662,Long QT syndrome 9, acquired, susceptibility to 
2663,Long QT syndrome 2/9, digenic 
2664,Myopathy, centronuclear, 2 
2665,Deficiency of guanidinoacetate methyltransferase 
2666,Cerebral creatine deficiency syndrome 
2667,Left ventricular noncompaction 1 
2668,Seckel syndrome 1 
2669,Branchiootic syndrome 3 
2670,Autosomal dominant nonsyndromic hearing loss 23 
2671,Branchiootorenal syndrome 1;Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23 
2672,Familial hypocalciuric hypercalcemia 1 
2673,Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1 
2674,Autosomal dominant hypocalcemia 1 
2675,Neonatal severe primary hyperparathyroidism 
2676,Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia 
2677,Familial hypocalciuric hypercalcemia 
2678,Bartter syndrome with hypocalcemia 
2679,Serum calcium level 
2680,Familial hypoparathyroidism 
2681,Autosomal dominant hypocalcemia 
2682,Epilepsy, idiopathic generalized, susceptibility to, 8 
2683,Leprosy, protection against 
2684,Leprosy, susceptibility to, 5 
2685,Familial acute necrotizing encephalopathy 
2686,Klippel-Feil syndrome 1, autosomal dominant 
2687,Isolated microphthalmia 4 
2688,Leber congenital amaurosis 17 
2689,Klippel-Feil syndrome 
2690,Klippel-Feil syndrome 1, autosomal dominant;Congenital anomaly of kidney and urinary tract 
2691,Leber congenital amaurosis 17;Microphthalmia, isolated, with coloboma 6;Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4 
2692,Klippel-Feil syndrome 1, autosomal dominant;Leber congenital amaurosis 17;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6 
2693,Klippel-Feil syndrome 1, autosomal dominant;Autosomal dominant Parkinson disease 8 
2694,Brachydactyly type C 
2695,Grebe syndrome 
2696,Acromesomelic dysplasia 2B 
2697,Symphalangism, proximal, 1B 
2698,Multiple synostoses syndrome 2 
2699,Unverricht-Lundborg syndrome 
2700,Childhood epilepsy with centrotemporal spikes 
2701,Neuronopathy, distal hereditary motor, type 7B 
2702,Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1 
2703,Amyotrophic lateral sclerosis, susceptibility to 
2704,Perry syndrome 
2705,Amyotrophic lateral sclerosis type 1 
2706,Neuronopathy, distal hereditary motor, type 7B;Perry syndrome;Amyotrophic lateral sclerosis type 1 
2707,Perry syndrome;Amyotrophic lateral sclerosis type 1;Neuronopathy, distal hereditary motor, type 7B 
2708,Dubin-Johnson syndrome 
2709,Pyknodysostosis 
2710,Charcot-Marie-Tooth disease, type IA 
2711,Charcot-Marie-Tooth disease, type I 
2712,Charcot-Marie-Tooth disease, type 1a, autosomal recessive 
2713,Hereditary liability to pressure palsies 
2714,Dejerine-Sottas syndrome, autosomal dominant 
2715,Roussy-L√©vy syndrome 
2716,Charcot-Marie-Tooth disease type 1E 
2717,Charcot-Marie-Tooth disease, type 1a, with focally folded myelin sheaths 
2718,PMP22-Related Disorders 
2719,Congenital primary aphakia 
2720,Anterior segment dysgenesis 3 
2721,Axenfeld-Rieger syndrome type 3 
2722,Alveolar capillary dysplasia with pulmonary venous misalignment 
2723,Charcot-Marie-Tooth disease axonal type 2N 
2724,Congenital generalized lipodystrophy type 3 
2725,Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 
2726,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 
2727,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 
2728,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 
2729,Long QT syndrome 12 
2730,Long QT syndrome;Atrial fibrillation 
2731,Niemann-Pick disease, type C2 
2732,Familial hemiplegic migraine 
2733,Migraine, familial hemiplegic, 1 
2734,Migraine, sporadic hemiplegic, with progressive cerebellar ataxia 
2735,Episodic ataxia type 2 
2736,Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42 
2737,Spinocerebellar ataxia type 6 
2738,Developmental and epileptic encephalopathy, 42 
2739,Developmental and epileptic encephalopathy, 42;Episodic ataxia type 2 
2740,Sporadic hemiplegic migraine 
2741,Developmental and epileptic encephalopathy, 52;Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2 
2742,Episodic ataxia type 2;Spinocerebellar ataxia type 6;Developmental and epileptic encephalopathy, 42;Migraine, familial hemiplegic, 1 
2743,Episodic ataxia, type 2, and epilepsy 
2744,LEPTIN RECEPTOR POLYMORPHISM 
2745,Obesity due to leptin receptor gene deficiency 
2746,Monogenic Non-Syndromic Obesity 
2747,Gluthathione synthetase deficiency 
2748,Glutathione synthetase deficiency without 5-oxoprolinuria 
2749,Prostate cancer/brain cancer susceptibility 
2750,Generalized juvenile polyposis/juvenile polyposis coli 
2751,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome 
2752,Lung adenocarcinoma 
2753,Carcinoma of esophagus 
2754,Ehlers-Danlos syndrome due to tenascin-X deficiency 
2755,Ehlers-Danlos syndrome 
2756,Autosomal dominant pseudohypoaldosteronism type 1 
2757,Autism spectrum disorder 
2758,Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy 
2759,Hypophosphatemic rickets, autosomal recessive, 1 
2760,Autosomal dominant nonsyndromic hearing loss 22 
2761,Autosomal recessive nonsyndromic hearing loss 37 
2762,Sensorineural deafness with hypertrophic cardiomyopathy 
2763,Familial hypokalemia-hypomagnesemia 
2764,Bartter syndrome;Familial hypokalemia-hypomagnesemia 
2765,Branchiootorenal syndrome 2 
2766,Hypertrophic cardiomyopathy 4;Left ventricular noncompaction 10 
2767,Left ventricular noncompaction 10 
2768,Persistent mullerian duct syndrome, type I 
2769,Persistent mullerian duct syndrome, type II 
2770,Delayed sleep phase syndrome, susceptibility to 
2771,Laron-type isolated somatotropin defect 
2772,Short stature due to partial GHR deficiency 
2773,Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect 
2774,Short stature due to partial GHR deficiency;Short stature due to growth hormone secretagogue receptor deficiency;Hypercholesterolemia, familial, 1;Laron-type isolated somatotropin defect 
2775,Laron syndrome with elevated serum GH-binding protein 
2776,Laron syndrome with undetectable serum GH-binding protein 
2777,Hyperinsulinemic hypoglycemia, familial, 2 
2778,Maturity onset diabetes mellitus in young 
2779,Permanent neonatal diabetes mellitus 
2780,Diabetes mellitus, transient neonatal, 3 
2781,Neonatal insulin-dependent diabetes mellitus 
2782,Diabetes mellitus, permanent neonatal 2 
2783,Neonatal diabetes mellitus 
2784,Hyperinsulinemia 
2785,Transitory neonatal diabetes mellitus 
2786,Diabetes mellitus 
2787,Maturity-onset diabetes of the young type 13 
2788,Exercise stress response, impaired, association with 
2789,Hyperinsulinism, Dominant/Recessive 
2790,Transient Neonatal Diabetes, Dominant 
2791,Glibenclamide response 
2792,Hyperinsulinemic hypoglycemia, familial, 2;Permanent neonatal diabetes mellitus;Diabetes mellitus, transient neonatal, 3 
2793,Hypoglycemia 
2794,Neonatal hypoglycemia 
2795,Maturity-onset diabetes of the young type 13;Hyperinsulinemic hypoglycemia, familial, 2;Type 2 diabetes mellitus;Permanent neonatal diabetes mellitus;Diabetes mellitus, transient neonatal, 3 
2796,Cataract 17 multiple types 
2797,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 
2798,Variegate porphyria, homozygous 
2799,Multiple synostoses syndrome 3 
2800,Insulin resistance, susceptibility to 
2801,Fanconi anemia complementation group E 
2802,Autosomal recessive limb-girdle muscular dystrophy type 2E 
2803,Cataract 1 multiple types 
2804,Lchad deficiency with maternal acute fatty liver of pregnancy 
2805,Mitochondrial trifunctional protein deficiency 
2806,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency 
2807,Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency 
2808,HADHA-Related Disorders 
2809,Neutropenia, severe congenital, 2, autosomal dominant 
2810,Nonimmune chronic idiopathic neutropenia of adults 
2811,Advanced sleep phase syndrome 2 
2812,Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5 
2813,Dilated cardiomyopathy 1GG 
2814,Fasting plasma glucose level quantitative trait locus 5 
2815,Bartter disease type 1 
2816,T-cell immunodeficiency, congenital alopecia, and nail dystrophy 
2817,T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 
2818,Hirschsprung disease, susceptibility to, 3 
2819,Cone dystrophy 4 
2820,Achromatopsia 5 
2821,Dilated cardiomyopathy 1M 
2822,Hypertrophic cardiomyopathy 12 
2823,Sudden unexplained death;Hypertrophic cardiomyopathy 
2824,Hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M 
2825,Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12 
2826,Ataxia-telangiectasia-like disorder 1 
2827,Ataxia-telangiectasia-like disorder 
2828,Xeroderma pigmentosum, group E 
2829,Junctional epidermolysis bullosa gravis of Herlitz 
2830,Epidermolysis bullosa, junctional 2B, severe 
2831,Epidermolysis bullosa, junctional 2A, intermediate 
2832,Pulmonary hypertension, primary, 1 
2833,Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1, autosomal dominant 
2834,Primary pulmonary hypertension 
2835,Pulmonary arterial hypertension;Idiopathic and/or familial pulmonary arterial hypertension 
2836,Pulmonary hypertension, primary, dexfenfluramine-associated 
2837,Pulmonary hypertension, primary, fenfluramine-associated 
2838,Pulmonary venoocclusive disease 1 
2839,Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia 
2840,DIABETES, TYPE II, SUSCEPTIBILITY TO 
2841,Multiple endocrine neoplasia type 4 
2842,Liddle syndrome 2 
2843,Bronchiectasis with or without elevated sweat chloride 3 
2844,Autosomal recessive pseudohypoaldosteronism type 1 
2845,Liddle syndrome 1 
2846,Bronchiectasis with or without elevated sweat chloride 1 
2847,Alzheimer disease 4 
2848,Dilated cardiomyopathy 1V 
2849,Long QT syndrome 13 
2850,Andersen Tawil syndrome 
2851,Familial hyperaldosteronism type III 
2852,Maturity-onset diabetes of the young type 4 
2853,Pancreatic agenesis 1 
2854,Brachydactyly type A1 
2855,Brachydactyly type A1A 
2856,Acrocapitofemoral dysplasia 
2857,Holoprosencephaly 3 
2858,Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 
2859,Schizencephaly 
2860,Microphthalmia, isolated, with coloboma 5 
2861,Solitary median maxillary central incisor syndrome 
2862,Retinitis pigmentosa 45 
2863,Neuronal ceroid lipofuscinosis 1 
2864,Neuronal Ceroid-Lipofuscinosis, Recessive 
2865,Arthrogryposis, distal, type 2B2 
2866,Arthyrgryposis, distal, type 2B 
2867,Metabolic myopathy due to lactate transporter defect 
2868,Short QT syndrome type 3;Andersen Tawil syndrome 
2869,Atrial fibrillation, familial, 9;Short QT syndrome type 3;Andersen Tawil syndrome 
2870,Short QT syndrome type 3 
2871,Colorectal cancer, hereditary nonpolyposis, type 5 
2872,Colorectal / endometrial cancer 
2873,Melanoma, cutaneous malignant, susceptibility to, 6 
2874,Cocoon syndrome 
2875,Intellectual disability, autosomal dominant 20 
2876,Coronary artery disease/myocardial infarction 
2877,Carnitine palmitoyl transferase II deficiency, severe infantile form 
2878,Carnitine palmitoyltransferase II deficiency 
2879,Carnitine palmitoyl transferase II deficiency, myopathic form 
2880,Carnitine palmitoyl transferase II deficiency, neonatal form 
2881,Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form 
2882,Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form 
2883,Abnormality of the nervous system;Seizure 
2884,Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form 
2885,Cleft lip/palate-ectodermal dysplasia syndrome 
2886,Orofacial cleft 7 
2887,Benign hereditary chorea 
2888,Brain-lung-thyroid syndrome 
2889,Acute myeloid leukemia 
2890,Congenital lipoid adrenal hyperplasia due to STAR deficency 
2891,BLOOD GROUP--LUTHERAN INHIBITOR 
2892,Fetal hemoglobin quantitative trait locus 6 
2893,Atrial septal defect 7 
2894,Hypothyroidism, congenital, nongoitrous, 5 
2895,Truncus arteriosus 
2896,Aortic arch interruption 
2897,Hypoplastic left heart syndrome 2 
2898,Congenital heart disease 
2899,Atrioventricular septal defect, somatic 
2900,Non-acquired combined pituitary hormone deficiency with spine abnormalities 
2901,Atrial septal defect 2 
2902,Transposition of the great arteries 
2903,Atrioventricular septal defect 4 
2904,Pulmonary valve atresia;Tricuspid regurgitation;Pulmonic stenosis 
2905,Epilepsy, juvenile absence 2 
2906,Leukoencephalopathy with mild cerebellar ataxia and white matter edema 
2907,Epilepsy, juvenile myoclonic 8 
2908,Epilepsy, idiopathic generalized, susceptibility to, 11 
2909,Familial hyperaldosteronism type II;Epilepsy, idiopathic generalized, susceptibility to, 11;Leukoencephalopathy with mild cerebellar ataxia and white matter edema 
2910,Pitt-Hopkins-like syndrome 2 
2911,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency 
2912,Immunodeficiency 31B 
2913,Parkinson disease, mitochondrial 
2914,Mitochondrial complex 1 deficiency, nuclear type 7 
2915,3-methylglutaconic aciduria type 1 
2916,Carnitine palmitoyl transferase 1A deficiency 
2917,Microcytic anemia with liver iron overload 
2918,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder 
2919,Platelet-type bleeding disorder 8 
2920,Hyperinsulinemic hypoglycemia, familial, 1 
2921,Familial hyperinsulinism 
2922,Hereditary hyperinsulinism 
2923,Leucine-induced hypoglycemia 
2924,Diabetes mellitus, permanent neonatal 3 
2925,Diabetes mellitus, transient neonatal, 2 
2926,Autosomal recessive distal spinal muscular atrophy 1 
2927,Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1 
2928,Charcot-Marie-Tooth disease axonal type 2S 
2929,Autosomal recessive distal spinal muscular atrophy 1;Charcot-Marie-Tooth disease axonal type 2S 
2930,Hypogonadotropic hypogonadism 6 with or without anosmia 
2931,Holoprosencephaly 1 
2932,Obesity, hyperphagia, and developmental delay 
2933,Cataract 13 with adult I phenotype 
2934,ADULT i BLOOD GROUP PHENOTYPE 
2935,Hirschsprung disease, cardiac defects, and autonomic dysfunction 
2936,Ataxia and retinitis pigmentosa with isolated vitamin E deficiency 
2937,Familial isolated deficiency of vitamin E 
2938,Ataxia, Friedreich-like, with isolated vitamin E deficiency 
2939,Peroxisome biogenesis disorder 2B 
2940,Peroxisome biogenesis disorder 2A (Zellweger) 
2941,Bardet-Biedl syndrome 4 
2942,Cone dystrophy 3 
2943,Bartter disease type 2 
2944,Spinal muscular atrophy, type II 
2945,Werdnig-Hoffmann disease 
2946,Retinitis pigmentosa 44 
2947,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome 
2948,Epiphyseal dysplasia, multiple, 1, severe 
2949,Multiple epiphyseal dysplasia type 1 
2950,Pseudoachondroplasia, severe 
2951,Carpal tunnel syndrome 2 
2952,Deficiency of 2-methylbutyryl-CoA dehydrogenase 
2953,Charcot-Marie-Tooth disease type 2D 
2954,Neuronopathy, distal hereditary motor, type 5A;Charcot-Marie-Tooth disease type 2D 
2955,Maturity-onset diabetes of the young type 1 
2956,Maturity-onset diabetes of the young type 1;Type 2 diabetes mellitus;Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young 
2957,Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 
2958,Migraine without aura;Stroke 
2959,NOTCH3-Related Disorders 
2960,Recurrent subcortical infarcts 
2961,Alagille syndrome due to a NOTCH2 point mutation 
2962,Hereditary hypotrichosis with recurrent skin vesicles 
2963,Mycobacterium tuberculosis, susceptibility to infection by 
2964,Buruli ulcer, susceptibility to 
2965,Mismatch repair cancer syndrome 4 
2966,Colorectal cancer, hereditary nonpolyposis, type 4 
2967,Turcot syndrome 
2968,Pituitary carcinoma 
2969,Colorectal cancer, hereditary nonpolyposis, type 4;Turcot syndrome 
2970,Generalized epilepsy with febrile seizures plus, type 1 
2971,Generalized epilepsy with febrile seizures plus 
2972,Atrial fibrillation, familial, 13 
2973,Brugada syndrome 5 
2974,Atrial fibrillation, familial, 13;Developmental and epileptic encephalopathy, 52;Generalized epilepsy with febrile seizures plus, type 1;Brugada syndrome 5 
2975,Cardiac conduction defect, nonspecific 
2976,3-hydroxy-3-methylglutaryl-CoA synthase deficiency 
2977,Bronchiectasis with or without elevated sweat chloride 2 
2978,Dystonia 5 
2979,Autosomal recessive DOPA responsive dystonia 
2980,GTP cyclohydrolase I deficiency;Dystonia 5 
2981,GTP cyclohydrolase I deficiency 
2982,Dopa-responsive dystonia 
2983,Multiple cutaneous and mucosal venous malformations 
2984,Segmental undergrowth associated with venous malformation without capillary component 
2985,Blue rubber bleb nevus 
2986,Cleidocranial dysostosis 
2987,Cleidocranial dysplasia, forme fruste, dental anomalies only 
2988,Ichthyosis bullosa of Siemens 
2989,Exfoliative ichthyosis 
2990,Breast-ovarian cancer, familial, susceptibility to, 2 
2991,Fanconi anemia complementation group D1 
2992,BRCA2-Related Disorders 
2993,Glioma susceptibility 3 
2994,Breast-ovarian cancer, familial, susceptibility to, 1 
2995,Cone-rod dystrophy 6;Leber congenital amaurosis 1 
2996,Cone-rod dystrophy 6 
2997,Choroidal dystrophy, central areolar, 1 
2998,Leber congenital amaurosis 1;Cone-rod dystrophy 6 
2999,Macular dystrophy;Visual impairment 
3000,Progressive cone dystrophy (without rod involvement) 
3001,T-B+ severe combined immunodeficiency due to JAK3 deficiency 
3002,Long QT syndrome 3 
3003,Brugada syndrome 1 
3004,Sick sinus syndrome 1 
3005,Sinus node disease 
3006,Congenital long QT syndrome;Brugada syndrome 
3007,SCN5A-Related Disorders 
3008,Brugada syndrome;Long QT syndrome 
3009,Ventricular fibrillation, paroxysmal familial, type 1 
3010,Ventricular fibrillation 
3011,Progressive familial heart block, type 1A 
3012,Atrioventricular block 
3013,Atrial fibrillation, familial, 10 
3014,Cardiac conduction defect, nonprogressive 
3015,Hemiplegia;Migraine;Primary dilated cardiomyopathy 
3016,Dilated cardiomyopathy 1E 
3017,Long qt syndrome 3, acquired, susceptibility to 
3018,Left ventricular noncompaction 
3019,Sick sinus syndrome 
3020,AV junctional rhythm 
3021,Atrial standstill 1, digenic 
3022,Long QT syndrome 2/3, digenic 
3023,Long QT syndrome 3;Brugada syndrome 1 
3024,Brugada syndrome, lidocaine-induced 
3025,Melanoma, cutaneous malignant, susceptibility to, 2 
3026,Familial melanoma 
3027,Lip and oral cavity carcinoma 
3028,Melanoma-pancreatic cancer syndrome 
3029,Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome;Melanoma-pancreatic cancer syndrome 
3030,Generalized epilepsy-paroxysmal dyskinesia syndrome 
3031,Rubinstein-Taybi syndrome due to CREBBP mutations 
3032,Autosomal recessive limb-girdle muscular dystrophy type 2D 
3033,Sarcoglycanopathy 
3034,Episodic ataxia type 6 
3035,Spondyloepimetaphyseal dysplasia, Missouri type 
3036,Metaphyseal anadysplasia 1, autosomal dominant 
3037,Metaphyseal chondrodysplasia, Spahr type 
3038,Noonan syndrome 12 
3039,Donnai-Barrow syndrome 
3040,Leukocyte adhesion deficiency 1 
3041,Achromatopsia 2 
3042,Monochromacy 
3043,Color vision defect;Macular degeneration;Photophobia 
3044,Tangier disease 
3045,ABCA1-Related Disorders 
3046,Tangier disease, variant 
3047,Hypoalphalipoproteinemia, primary, 1 
3048,Coronary heart disease in familial hypercholesterolemia, protection against 
3049,T-cell acute lymphoblastic leukemia 
3050,Syndromic microphthalmia type 5 
3051,Chitotriosidase deficiency 
3052,Pelger-Hu√´t anomaly 
3053,Reynolds syndrome 
3054,Greenberg dysplasia 
3055,Malignant tumor of prostate 
3056,Neurofibrosarcoma 
3057,Opioid dependence, susceptibility to, 1 
3058,Tramadol response 
3059,Bare lymphocyte syndrome type 2, complementation group A 
3060,Brugada syndrome 4 
3061,46,XY sex reversal 1 
3062,46,XY true hermaphroditism, SRY-related 
3063,Intellectual disability, X-linked 45 
3064,Intellectual disability, X-linked 97 
3065,McLeod neuroacanthocytosis syndrome 
3066,Syndromic X-linked intellectual disability Claes-Jensen type 
3067,Infantile-onset X-linked spinal muscular atrophy 
3068,Thyroxine-binding globulin quantitative trait locus 
3069,Thyroxine-binding globulin, variant A 
3070,Thyroxine-binding globulin deficiency 
3071,Thyroxine-binding globulin, variant P 
3072,Thyroxine-binding globulin, slow 
3073,Thyroxine-binding globulin deficiency, partial 
3074,Thyroxine-binding globulin, Chicago 
3075,Androgen resistance syndrome 
3076,Kennedy disease;Androgen resistance syndrome 
3077,Hypospadias 1, X-linked;Partial androgen insensitivity syndrome;Androgen resistance syndrome;Malignant tumor of prostate;Kennedy disease 
3078,Androgen resistance syndrome;Kennedy disease 
3079,Partial androgen insensitivity syndrome 
3080,Hypospadias 1, X-linked 
3081,Androgen insensitivity, partial, with breast cancer 
3082,Prostate cancer susceptibility 
3083,Castleman-Kojima disease 
3084,Intellectual disability, X-linked 96 
3085,X-linked epilepsy-learning disabilities-behavior disorders syndrome 
3086,SHOX-related short stature 
3087,Leri-Weill dyschondrosteosis 
3088,Langer mesomelic dysplasia syndrome 
3089,Juvenile retinoschisis 
3090,Retinoschisis 
3091,Retinitis pigmentosa 3 
3092,Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness 
3093,X-linked cone-rod dystrophy 1 
3094,Syndromic X-linked intellectual disability Nascimento type 
3095,Glycogen storage disease IXd 
3096,Phosphoribosylpyrophosphate synthetase superactivity 
3097,Arts syndrome 
3098,Charcot-Marie-Tooth disease X-linked recessive 5 
3099,Charcot-Marie-Tooth Neuropathy X 
3100,Hearing loss, X-linked 1 
3101,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency 
3102,Phosphoglycerate kinase electrophoretic variant PGK II 
3103,Paroxysmal nocturnal hemoglobinuria 
3104,Brunner syndrome 
3105,Fragile X syndrome 
3106,Danon disease 
3107,Hypertrophic cardiomyopathy;Danon disease 
3108,X-linked hydrocephalus syndrome 
3109,MASA syndrome 
3110,Hydrocephalus due to aqueductal stenosis 
3111,L1 syndrome 
3112,Hydrops fetalis;Severe hydrocephalus 
3113,Hydrocephalus, X-linked, with hirschsprung disease 
3114,Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction 
3115,X-linked complicated corpus callosum dysgenesis 
3116,Hypogonadotropic hypogonadism 1 with or without anosmia 
3117,X-linked severe combined immunodeficiency 
3118,Combined immunodeficiency, X-linked 
3119,HPRT ANN ARBOR 
3120,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency 
3121,HPRT ARLINGTON 
3122,Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency 
3123,HPRT ASHVILLE 
3124,Lesch-Nyhan syndrome 
3125,HPRT DETROIT 
3126,HPRT FLINT 
3127,HPRT LONDON 
3128,HPRT MIDLAND 
3129,HPRT MILWAUKEE 
3130,HPRT MUNICH 
3131,HPRT NEW BRITON 
3132,HPRT NEW HAVEN 
3133,HPRT YALE 
3134,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome 
3135,HPRT TORONTO 
3136,HPRT FUJIMI 
3137,Lesch-nyhan syndrome, neurologic variant 
3138,HPRT MONTREAL 
3139,HPRT1-Related Disorder 
3140,HPRT URANGAN 
3141,HPRT TOOWONG 
3142,HPRT SWAN 
3143,HPRT EDINBURGH 
3144,HPRT TOKYO 
3145,HPRT MOOSE JAW 
3146,HPRT PARIS 
3147,Hereditary factor VIII deficiency disease 
3148,Hereditary factor IX deficiency disease 
3149,FACTOR VIII (OKAYAMA) 
3150,FACTOR VIII (EAST HARTFORD) 
3151,Thrombophilia 13, X-linked, due to factor VIII defect 
3152,Hemorrhage 
3153,Surfactant metabolism dysfunction, pulmonary, 4 
3154,Syndromic X-linked intellectual disability 94 
3155,G6PD A+ 
3156,Anemia, nonspherocytic hemolytic, due to G6PD deficiency 
3157,G6PD deficiency 
3158,Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency 
3159,Bone mineral density quantitative trait locus 18 
3160,Anemia, nonspherocytic hemolytic, due to G6PD deficiency;G6PD deficiency 
3161,G6PD ASAHI 
3162,X-linked parkinsonism-spasticity syndrome 
3163,G6PD deficiency;Anemia, nonspherocytic hemolytic, due to G6PD deficiency 
3164,G6PD CHATHAM 
3165,Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to 
3166,G6PD ILESHA 
3167,G6PD MAHIDOL 
3168,G6PD SASSARI 
3169,G6PD MEDITERRANEAN 
3170,G6PD CAGLIARI 
3171,Susceptibility to angioedema induced by ACE inhibitors 
3172,G6PD deficient hemolytic anemia 
3173,Hemolytic anemia, G6PD deficient (favism) 
3174,Malaria, susceptibility to 
3175,Decreased glucose-6-phosphate dehydrogenase level in blood 
3176,G6PD METAPONTO 
3177,G6PD PORTICI 
3178,G6PD NASHVILLE 
3179,G6PD ANAHEIM 
3180,G6PD SANTIAGO DE CUBA 
3181,G6PD SEATTLE-LIKE 
3182,G6PD MODENA 
3183,G6PD HARILAOU 
3184,G6PD IOWA 
3185,G6PD SPRINGFIELD 
3186,G6PD WALTER REED 
3187,G6PD IOWA CITY 
3188,G6PD BEVERLY HILLS 
3189,G6PD TOMAH 
3190,G6PD RIVERSIDE 
3191,G6PD ANDALUS 
3192,G6PD GIFU 
3193,G6PD AGRIGENTO 
3194,G6PD TAIWAN-HAKKA 
3195,G6PD CANTON 
3196,G6PD PUERTO LIMON 
3197,G6PD MALAGA 
3198,G6PD GASTONIA 
3199,G6PD MINNESOTA 
3200,G6PD MARION 
3201,G6PD IERAPETRA 
3202,G6PD VIANGCHAN 
3203,G6PD JAMMU 
3204,G6PD PETRICH-LIKE 
3205,G6PD SAPPORO-LIKE 
3206,G6PD ANANT 
3207,G6PD KAIPING 
3208,G6PD DHON 
3209,G6PD LOMA LINDA 
3210,G6PD COIMBRA 
3211,G6PD TAIWAN-HAKKA 2 
3212,G6PD SANTIAGO 
3213,G6PD MEXICO CITY 
3214,G6PD GUADALAJARA 
3215,G6PD ALHAMBRA 
3216,G6PD JAPAN 
3217,G6PD PAWNEE 
3218,G6PD KALYAN 
3219,G6PD KERALA-KALYAN 
3220,G6PD KERALA 
3221,G6PD AURES 
3222,G6PD GAOHE 
3223,G6PD QUING YUAN 
3224,G6PD MAHIDOL-LIKE 
3225,G6PD ORISSA 
3226,G6PD NANKANG 
3227,G6PD NEAPOLIS 
3228,G6PD SERRES 
3229,G6PD AVEIRO 
3230,G6PD REHOVOT 
3231,G6PD SPLIT 
3232,G6PD NAMORU 
3233,G6PD NILGIRI 
3234,G6PD COSENZA 
3235,Thrombocytopenia, X-linked, with dyserythropoietic anemia 
3236,Thrombocytopenia, X-linked, with or without dyserythropoietic anemia 
3237,Thrombocytopenia, X-linked, without dyserythropoietic anemia 
3238,Beta-thalassemia-X-linked thrombocytopenia syndrome 
3239,Diamond-Blackfan anemia;GATA binding protein 1 related thrombocytopenia with dyserythropoiesis 
3240,Charcot-Marie-Tooth disease X-linked dominant 1 
3241,X-linked Alport syndrome 
3242,Alport syndrome 
3243,Hematuria 
3244,X-linked sideroblastic anemia 1 
3245,Sideroblastic anemia 1, late-onset 
3246,Anemia, hereditary sideroblastic 1, pyridoxine refractory 
3247,Mucopolysaccharidosis, MPS-II 
3248,Mucopolysaccharidosis, type II, mild form 
3249,Mucopolysaccharidosis type 2, severe form 
3250,Cone monochromatism 
3251,Protan defect 
3252,Deuteranopia 
3253,Deuteranomaly 
3254,Cone dystrophy 5, X-linked 
3255,Ocular albinism, type I 
3256,Nystagmus 6, congenital, X-linked 
3257,Glycogen storage disease IXa1 
3258,Glycogen storage disease IXa2 
3259,Intellectual disability, X-linked 72 
3260,Retinitis pigmentosa 2 
3261,X-linked ichthyosis with steryl-sulfatase deficiency 
3262,Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease 
3263,Thrombophilia, X-linked, due to factor 9 defect 
3264,Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect 
3265,Deep venous thrombosis, protection against 
3266,Hemophilia b(m) 
3267,FACTOR IX, DNA POLYMORPHISM 
3268,FACTOR IX POLYMORPHISM 
3269,Intellectual disability, X-linked syndromic, Turner type 
3270,Atrophia bulborum hereditaria 
3271,Exudative vitreoretinopathy 2, X-linked 
3272,Exudative vitreoretinopathy, X-linked 
3273,Focal dermal hypoplasia 
3274,Osteopathia striata with cranial sclerosis 
3275,Syndromic X-linked intellectual disability Raymond type 
3276,Fabry disease 
3277,Fabry disease, cardiac variant 
3278,Fabry disease;Hypertrophic cardiomyopathy 
3279,Sudden unexplained death 
3280,Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked 
3281,Pettigrew syndrome 
3282,Nystagmus 1, congenital, X-linked 
3283,Polyagglutinable erythrocyte syndrome 
3284,Premature ovarian failure 2B 
3285,Premature ovarian insufficiency 
3286,X-linked intellectual disability, Stocco dos Santos type 
3287,Syndromic X-linked intellectual disability Siderius type 
3288,Syndromic X-linked intellectual disability Hedera type 
3289,Intellectual disability, X-linked 93 
3290,X-linked Opitz G/BBB syndrome 
3291,Familial X-linked hypophosphatemic vitamin D refractory rickets 
3292,Aarskog syndrome 
3293,Diabetes insipidus, nephrogenic, X-linked 
3294,Nephrogenic diabetes insipidus 
3295,Nephrogenic syndrome of inappropriate antidiuresis 
3296,Nephrogenic syndrome of inappropriate antidiuresis;Diabetes insipidus, nephrogenic, X-linked 
3297,Lowe syndrome 
3298,Dent disease type 2 
3299,Intellectual disability, X-linked 1 
3300,Pyruvate dehydrogenase E1-alpha deficiency 
3301,Pyruvate dehydrogenase complex deficiency 
3302,Intellectual disability, X-linked 9 
3303,X-linked lymphoproliferative disease due to SH2D1A deficiency 
3304,X-linked lymphoproliferative syndrome 
3305,Oculofaciocardiodental syndrome 
3306,Granulomatous disease, chronic, X-linked, variant 
3307,Granulomatous disease, chronic, X-linked 
3308,Deficiency of glycerol kinase 
3309,Congenital adrenal hypoplasia, X-linked 
3310,Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2 
3311,Mineralocorticoid deficiency, isolated 
3312,Renpenning syndrome 
3313,Ornithine carbamoyltransferase deficiency 
3314,ORNITHINE TRANSCARBAMYLASE POLYMORPHISM 
3315,Developmental and epileptic encephalopathy, 9 
3316,Nance-Horan syndrome 
3317,Hypohidrotic X-linked ectodermal dysplasia 
3318,Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1 
3319,Tooth agenesis, selective, X-linked, 1;Hypohidrotic X-linked ectodermal dysplasia 
3320,Tooth agenesis, selective, X-linked, 1 
3321,Developmental and epileptic encephalopathy, 8 
3322,Borjeson-Forssman-Lehmann syndrome 
3323,Pelizaeus-Merzbacher disease 
3324,Hereditary spastic paraplegia 2 
3325,Pelizaeus-Merzbacher disease, connatal 
3326,Pelizaeus-Merzbacher disease, mild 
3327,Pelizaeus-Merzbacher disease, atypical 
3328,3-Methylglutaconic aciduria type 2 
3329,Wiskott-Aldrich syndrome 
3330,Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1 
3331,Thrombocytopenia 1 
3332,Wiskott-Aldrich syndrome, attenuated 
3333,Thrombocytopenia 1;Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia 
3334,X-linked severe congenital neutropenia 
3335,Thrombocytopenia, X-linked, intermittent 
3336,Amelogenesis imperfecta type 1E 
3337,Choroideremia 
3338,Hyper-IgM syndrome type 1 
3339,X-linked Emery-Dreifuss muscular dystrophy 
3340,Properdin deficiency, X-linked 
3341,Properdin deficiency, type II 
3342,Properdin deficiency, type III 
3343,Developmental and epileptic encephalopathy, 1 
3344,X-linked lissencephaly with abnormal genitalia 
3345,Intellectual disability, X-linked, with or without seizures, arx-related 
3346,Intellectual disability, X-linked, with or without seizures, arx-related;Developmental and epileptic encephalopathy, 1 
3347,Corpus callosum agenesis-abnormal genitalia syndrome 
3348,Hydranencephaly with abnormal genitalia 
3349,Duchenne muscular dystrophy 
3350,Duchenne muscular dystrophy;Becker muscular dystrophy;Dystrophin deficiency;Cardiomyopathy 
3351,Becker muscular dystrophy 
3352,Duchenne muscular dystrophy;Cardiomyopathy;Dystrophin deficiency;Becker muscular dystrophy 
3353,Duchenne muscular dystrophy, intellectual disability, and absence of erg b-wave 
3354,Intermediate muscular dystrophy 
3355,Dilated cardiomyopathy 3B 
3356,Duchenne muscular dystrophy;Dystrophin deficiency;Cardiomyopathy;Becker muscular dystrophy 
3357,X-linked DMD-related dystrophinopathy 
3358,Dilated cardiomyopathy 3B;Duchenne muscular dystrophy;Becker muscular dystrophy 
3359,Adrenoleukodystrophy 
3360,X-linked spondyloepimetaphyseal dysplasia 
3361,Primary adrenocortical insufficiency 
3362,Deafness dystonia syndrome 
3363,Asperger syndrome, X-linked, susceptibility to, 1 
3364,Autism, susceptibility to, X-linked 1 
3365,Cleft palate with ankyloglossia 
3366,X-linked intellectual disability Cabezas type 
3367,Global developmental delay;Intellectual disability;Seizure;Abnormal facial shape;Short stature 
3368,X-linked agammaglobulinemia 
3369,Autosomal recessive agammaglobulinemia 1 
3370,X-linked agammaglobulinemia with growth hormone deficiency 
3371,Inherited Immunodeficiency Diseases 
3372,X-linked agammaglobulinemia;X-linked agammaglobulinemia with growth hormone deficiency 
3373,Syndromic X-linked intellectual disability 14 
3374,IFAP syndrome with or without BRESHECK syndrome 
3375,Insulin-dependent diabetes mellitus secretory diarrhea syndrome 
3376,Hydrops fetalis 
3377,Congenital stationary night blindness 1A 
3378,Child syndrome 
3379,Heterotaxy, visceral, 1, X-linked 
3380,Congenital heart defects, multiple types, 1, X-linked 
3381,VACTERL association, X-linked, with or without hydrocephalus 
3382,Congenital heart defects 1, nonsyndromic, 1 
3383,HSD10 mitochondrial disease 
3384,Incontinentia pigmenti syndrome 
3385,ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED 
3386,Ectodermal dysplasia and immunodeficiency 1 
3387,Immunodeficiency 33 
3388,Ovarian dysgenesis 2 
3389,Premature ovarian failure 4 
3390,Christianson syndrome 
3391,Intellectual disability, X-linked 21 
3392,Chondrodysplasia punctata 2 X-linked dominant 
3393,MEND syndrome 
3394,Developmental and epileptic encephalopathy, 2 
3395,Atypical Rett syndrome 
3396,Angelman syndrome-like;Developmental and epileptic encephalopathy, 2 
3397,CDKL5 disorder 
3398,Rett syndrome 
3399,Spondyloepiphyseal dysplasia tarda 
3400,FG syndrome 1 
3401,Blepharophimosis - intellectual disability syndrome, MKB type;FG syndrome 1;X-linked intellectual disability with marfanoid habitus 
3402,Blepharophimosis - intellectual disability syndrome, MKB type 
3403,X-linked intellectual disability with marfanoid habitus 
3404,X-linked chondrodysplasia punctata 1 
3405,Syndromic X-linked intellectual disability Najm type 
3406,FG syndrome 4;Anemia, nonspherocytic hemolytic, due to G6PD deficiency 
3407,FG syndrome 4;Syndromic X-linked intellectual disability Najm type;Anemia, nonspherocytic hemolytic, due to G6PD deficiency 
3408,Intellectual disability, CASK-related, X-linked 
3409,Orofaciodigital syndrome I 
3410,X-linked scapuloperoneal muscular dystrophy 
3411,X-linked myopathy with postural muscle atrophy 
3412,Myopathy, reducing body, X-linked, early-onset, severe 
3413,Myopathy, reducing body, X-linked, childhood-onset 
3414,Emery-Dreifuss muscular dystrophy 6 
3415,Intellectual disability, X-linked 63 
3416,Intellectual disability, X-linked 30 
3417,X-linked sideroblastic anemia with ataxia 
3418,X-linked intellectual disability-cerebellar hypoplasia syndrome 
3419,Dyskeratosis congenita, X-linked 
3420,Hoyeraal-Hreidarsson syndrome 
3421,Subcortical laminar heterotopia, X-linked 
3422,Lissencephaly type 1 due to doublecortin gene mutation 
3423,Heterotopia 
3424,Abnormal cerebral morphology 
3425,Hypospadias 2, X-linked 
3426,46,XY ovotesticular disorder of sex development 
3427,Congenital stationary night blindness 2A 
3428,Congenital stationary night blindness, type 2A, severe 
3429,Syndromic X-linked intellectual disability Snyder type 
3430,Intellectual disability, X-linked 41 
3431,Intellectual disability, X-linked 58 
3432,Allan-Herndon-Dudley syndrome 
3433,TARP syndrome 
3434,X-linked lymphoproliferative disease due to XIAP deficiency 
3435,Mitochondrial complex 1 deficiency, nuclear type 12 
3436,Coffin-Lowry syndrome 
3437,Intellectual disability, X-linked 19 
3438,Linear skin defects with multiple congenital anomalies 1 
3439,Congenital muscular hypertrophy-cerebral syndrome 
3440,X-linked mixed hearing loss with perilymphatic gusher 
3441,Simpson-Golabi-Behmel syndrome type 1 
3442,Creatine transporter deficiency 
3443,Craniofrontonasal syndrome 
3444,Intellectual disability, X-linked 88 
3445,Alpha thalassemia-X-linked intellectual disability syndrome 
3446,Atypical teratoid rhabdoid tumor 
3447,Astrocytoma, anaplastic 
3448,Cryptorchidism;Ambiguous genitalia;Bone osteosarcoma;Microcephaly;Intellectual disability, severe 
3449,Intellectual disability-hypotonic facies syndrome, X-linked 
3450,Intellectual disability-hypotonic facies syndrome, X-linked, 1;Alpha thalassemia-X-linked intellectual disability syndrome 
3451,Renier-Gabreels-Jasper syndrome 
3452,Intellectual disability-hypotonic facies syndrome, X-linked, 1 
3453,Acquired hemoglobin H disease;Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1 
3454,Acquired hemoglobin H disease 
3455,Heterotopia, periventricular, X-linked dominant 
3456,Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II 
3457,Oto-palato-digital syndrome, type I 
3458,Cleft palate;Short stature;Conductive hearing impairment 
3459,FLNA related disorders 
3460,Oto-palato-digital syndrome, type II 
3461,Oto-palato-digital syndrome, type II;Melnick-Needles syndrome;Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia 
3462,Frontometaphyseal dysplasia 1 
3463,Melnick-Needles syndrome 
3464,Heterotopia, periventricular, with frontometaphyseal dysplasia 
3465,Otopalatodigital syndrome spectrum disorder 
3466,Cardiac valvular dysplasia, X-linked 
3467,FLNA-related periventricular nodular heterotopia 
3468,FG syndrome 2 
3469,Terminal osseous dysplasia-pigmentary defects syndrome 
3470,Cutis laxa, X-linked 
3471,Menkes kinky-hair syndrome 
3472,Cutis laxa, X-linked;Menkes kinky-hair syndrome;X-linked distal spinal muscular atrophy type 3 
3473,X-linked distal spinal muscular atrophy type 3 
3474,Dent disease type 1 
3475,Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis 
3476,Nephrolithiasis, X-linked recessive 
3477,X-linked recessive nephrolithiasis with renal failure 
3478,Hypophosphatemic rickets, X-linked recessive 
3479,Rett syndrome, zappella variant 
3480,X-linked intellectual disability-psychosis-macroorchidism syndrome 
3481,Severe neonatal-onset encephalopathy with microcephaly 
3482,Autism, susceptibility to, X-linked 3 
3483,Severe neonatal-onset encephalopathy with microcephaly;Autism, susceptibility to, X-linked 3;Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome;Syndromic X-linked intellectual disability Lubs type 
3484,Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome 
3485,Syndromic X-linked intellectual disability Lubs type 
3486,Syndromic X-linked intellectual disability Lubs type;Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome 
3487,Behavioral abnormality 
3488,Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly;Autism, susceptibility to, X-linked 3;Syndromic X-linked intellectual disability Lubs type 
3489,Global developmental delay;Developmental regression 
3490,Usher syndrome type 1B 
3491,Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2 
3492,Autosomal recessive nonsyndromic hearing loss 2 
3493,Autosomal dominant nonsyndromic hearing loss 11 
3494,Tyrosinemia type I 
3495,Fumarylacetoacetase pseudodeficiency 
3496,Trypsinogen deficiency;Hereditary pancreatitis 
3497,Ghosal hematodiaphyseal syndrome 
3498,Ghosal hematodiaphyseal dysplasia 
3499,Hereditary factor XI deficiency disease 
3500,Plasma factor XI deficiency 
3501,Factor XI 
3502,Orotic aciduria 
3503,Hurler syndrome 
3504,Mucopolysaccharidosis type 1 
3505,Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S 
3506,Mucopolysaccharidosis, MPS-I-H/S 
3507,Mucopolysacchariduria 
3508,Mucopolysaccharidosis, MPS-I-S 
3509,Interstitial pneumonitis 
3510,IDUA pseudodeficiency 
3511,Mevalonic aciduria 
3512,Hyperimmunoglobulin D with periodic fever 
3513,Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria 
3514,Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria 
3515,MVK-Related Disorders 
3516,Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria 
3517,MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB 
3518,Maple syrup urine disease type 1B 
3519,Maple syrup urine disease, thiamine-responsive, type II 
3520,Intermediate maple syrup urine disease type 2 
3521,Maple syrup urine disease type 2 
3522,Deficiency of hydroxymethylglutaryl-CoA lyase 
3523,Infantile nephronophthisis 
3524,Pyruvate dehydrogenase E3 deficiency 
3525,DLD-Related Disorders 
3526,Non-ketotic hyperglycinemia 
3527,Generalized epilepsy;Global developmental delay;Obesity 
3528,Glycogen storage disease, type VI 
3529,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA 
3530,Glycogen storage disease 
3531,Short stature;Hypoglycemia 
3532,Propionic acidemia 
3533,Glutaric acidemia IIc 
3534,Essential fructosuria 
3535,Prekallikrein deficiency 
3536,Fanconi anemia complementation group D2 
3537,Fanconi anemia complementation group C 
3538,Fanconi anemia complementation group C;Tracheoesophageal fistula 
3539,Factor X deficiency 
3540,Hereditary factor X deficiency disease 
3541,Factor VII deficiency 
3542,Congenital factor VII deficiency 
3543,Myocardial infarction, decreased susceptibility to 
3544,Deficiency of bisphosphoglycerate mutase 
3545,Apparent mineralocorticoid excess 
3546,Apparent mineralocorticoid excess, mild 
3547,Complement component 7 deficiency 
3548,C7 and C6 deficiency, combined subtotal 
3549,Factor I deficiency 
3550,Atypical hemolytic-uremic syndrome with I factor anomaly 
3551,C2 deficiency, type II 
3552,Age related macular degeneration 14 
3553,Complement component 2 deficiency 
3554,Carnitine acylcarnitine translocase deficiency 
3555,Bombay phenotype 
3556,Para-Bombay phenotype 
3557,BOMBAY PHENOTYPE, DIGENIC 
3558,Bardet-Biedl syndrome 1 
3559,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 
3560,Adenoma, cortisol-producing 
3561,Carcinoma, adrenocortical, androgen-secreting 
3562,21-HYDROXYLASE POLYMORPHISM 
3563,Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency 
3564,3 beta-Hydroxysteroid dehydrogenase deficiency 
3565,Dilated cardiomyopathy 1W 
3566,Hypertrophic cardiomyopathy 15 
3567,Cataract 30 
3568,Cerebellar ataxia and intellectual disability with quadrupedal locomotion 1 
3569,Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 
3570,Neurohypophyseal diabetes insipidus 
3571,Diabetes insipidus, neurohypophyseal, autosomal recessive 
3572,Renal tubular acidosis with progressive nerve deafness 
3573,Distal renal tubular acidosis 
3574,Hereditary diffuse gastric adenocarcinoma 
3575,Breast lobular carcinoma 
3576,Familial juvenile hyperuricemic nephropathy type 1 
3577,Crigler-Najjar syndrome type 1 
3578,Gilbert syndrome 
3579,Crigler-Najjar syndrome, type II 
3580,Lucey-Driscoll syndrome 
3581,Hyperbilirubinemia 
3582,Lucey-Driscoll syndrome;Crigler-Najjar syndrome, type II;Bilirubin, serum level of, quantitative trait locus 1;Crigler-Najjar syndrome type 1;Gilbert syndrome 
3583,UGT1A1-Related Disorders 
3584,Hyper-IgM syndrome type 5 
3585,DPAGT1-CDG 
3586,Congenital myasthenic syndrome 13;DPAGT1-CDG 
3587,Parkinson disease 5, autosomal dominant, susceptibility to 
3588,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome 
3589,Hereditary insensitivity to pain with anhidrosis 
3590,Familial medullary thyroid carcinoma 
3591,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 
3592,Maturity-onset diabetes of the young type 11 
3593,TNF receptor-associated periodic fever syndrome (TRAPS) 
3594,Li-Fraumeni syndrome 1 
3595,B-cell chronic lymphocytic leukemia 
3596,Multiple myeloma 
3597,Brainstem glioma 
3598,Ovarian serous cystadenocarcinoma 
3599,Myelodysplastic syndrome 
3600,Hepatocellular carcinoma 
3601,Transitional cell carcinoma of the bladder 
3602,Squamous cell carcinoma of the skin 
3603,Choroid plexus carcinoma 
3604,Gallbladder cancer 
3605,CODON 72 POLYMORPHISM 
3606,Cancer of cervix 
3607,Li-Fraumeni-like syndrome 
3608,Sarcoma 
3609,Lymphoma 
3610,Ductal carcinoma in situ 
3611,Papillary renal cell carcinoma, sporadic 
3612,Gallbladder carcinoma 
3613,Pleomorphic xanthoastrocytoma;Astrocytoma, anaplastic 
3614,Adenocarcinoma 
3615,Familial ovarian cancer 
3616,Thyroid gland undifferentiated (anaplastic) carcinoma 
3617,Adrenal cortex carcinoma 
3618,Colorectal cancer;Multiple myeloma 
3619,Nasopharyngeal carcinoma 
3620,Nasopharyngeal neoplasm 
3621,Breast adenocarcinoma 
3622,Adenoid cystic carcinoma 
3623,Malignant tumor of esophagus 
3624,Adrenocortical carcinoma, pediatric 
3625,Adrenocortical carcinoma, hereditary 
3626,TNF receptor binding, altered 
3627,Tuberous sclerosis 2 
3628,Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2 
3629,Lymphangiomyomatosis;Tuberous sclerosis 2;Isolated focal cortical dysplasia type II 
3630,Dilated cardiomyopathy 1D 
3631,Hypertrophic cardiomyopathy 2 
3632,Cardiomyopathy, familial restrictive, 3 
3633,Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2 
3634,Dilated cardiomyopathy 1D;Cardiomyopathy, familial restrictive, 3;Hypertrophic cardiomyopathy 2 
3635,Costello syndrome 
3636,Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3 
3637,Primary dilated cardiomyopathy;Hypertrophic cardiomyopathy 
3638,Familial isolated dilated cardiomyopathy 
3639,Hypertrophic cardiomyopathy 2;Dilated cardiomyopathy 1D;Cardiomyopathy, familial restrictive, 3 
3640,Hypertrophic cardiomyopathy 7 
3641,Dilated Cardiomyopathy, Recessive 
3642,Familial restrictive cardiomyopathy 
3643,Cardiomyopathy;Amyloidogenic transthyretin amyloidosis 
3644,Dilated cardiomyopathy 2A 
3645,Cardiomyopathy, familial restrictive, 1 
3646,Restrictive cardiomyopathy;Hypertrophic cardiomyopathy 
3647,Restrictive cardiomyopathy 
3648,Hypertrophic cardiomyopathy;Restrictive cardiomyopathy 
3649,Dilated cardiomyopathy 1FF 
3650,Distal arthrogryposis type 2B1 
3651,Distal arthrogryposis;Calcaneovalgus deformity;Ulnar deviation of the wrist;Congenital finger flexion contractures 
3652,Nemaline myopathy 5 
3653,Dilated cardiomyopathy 1Z 
3654,Hypertrophic cardiomyopathy 13 
3655,Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z 
3656,Nemaline myopathy 1 
3657,Congenital myopathy with fiber type disproportion;Nemaline myopathy 1 
3658,Cap myopathy 1 
3659,Hypertrophic cardiomyopathy 3 
3660,Dilated cardiomyopathy 1Y 
3661,Arthrogryposis, distal, type 1A 
3662,Nemaline myopathy 4 
3663,Arthrogryposis, distal, type 2B4 
3664,Cap myopathy 2 
3665,Triosephosphate isomerase deficiency 
3666,Triosephosphate isomerase manchester 
3667,Aortic valve disease 1 
3668,Adams-Oliver syndrome 5 
3669,Autosomal recessive congenital ichthyosis 1 
3670,Congenital ichthyosiform erythroderma 
3671,Colorectal cancer, hereditary nonpolyposis, type 6 
3672,Loeys-Dietz syndrome 
3673,Marfan syndrome 
3674,Loeys-Dietz syndrome 2 
3675,Malignant tumor of esophagus;Colorectal cancer, hereditary nonpolyposis, type 6;Loeys-Dietz syndrome 2 
3676,Loeys-Dietz syndrome 1 
3677,Marfan syndrome;Loeys-Dietz syndrome 1 
3678,Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection 
3679,Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome 
3680,Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1 
3681,Diaphyseal dysplasia 
3682,Breast cancer, invasive, susceptibility to 
3683,Inflammatory bowel disease, immunodeficiency, and encephalopathy 
3684,Thyroid hormone resistance, generalized, autosomal dominant 
3685,Generalized resistance to thyroid hormone 
3686,Thyroid hormone resistance syndrome 
3687,Selective pituitary resistance to thyroid hormone 
3688,Colon cancer, advanced 
3689,Burkitt lymphoma 
3690,Thyroid tumor 
3691,Malignant tumor of urinary bladder 
3692,Autoimmune lymphoproliferative syndrome type 4 
3693,OCULOECTODERMAL SYNDROME, SOMATIC 
3694,Encephalocraniocutaneous lipomatosis 
3695,Nevus sebaceous 
3696,Bladder cancer, transitional cell, somatic 
3697,Epidermal nevus 
3698,Linear nevus sebaceous syndrome 
3699,Cerebral arteriovenous malformation 
3700,Vascular Tumors Including Pyogenic Granuloma 
3701,Primary low grade serous adenocarcinoma of ovary 
3702,Capillary malformation-arteriovenous malformation 1 
3703,Cardiofaciocutaneous syndrome 2 
3704,Cardio-facio-cutaneous syndrome;Noonan syndrome 
3705,Noonan syndrome 3 
3706,Noonan syndrome;Cardio-facio-cutaneous syndrome 
3707,Acute myeloid leukemia;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2;Noonan syndrome 3 
3708,Pilocytic astrocytoma 
3709,Congenital myopathy with excess of muscle spindles 
3710,Spermatocytic seminoma 
3711,Epidermal nevus with urothelial cancer, somatic 
3712,Woolly hair nevus 
3713,Costello syndrome, severe 
3714,Urinary bladder carcinoma 
3715,Transferrin variant d1 
3716,Transferrin variant chi 
3717,Atransferrinemia 
3718,Transferrin variant b2 
3719,Transferrin variant c1/c2 
3720,Transferrin variant bv 
3721,Iron deficiency anemia 
3722,Leukemia, Philadelphia chromosome-positive, resistant to imatinib 
3723,Lymphoblastic leukemia, acute, with lymphomatous features 
3724,Helicoid peripapillary chorioretinal degeneration 
3725,Posterior polymorphous corneal dystrophy 3 
3726,Corneal dystrophy, Fuchs endothelial, 6 
3727,Renal cysts and diabetes syndrome 
3728,Autosomal dominant medullary cystic kidney disease with or without hyperuricemia 
3729,Hypertrophic cardiomyopathy 9 
3730,Dilated cardiomyopathy 1G 
3731,Tibial muscular dystrophy 
3732,Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G 
3733,Dilated cardiomyopathy 1G;Autosomal recessive limb-girdle muscular dystrophy type 2J 
3734,Myopathy, myofibrillar, 9, with early respiratory failure 
3735,Autosomal recessive limb-girdle muscular dystrophy type 2J 
3736,Early-onset myopathy with fatal cardiomyopathy 
3737,Carney complex, type 1 
3738,Carney complex 
3739,Sorsby fundus dystrophy 
3740,Hypothyroidism, congenital, nongoitrous, 7 
3741,Secondary hypothyroidism 
3742,Iodotyrosyl coupling defect 
3743,Premature ovarian failure 
3744,Autoimmune thyroid disease, susceptibility to, 3 
3745,Mitochondrial DNA depletion syndrome, myopathic form 
3746,Bleeding diathesis due to thromboxane synthesis deficiency 
3747,Thrombomodulin-related bleeding disorder 
3748,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly 
3749,Atypical hemolytic-uremic syndrome 
3750,Thiopurine methyltransferase deficiency 
3751,Forebrain defects 
3752,Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 
3753,Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis 
3754,Dyskeratosis congenita, autosomal dominant 2 
3755,Autosomal recessive dyskeratosis congenita 4 
3756,Idiopathic Pulmonary Fibrosis;Dyskeratosis congenita, autosomal dominant 2 
3757,Idiopathic Pulmonary Fibrosis 
3758,Lymphoproliferative syndrome 1 
3759,Susceptibility to respiratory infections associated with CD8alpha chain mutation 
3760,Immunodeficiency 18 
3761,Immunodeficiency 19 
3762,Immunodeficiency 25 
3763,Combined immunodeficiency due to CD3gamma deficiency 
3764,Obesity, association with 
3765,Congenital diarrhea 5 with tufting enteropathy 
3766,Superoxide dismutase, elevated extracellular 
3767,Paragangliomas 4 
3768,Gastrointestinal stromal tumor;Pheochromocytoma;Paragangliomas 4 
3769,Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas 4 
3770,Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor 
3771,SDHB-Related Disorders 
3772,ADRENAL INSUFFICIENCY, NR5A1-RELATED 
3773,46,XX sex reversal 4 
3774,Premature ovarian failure 7 
3775,Hyperpigmentation with or without hypopigmentation, familial progressive 
3776,Anophthalmia/microphthalmia-esophageal atresia syndrome 
3777,Optic nerve hypoplasia and abnormalities of the central nervous system 
3778,Elliptocytosis 3 
3779,Hereditary spherocytosis type 2 
3780,Pyropoikilocytosis, hereditary 
3781,ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL 
3782,Elliptocytosis 2 
3783,Spherocytosis, type 3, autosomal recessive 
3784,Hereditary spherocytosis type 3 
3785,Hereditary spherocytosis type 2;Elliptocytosis 2 
3786,Prenatal anemia 
3787,Noonan syndrome 4 
3788,Noonan syndrome 4;Fibromatosis, gingival, 1 
3789,Noonan syndrome 1 
3790,Somatostatin analog, resistance to 
3791,Seizures, benign familial infantile, 3 
3792,Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3 
3793,Seizures, benign familial infantile, 3;Developmental and epileptic encephalopathy, 11 
3794,Developmental and epileptic encephalopathy, 11 
3795,Benign familial infantile epilepsy 
3796,Complex neurodevelopmental disorder 
3797,Generalized epilepsy with febrile seizures plus, type 2 
3798,Severe myoclonic epilepsy in infancy 
3799,Autosomal dominant epilepsy 
3800,Severe myoclonic epilepsy in infancy;Migraine, familial hemiplegic, 3;Generalized epilepsy with febrile seizures plus, type 2 
3801,Migraine, familial hemiplegic, 3 
3802,Febrile seizures, familial, 3a 
3803,Familial renal glucosuria 
3804,Congenital glucose-galactose malabsorption 
3805,Dystonia 12 
3806,Alternating hemiplegia of childhood 2 
3807,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;Alternating hemiplegia of childhood 2;Dystonia 12 
3808,Migraine, familial hemiplegic, 2 
3809,Alternating hemiplegia of childhood 1 
3810,Migraine, familial basilar 
3811,Hypophosphatemic nephrolithiasis/osteoporosis 1 
3812,Obsessive-compulsive disorder, susceptibility to 
3813,Behavior disorder 
3814,Dopa-responsive dystonia due to sepiapterin reductase deficiency 
3815,Vitamin b12 plasma level quantitative trait locus 1 
3816,SECRETOR/NONSECRETOR POLYMORPHISM 
3817,Familial Otitis Media 
3818,SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE 
3819,Microcephaly 7, primary, autosomal recessive 
3820,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 
3821,Catecholaminergic polymorphic ventricular tachycardia 1 
3822,Catecholaminergic polymorphic ventricular tachycardia 
3823,Arrhythmogenic right ventricular dysplasia 2 
3824,Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome 
3825,Malignant hyperthermia, susceptibility to, 1 
3826,RYR1-Related Disorders 
3827,Malignant hyperthermia of anesthesia 
3828,enflurane response - Toxicity 
3829,succinylcholine response - Toxicity 
3830,desflurane response - Toxicity 
3831,halothane response - Toxicity 
3832,isoflurane response - Toxicity 
3833,methoxyflurane response - Toxicity 
3834,sevoflurane response - Toxicity 
3835,Central core myopathy 
3836,Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;Central core myopathy 
3837,Congenital multicore myopathy with external ophthalmoplegia 
3838,Absence of the sacrum;History of neonatal hypotonia;Ptosis 
3839,King Denborough syndrome 
3840,Neuromuscular disease, congenital, with uniform type 1 fiber 
3841,Central core disease, autosomal recessive 
3842,Clubfoot;Lower limb amyotrophy;EMG abnormality 
3843,Diamond-Blackfan anemia 4 
3844,Diamond-Blackfan anemia 5 
3845,Prostate cancer, hereditary, 1 
3846,Deficiency of ribose-5-phosphate isomerase 
3847,Oguchi disease-2 
3848,Retinitis pigmentosa 4 
3849,Retinitis pigmentosa 4;Pigmentary retinal dystrophy;Congenital stationary night blindness autosomal dominant 1 
3850,Peripheral visual field loss;Blurred vision;Night blindness 
3851,Retinitis punctata albescens 
3852,Retinitis pigmentosa 4, autosomal recessive 
3853,Congenital stationary night blindness autosomal dominant 1 
3854,Rh mod blood group phenotype 
3855,Rh-null, regulator type 
3856,Progressive retinal dystrophy due to retinol transport defect 
3857,Retinoblastoma 
3858,Vulvar adenocarcinoma of mammary gland type 
3859,Retinoblastoma;Malignant tumor of urinary bladder;Small cell lung carcinoma;Bone osteosarcoma 
3860,Trilateral retinoblastoma 
3861,Newfoundland cone-rod dystrophy 
3862,Bothnia retinal dystrophy 
3863,RLBP1-Related Disorders 
3864,Retinitis pigmentosa 40 
3865,Congenital stationary night blindness autosomal dominant 2 
3866,Retinitis pigmentosa 43 
3867,Leber congenital amaurosis 2 
3868,Leber congenital amaurosis 2;Retinitis pigmentosa 20 
3869,Retinitis pigmentosa 20 
3870,Retinitis pigmentosa 20;Leber congenital amaurosis 2 
3871,Retinitis pigmentosa 20;Leber congenital amaurosis;RPE65-Related Disorders 
3872,Hyperproreninemia, familial 
3873,Renal tubular dysgenesis 
3874,Familial juvenile hyperuricemic nephropathy type 2 
3875,Mirror movements 2 
3876,Severe combined immunodeficiency, B cell-negative 
3877,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn errors of immunity 
3878,Recombinase activating gene 2 deficiency;Inborn errors of immunity;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis 
3879,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas 
3880,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn errors of immunity 
3881,Recombinase activating gene 2 deficiency;Inborn errors of immunity;Histiocytic medullary reticulosis 
3882,Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas;Histiocytic medullary reticulosis 
3883,Combined immunodeficiency with skin granulomas 
3884,Combined immunodeficiency with skin granulomas;Recombinase activating gene 2 deficiency;Inborn errors of immunity 
3885,Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive 
3886,RECOMBINATION ACTIVATING GENE 1 POLYMORPHISM 
3887,Combined immunodeficiency due to partial RAG1 deficiency 
3888,Retinitis pigmentosa 7 
3889,PRPH2-Related Disorders 
3890,Patterned dystrophy of the retinal pigment epithelium 
3891,Retinitis pigmentosa 7, digenic 
3892,Patterned macular dystrophy 1 
3893,Leber congenital amaurosis 18 
3894,Choroidal dystrophy, central areolar 2 
3895,Vitelliform macular dystrophy 3 
3896,Adult-onset foveomacular vitelliform dystrophy 
3897,maculopathy 
3898,Autosomal recessive nonsyndromic hearing loss 24 
3899,Pyruvate dehydrogenase E1-beta deficiency 
3900,Autosomal recessive cutis laxa type 2B 
3901,PYCR1-related de Barsy syndrome 
3902,Wiedemann-Rautenstrauch-like progeroid syndrome 
3903,Neonatal acute respiratory distress due to SP-B deficiency 
3904,Pulmonary fibrosis, idiopathic, susceptibility to 
3905,Surfactant metabolism dysfunction, pulmonary, 2 
3906,Postanesthetic apnea 
3907,Deficiency of butyrylcholinesterase 
3908,Bche, h variant 
3909,BCHE, flouride 1 
3910,BCHE, fluoride 2 
3911,Butyrylcholinesterase activity 
3912,Bche, j variant 
3913,Butyrylcholinesterase deficiency, fluoride-resistant, japanese type 
3914,Cataract 21 multiple types 
3915,Hereditary spherocytosis type 5 
3916,Polycystic liver disease 1 
3917,Spinocerebellar ataxia type 14 
3918,Combined immunodeficiency due to ZAP70 deficiency 
3919,ZAP70-Related Severe Combined Immunodeficiency 
3920,Cataract 6 multiple types 
3921,Cataract 6, age-related cortical 
3922,Cortical senile cataract 
3923,Crouzon syndrome 
3924,Pfeiffer syndrome 
3925,Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis 
3926,FGFR2 related craniosynostosis 
3927,Craniosynostosis syndrome 
3928,Jackson-Weiss syndrome 
3929,Scaphocephaly and axenfeld-rieger anomaly 
3930,Craniosynostosis, nonclassifiable autosomal dominant 
3931,Acrocephalosyndactyly type I 
3932,FGFR2-related disorder 
3933,22 conditions 
3934,Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation 
3935,Acrocephalosyndactyly 
3936,Endometrial neoplasm 
3937,Head and neck neoplasm 
3938,Beare-Stevenson cutis gyrata syndrome 
3939,Aural atresia, congenital 
3940,Pfeiffer syndrome type 3 
3941,Craniosynostosis, nonsyndromic unicoronal 
3942,Craniofacial-skeletal-dermatologic dysplasia 
3943,Familial scaphocephaly syndrome, McGillivray type 
3944,PROTHROMBIN TYPE 3 
3945,Congenital prothrombin deficiency 
3946,Hereditary factor II deficiency disease 
3947,DYSPROTHROMBINEMIA PROTHROMBIN HIMI-II 
3948,Protein S Heerlen 
3949,Thrombophilia due to protein S deficiency, autosomal recessive 
3950,Thrombophilia due to protein S deficiency, autosomal dominant 
3951,Protein S deficiency disease 
3952,LEOPARD syndrome 1;Noonan syndrome 1 
3953,Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1 
3954,Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;Noonan syndrome 1 
3955,Metachondromatosis;LEOPARD syndrome 1;Noonan syndrome 1 
3956,LEOPARD syndrome 1 
3957,PTPN11 Related Disorders 
3958,Noonan syndrome with multiple lentigines 
3959,CBL-related disorder 
3960,Noonan syndrome with multiple lentigines;Noonan syndrome 
3961,Noonan syndrome;Juvenile myelomonocytic leukemia 
3962,Short stature;Abnormality of cardiovascular system morphology 
3963,PTPN11-related disorder 
3964,Juvenile myelomonocytic leukemia;Noonan syndrome 
3965,B lymphoblastic leukemia lymphoma, no ICD-O subtype;Lymphoma 
3966,Juvenile myelomonocytic leukemia;Metachondromatosis;Noonan syndrome 1;LEOPARD syndrome 1 
3967,Early T cell progenitor acute lymphoblastic leukemia 
3968,Astrocytoma 
3969,Malignant neoplastic disease 
3970,LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;Noonan syndrome 1 
3971,Acute megakaryoblastic leukemia in down syndrome 
3972,Metachondromatosis 
3973,Cardiofaciocutaneous syndrome 3 
3974,Cardiofaciocutaneous syndrome 3;Noonan syndrome 1 
3975,Melorheostosis 
3976,Obesity due to pro-opiomelanocortin deficiency 
3977,Obesity, early-onset, susceptibility to 
3978,Sphingolipid activator protein 1 deficiency 
3979,Encephalopathy due to prosaposin deficiency 
3980,Atypical Gaucher disease due to saposin C deficiency 
3981,Skeletal defects, genital hypoplasia, and intellectual disability 
3982,Hyperproinsulinemia 
3983,Diabetes mellitus, permanent neonatal 4 
3984,Maturity-onset diabetes of the young type 10 
3985,Type 1 diabetes mellitus 2 
3986,Gerstmann-Straussler-Scheinker syndrome 
3987,Huntington disease-like 1 
3988,Spongiform encephalopathy with neuropsychiatric features 
3989,Inherited Creutzfeldt-Jakob disease 
3990,Alzheimer disease, early-onset, susceptibility to 
3991,Aphasia, primary progressive, susceptibility to 
3992,Prion disease, susceptibility to 
3993,Inherited prion disease 
3994,Fatal familial insomnia 
3995,Protection against Creutzfeldt-Jakob disease 
3996,Kuru, protection against 
3997,Amyloidogenic transthyretin amyloidosis 
3998,Hyperthyroxinemia, dystransthyretinemic;Amyloidogenic transthyretin amyloidosis;Carpal tunnel syndrome 
3999,Amyloid Cardiomyopathy, Transthyretin-related 
4000,Bone marrow hypocellularity;Pancytopenia;Anemia 
4001,ATTRV122I amyloidosis 
4002,Postural tremor 
4003,Heart failure 
4004,AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED, MODIFIER OF 
4005,Carpal tunnel syndrome 1 
4006,TRANSTHYRETIN POLYMORPHISM 
4007,Hyperthyroxinemia, dystransthyretinemic 
4008,AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED 
4009,Atrial fibrillation, familial, 7 
4010,Spinocerebellar ataxia type 13 
4011,Jervell and Lange-Nielsen syndrome 2 
4012,Long QT syndrome 5 
4013,Sudden unexplained death;Arrhythmogenic right ventricular cardiomyopathy;Brugada syndrome 
4014,Jervell and Lange-Nielsen syndrome 
4015,Long QT syndrome 5, acquired, susceptibility to 
4016,Long QT syndrome 2/5, digenic 
4017,Episodic ataxia type 1 
4018,Myokymia 1 
4019,Episodic ataxia/myokymia syndrome 
4020,Myokymia 1 with hypomagnesemia 
4021,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 
4022,Progressive sclerosing poliodystrophy 
4023,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1 
4024,Spinocerebellar ataxia with epilepsy 
4025,POLG-Related Spectrum Disorders 
4026,POLG-related condition 
4027,Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy 
4028,POLG-related disorders 
4029,Mitochondrial DNA depletion syndrome 4b 
4030,Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive sclerosing poliodystrophy;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1 
4031,Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1 
4032,Abnormality of the mitochondrion 
4033,POLG- Related Disorder 
4034,Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy 
4035,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy 
4036,Mitochondrial DNA depletion syndrome 1 
4037,Intellectual developmental disorder, X-linked 108 
4038,Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy 
4039,Abnormality of corpus callosum 
4040,Polycystic kidney disease 2 
4041,Autosomal dominant polycystic kidney disease 
4042,IgA glomerulonephritis 
4043,SELECTIN P POLYMORPHISM 
4044,Bernard-Soulier syndrome type C 
4045,Bernard Soulier syndrome 
4046,Platelet-type bleeding disorder 10 
4047,Inherited bleeding disorder, platelet-type 
4048,Malaria, cerebral, susceptibility to 
4049,Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal 
4050,Hypereosinophilic syndrome, idiopathic, resistant to imatinib 
4051,Glanzmann thrombasthenia 2 
4052,Platelet-type bleeding disorder 16 
4053,PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM 
4054,PL(A1)/(A2) ALLOANTIGEN POLYMORPHISM 
4055,Mo ALLOANTIGEN POLYMORPHISM 
4056,Ca/Tu ALLOANTIGEN POLYMORPHISM 
4057,Congenital plasminogen activator inhibitor type 1 deficiency 
4058,Dysplasminogenemia 
4059,Plasminogen deficiency, type I 
4060,Otitis media, susceptibility to 
4061,Arterial calcification, generalized, of infancy, 1 
4062,Hypophosphatemic rickets, autosomal recessive, 2 
4063,Hypopigmentation-punctate palmoplantar keratoderma syndrome 
4064,Hypophosphatemic rickets 
4065,Coronary sclerosis, medial, of infancy 
4066,Autosomal recessive nonsyndromic hearing loss 91 
4067,Pituitary hormone deficiency, combined, 1 
4068,Glycogen storage disease IXb 
4069,Deficiency of phosphoserine phosphatase 
4070,Glycogen storage disease IXc 
4071,Spina bifida, folate-sensitive, susceptibility to 
4072,Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia 
4073,Dilated cardiomyopathy 1P 
4074,Hypertrophic cardiomyopathy 18 
4075,Sudden cardiac death 
4076,Cardiac arrest 
4077,Hemolytic anemia due to glucophosphate isomerase deficiency 
4078,Hemolytic anemia, nonspherocytic, and neurologic deficits, due to glucose phosphate isomerase deficiency 
4079,PGM1-CDG 
4080,Seborrheic keratosis 
4081,OVARIAN CANCER, EPITHELIAL, SOMATIC 
4082,CLOVES syndrome 
4083,PIK3CA related overgrowth spectrum 
4084,Rosette-forming glioneuronal tumor 
4085,MACRODACTYLY, SOMATIC 
4086,CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC 
4087,CLAPO syndrome 
4088,Cerebrofacial Vascular Metameric Syndrome (CVMS) 
4089,Congenital macrodactylia 
4090,Segmental undergrowth associated with mainly venous malformation with capillary component 
4091,Segmental undergrowth associated with lymphatic malformation 
4092,Megalencephaly-capillary malformation-polymicrogyria syndrome 
4093,Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes 
4094,Macrodactyly of toe;Stroke 
4095,Hemihypertrophy 
4096,Eccrine Angiomatous Hamartoma 
4097,ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM 
4098,Infantile hypophosphatasia 
4099,Hypophosphatasia 
4100,Childhood hypophosphatasia 
4101,Adult hypophosphatasia 
4102,Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia 
4103,Odontohypophosphatasia 
4104,Perinatal lethal hypophosphatasia 
4105,Adult hypophosphatasia;Infantile hypophosphatasia;Childhood hypophosphatasia 
4106,ACID PHOSPHATASE 1, SOLUBLE, A/B POLYMORPHISM OF 
4107,Progressive familial intrahepatic cholestasis type 3 
4108,Low phospholipid associated cholelithiasis 
4109,ABCB4-related disorders 
4110,Colchicine resistance 
4111,Hyperapobetalipoproteinemia, susceptibility to 
4112,Peroxisome biogenesis disorder 5A (Zellweger) 
4113,Peroxisome biogenesis disorder 5B 
4114,Familial hemophagocytic lymphohistiocytosis 2 
4115,Hemophagocytic lymphohistiocytosis, familial, 2, susceptibility to 
4116,PEPTIDE TRANSPORTER PSF2 POLYMORPHISM 
4117,MHC class I deficiency 
4118,PEPTIDE TRANSPORTER PSF1 POLYMORPHISM 
4119,TAP1 deficiency, somatic 
4120,PRB3S(CYS) 
4121,Coronary artery spasm 2, susceptibility to 
4122,Coronary artery disease, susceptibility to 
4123,Enzyme activity finding 
4124,Microvascular complications of diabetes, susceptibility to, 5 
4125,Brachydactyly type E2 
4126,Metaphyseal chondrodysplasia, Jansen type 
4127,Primary failure of tooth eruption 
4128,Chondrodysplasia Blomstrand type 
4129,Eiken syndrome 
4130,VON HIPPEL-LINDAU SYNDROME, MODIFIER OF 
4131,Multiple myeloma, translocation 11,14 type 
4132,Hypoparathyroidism, familial isolated 1 
4133,Primary hyperparathyroidism 
4134,Tooth agenesis, selective, 3 
4135,Partial congenital absence of teeth 
4136,PAX8 POLYMORPHISM 
4137,Hypothyroidism, congenital, nongoitrous, 2 
4138,Diabetes mellitus, ketosis-prone, susceptibility to 
4139,Maturity-onset diabetes of the young type 9 
4140,Renal coloboma syndrome 
4141,Papillorenal syndrome with macular abnormalities 
4142,CBL-related disorder;Fragile site 11b 
4143,Fragile site 11b;CBL-related disorder 
4144,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia 
4145,Hematologic neoplasm 
4146,Juvenile myelomonocytic leukemia;CBL-related disorder 
4147,Tetraamelia syndrome 1 
4148,Pallister-Hall syndrome 
4149,Postaxial polydactyly, type A1/B 
4150,Greig cephalopolysyndactyly syndrome 
4151,Polydactyly 
4152,Polydactyly, postaxial, type A1 
4153,Greig cephalopolysyndactyly syndrome;Pallister-Hall syndrome 
4154,Greig cephalopolysyndactyly syndrome, severe 
4155,Polysyndactyly 4 
4156,Hirschsprung disease, susceptibility to, 1 
4157,Pallister-Hall syndrome;Greig cephalopolysyndactyly syndrome 
4158,Holoprosencephaly 9 
4159,Deafness with labyrinthine aplasia, microtia, and microdontia 
4160,Partial albinism 
4161,Mast cell leukemia 
4162,Dysgerminoma 
4163,MAST CELL LEUKEMIA, SOMATIC 
4164,MASTOCYTOSIS, SYSTEMIC, SOMATIC 
4165,MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC DISORDER, SOMATIC 
4166,Cutaneous mastocytosis 
4167,Piebaldism with sensorineural deafness 
4168,MASTOCYTOSIS, CUTANEOUS AND SYSTEMIC, SOMATIC 
4169,Mastocytosis 
4170,Germ cell tumor of testis 
4171,Gastrointestinal stromal tumor, familial 
4172,Thymoma 
4173,Rett syndrome, congenital variant 
4174,ERBB2 POLYMORPHISM 
4175,Ovarian adenocarcinoma 
4176,Renal cell carcinoma 
4177,Carcinoma 
4178,Renal carcinoma 
4179,Autosomal recessive nonsyndromic hearing loss 97 
4180,Pediatric hepatocellular carcinoma 
4181,Feingold syndrome type 1 
4182,Feingold syndrome 
4183,Large congenital melanocytic nevus 
4184,Noonan syndrome 6 
4185,Neurocutaneous melanocytosis 
4186,Multiple endocrine neoplasia, type 2a 
4187,Multiple endocrine neoplasia, type 2 
4188,MEN2 phenotype: Unclassified 
4189,Multiple endocrine neoplasia, type 1 
4190,Multiple endocrine neoplasia, type 2b 
4191,Medullary thyroid carcinoma 
4192,Aganglionic megacolon 
4193,Multiple endocrine neoplasia, type 2;Aganglionic megacolon 
4194,Thyroid gland carcinoma 
4195,Thyroid carcinoma, sporadic medullary 
4196,MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE 
4197,Multiple endocrine neoplasia, type 2a;Familial medullary thyroid carcinoma 
4198,Multiple endocrine neoplasia 
4199,Multiple endocrine neoplasia;Familial medullary thyroid carcinoma 
4200,Congenital central hypoventilation 
4201,Noonan syndrome 5 
4202,LEOPARD syndrome 2 
4203,LEOPARD syndrome 2;Dilated cardiomyopathy 1NN;Noonan syndrome 5 
4204,RAF1-related disorders 
4205,Papillary thyroid carcinoma 
4206,Astrocytoma, low-grade, somatic 
4207,Nongerminomatous germ cell tumor 
4208,Colonic neoplasm 
4209,Cystic epithelial invagination containing papillae lined by columnar epithelium 
4210,Trametinib-Dabrafenib Response 
4211,Vemurafenib-Cobimetinib Response 
4212,Nephroblastoma 
4213,Lymphangioma 
4214,Cardiofaciocutaneous syndrome 1 
4215,Noonan syndrome 7 
4216,Noonan syndrome 7;LEOPARD syndrome 3;Cardiofaciocutaneous syndrome 1 
4217,LEOPARD syndrome 3 
4218,10 conditions 
4219,Familial cardiofaciocutaneous syndrome 
4220,PHACE syndrome;Tethered cord;Genetic syndrome with a Dandy-Walker malformation as major feature 
4221,Dandy-Walker syndrome 
4222,Noonan syndrome 7;LEOPARD syndrome 3;Noonan syndrome 1;Lung carcinoma;Cardiofaciocutaneous syndrome 1 
4223,Proteus syndrome 
4224,Tumor of meninges 
4225,Prostate neoplasm 
4226,Cowden syndrome 6 
4227,OAS1 polymorphism 
4228,Obesity due to congenital leptin deficiency 
4229,Purine-nucleoside phosphorylase deficiency 
4230,NUCLEOSIDE PHOSPHORYLASE POLYMORPHISM 
4231,Amyotrophic lateral sclerosis type 21 
4232,Ectodermal dysplasia and immunodeficiency 2 
4233,Neurocirculatory asthenia 
4234,Autosomal dominant Parkinson disease 1 
4235,Lewy body dementia;Autosomal dominant Parkinson disease 1 
4236,Autosomal dominant Parkinson disease 4 
4237,Coronary artery spasm 1, susceptibility to 
4238,Alzheimer disease, late-onset, susceptibility to 
4239,Hypertension resistant to conventional therapy 
4240,Hypertension, pregnancy-induced, susceptibility to 
4241,Ischemic heart disease, susceptibility to 
4242,Glaucoma 1, open angle, O 
4243,Intellectual disability, X-linked 99 
4244,Warts, hypogammaglobulinemia, infections, and myelokathexis 
4245,WHIM syndrome 1 
4246,NEUROPEPTIDE Y POLYMORPHISM 
4247,Hypogonadotropic hypogonadism 11 with or without anosmia 
4248,Hypogonadotropic hypogonadism 10 without anosmia 
4249,Charcot-Marie-Tooth disease type 2E 
4250,Hand muscle atrophy;Distal muscle weakness;Decreased nerve conduction velocity;Peripheral demyelination;Peripheral neuropathy 
4251,Pes cavus;Peripheral neuropathy;Distal lower limb muscle weakness 
4252,Charcot-Marie-Tooth disease type 1F 
4253,Obesity due to prohormone convertase I deficiency 
4254,Body mass index quantitative trait locus 12 
4255,Retinitis pigmentosa 27 
4256,Retinal degeneration, autosomal recessive, clumped pigment type 
4257,Congenital sensory neuropathy with selective loss of small myelinated fibers 
4258,Nemaline myopathy 2 
4259,Mitochondrial complex 1 deficiency, nuclear type 4 
4260,Hypertrophic cardiomyopathy 8 
4261,Hypertrophic cardiomyopathy 10 
4262,MYL2-Related Disorders 
4263,Death in early adulthood 
4264,Griscelli syndrome type 1 
4265,Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 
4266,MYH9-related disorder 
4267,Autosomal dominant nonsyndromic hearing loss 17 
4268,MYH7-Related Disorders 
4269,Left ventricular noncompaction cardiomyopathy 
4270,Myosin storage myopathy 
4271,MYH7-related late-onset scapuloperoneal muscular dystrophy 
4272,MYH7-related skeletal myopathy 
4273,Chest pain;Hypertrophic cardiomyopathy 
4274,Arrhythmogenic cardiomyopathy 
4275,Myopathy, myosin storage, autosomal recessive 
4276,Left ventricular noncompaction 5 
4277,Aortic aneurysm, familial thoracic 4 
4278,Carney complex - trismus - pseudocamptodactyly syndrome 
4279,Hecht syndrome 
4280,Myopathy, proximal, and ophthalmoplegia 
4281,Freeman-Sheldon syndrome 
4282,Arthrogryposis, distal, type 2B3 
4283,MYH3-Related Disorders 
4284,Freeman-Sheldon syndrome;Distal arthrogryposis type 2B1;Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A 
4285,Hypertrophic cardiomyopathy 14 
4286,Atrial septal defect 3 
4287,Hemiplegia;Primary dilated cardiomyopathy;Migraine 
4288,Dilated cardiomyopathy 1EE 
4289,Sudden cardiac death;Hypertrophic cardiomyopathy 14 
4290,Ventricular tachycardia;Primary dilated cardiomyopathy 
4291,Myopathy, centronuclear, 3 
4292,Congenital amegakaryocytic thrombocytopenia 
4293,Essential thrombocythemia;Congenital amegakaryocytic thrombocytopenia 
4294,Thrombocythemia 2 
4295,Thrombocythemia 1 
4296,Myeloproliferative neoplasm 
4297,Myelofibrosis 
4298,Primary myelofibrosis 
4299,Thrombocythemia 2, somatic 
4300,Charcot-Marie-Tooth disease type 1B 
4301,Decreased nerve conduction velocity;Distal muscle weakness;Distal lower limb amyotrophy;Sensory neuropathy;Pes cavus 
4302,Neuropathy, congenital hypomyelinating, 2 
4303,Charcot-Marie-Tooth disease type 2J 
4304,Charcot-Marie-Tooth disease dominant intermediate D 
4305,Distal hereditary motor neuropathy type 2 
4306,Charcot-Marie-Tooth disease type 2I 
4307,Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths 
4308,Mitochondrial complex 1 deficiency, nuclear type 5 
4309,Abetalipoproteinaemia 
4310,Metabolic syndrome, protection against 
4311,Frontotemporal dementia 
4312,Progressive supranuclear ophthalmoplegia 
4313,Pick disease;Parkinson disease, late-onset;Progressive supranuclear palsy-parkinsonism syndrome;Frontotemporal dementia;Progressive supranuclear ophthalmoplegia 
4314,Pick disease 
4315,MAPT-Related Spectrum Disorders 
4316,Waardenburg syndrome type 2A 
4317,Tietz syndrome 
4318,Heterochromia iridis;Poliosis;Prelingual sensorineural hearing impairment 
4319,Methylcobalamin deficiency type cblG 
4320,Epilepsy;Intellectual disability, profound 
4321,Decreased methionine synthase activity;Homocystinuria 
4322,Merosin deficient congenital muscular dystrophy 
4323,LAMA2-related muscular dystrophy 
4324,Merosin deficient congenital muscular dystrophy;Muscular dystrophy, limb-girdle, autosomal recessive 23 
4325,Congenital Muscular Dystrophy, LAMA2-related 
4326,Congenital muscular dystrophy due to partial LAMA2 deficiency 
4327,Spondyloepimetaphyseal dysplasia, aggrecan type 
4328,Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans 
4329,Skin/hair/eye pigmentation 2, red hair/fair skin 
4330,Melanoma, cutaneous malignant, susceptibility to, 5 
4331,Skin and Hair Hypopigmentation 
4332,Skin/hair/eye pigmentation 2, blond hair/fair skin 
4333,OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF 
4334,Increased analgesia from kappa-opioid receptor agonist, female-specific 
4335,UV-induced skin damage, susceptibility to 
4336,Schizophrenia 
4337,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 
4338,Body mass index quantitative trait locus 9 
4339,Keutel syndrome 
4340,MPI-CDG 
4341,Mannose-binding lectin deficiency 
4342,Cataract 15 multiple types 
4343,Cataract 19 multiple types 
4344,Exfoliation syndrome, susceptibility to 
4345,LYSYL OXIDASE POLYMORPHISM 
4346,Ehlers-Danlos syndrome, kyphoscoliotic type 1 
4347,Familial visceral amyloidosis, Ostertag type 
4348,Gonadotropin-independent familial sexual precocity 
4349,Precocious puberty in males 
4350,Gonadotropin-independent familial sexual precocity;Leydig cell agenesis 
4351,Leydig cell agenesis 
4352,Luteinizing hormone resistance, female 
4353,Leydig hypoplasia, type I 
4354,Leydig cell hypoplasia, type II 
4355,Leydig cell adenoma, somatic, with male-limited precocious puberty 
4356,Isolated lutropin deficiency 
4357,Variant of unknown significance 
4358,Obesity;Prolonged QT interval 
4359,Long QT syndrome, bradycardia-induced 
4360,Long QT syndrome 2, acquired, susceptibility to 
4361,Short QT syndrome type 1 
4362,Lipoprotein(a) deficiency, congenital 
4363,Hyperlipidemia due to hepatic triglyceride lipase deficiency 
4364,Stuve-Wiedemann syndrome 
4365,Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 
4366,Transient myeloproliferative disorder of Down syndrome 
4367,Leukemia, acute myeloid, m0 subtype 
4368,Acquired partial lipodystrophy 
4369,Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to 
4370,Progressive myoclonic epilepsy type 9 
4371,Benign scapuloperoneal muscular dystrophy with cardiomyopathy 
4372,Familial partial lipodystrophy, Dunnigan type 
4373,Laminopathy 
4374,Emery-Dreifuss muscular dystrophy 3, autosomal recessive 
4375,Mandibuloacral dysplasia with type A lipodystrophy 
4376,Hutchinson-Gilford syndrome 
4377,Hutchinson-Gilford progeria syndrome, childhood-onset 
4378,Familial partial lipodystrophy 
4379,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules 
4380,Congenital muscular dystrophy due to LMNA mutation 
4381,Charcot-Marie-Tooth disease type 2B1 
4382,Emery-Dreifuss muscular dystrophy 
4383,Autosomal recessive axonal hereditary motor and sensory neuropathy 
4384,Mandibuloacral dysplasia with type A lipodystrophy, atypical 
4385,Mandibuloacral dysplasia 
4386,Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy 
4387,Restrictive dermopathy 2 
4388,Hutchinson-Gilford progeria syndrome, atypical 
4389,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome 
4390,Pierson syndrome 
4391,LAMB2-related infantile-onset nephrotic syndrome 
4392,Pierson syndrome;LAMB2-related infantile-onset nephrotic syndrome 
4393,Junctional epidermolysis bullosa, non-Herlitz type 
4394,Junctional epidermolysis bullosa gravis of Herlitz;Junctional epidermolysis bullosa, non-Herlitz type;Amelogenesis imperfecta type 1A 
4395,Junctional epidermolysis bullosa 
4396,Epidermolysis bullosa, junctional 3B, severe 
4397,Epidermolysis bullosa, junctional 3A, intermediate 
4398,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency 
4399,Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency 
4400,Bullous ichthyosiform erythroderma 
4401,Annular epidermolytic ichthyosis;Bullous ichthyosiform erythroderma;Congenital reticular ichthyosiform erythroderma 
4402,Epidermolytic acanthoma 
4403,Cirrhosis, cryptogenic 
4404,Cirrhosis, noncryptogenic, susceptibility to 
4405,Pachyonychia congenita 2 
4406,Steatocystoma multiplex 
4407,Pachyonychia congenita 1 
4408,Palmoplantar keratoderma, nonepidermolytic, focal 1 
4409,Palmoplantar keratoderma, nonepidermolytic, focal 1;Pachyonychia congenita 1 
4410,Epidermolysis bullosa simplex, Koebner type 
4411,Epidermolysis bullosa simplex 1A, generalized severe 
4412,Epidermolysis bullosa simplex 
4413,Epidermolysis bullosa simplex 1A, generalized severe;Epidermolysis bullosa simplex, Koebner type 
4414,Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive 
4415,Epidermolysis bullosa simplex 1C, localized 
4416,Dermatopathia pigmentosa reticularis 
4417,White sponge nevus 2 
4418,Hepatitis C virus, susceptibility to 
4419,Corneal dystrophy, Meesmann, 2 
4420,Pachyonychia congenita 4 
4421,Pachyonychia congenita 3 
4422,Epidermolysis bullosa simplex 2A, generalized severe 
4423,Epidermolysis bullosa simplex 2B, generalized intermediate 
4424,Epidermolysis bullosa simplex 2C, localized 
4425,Dowling-Degos disease 1 
4426,Epidermolysis bullosa simplex with mottled pigmentation 
4427,Epidermolysis bullosa simplex 2C, localized, modifier of 
4428,Kallikrein, decreased urinary activity of 
4429,Soluble interleukin-6 receptor, serum level of, quantitative trait locus 
4430,Interleukin 6, serum level of, quantitative trait locus 
4431,Acquired polycythemia vera 
4432,Budd-Chiari syndrome, susceptibility to, somatic 
4433,Primary familial polycythemia due to EPO receptor mutation 
4434,Thrombocythemia 3 
4435,Myeloproliferative disorder 
4436,Subacute lymphoid leukemia 
4437,Splenomegaly;Myelofibrosis 
4438,Polycythemia 
4439,Atopy, susceptibility to 
4440,Acquired immunodeficiency syndrome, slow progression to 
4441,Atopy, resistance to 
4442,Allergic rhinitis 
4443,Sterile multifocal osteomyelitis with periostitis and pustulosis 
4444,Insulin-resistant diabetes mellitus AND acanthosis nigricans 
4445,Leprechaunism syndrome 
4446,Insulin resistance 
4447,Insulin-resistant diabetes mellitus 
4448,Pineal hyperplasia AND diabetes mellitus syndrome 
4449,Bailey-Bloch congenital myopathy 
4450,Hyperinsulinism due to INSR deficiency 
4451,D-2-hydroxyglutaric aciduria 2 
4452,Immunodeficiency 28 
4453,Junctional epidermolysis bullosa with pyloric atresia 
4454,Epidermolysis bullosa, junctional 5A, intermediate 
4455,Inosine triphosphatase deficiency 
4456,peginterferon alfa-2b and ribavirin response - Toxicity 
4457,SUPEROXIDE DISMUTASE 2 POLYMORPHISM 
4458,Microvascular complications of diabetes, susceptibility to, 6 
4459,Motor neuron disease 
4460,Amyotrophic lateral sclerosis 1, autosomal recessive 
4461,Amyotrophic Lateral Sclerosis, Dominant 
4462,Growth delay due to insulin-like growth factor type 1 deficiency 
4463,Growth delay due to insulin-like growth factor I resistance 
4464,Spinocerebellar ataxia type 16 
4465,Agammaglobulinemia 6, autosomal recessive 
4466,Atopic asthma, susceptibility to 
4467,Inflammatory bowel disease 28 
4468,Symmetrical dyschromatosis of extremities 
4469,Lupus nephritis, susceptibility to 
4470,Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis 
4471,Malaria, severe, susceptibility to 
4472,Agammaglobulinemia 2, autosomal recessive 
4473,IGG receptor I, phagocytic, familial deficiency of 
4474,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 
4475,Impdh2 enzyme activity, variation in 
4476,Retinitis pigmentosa 10 
4477,Leber congenital amaurosis 11 
4478,Immunodeficiency 104 
4479,Currarino triad 
4480,Microphthalmia, cataracts, and iris abnormalities 
4481,Isolated microphthalmia 2 
4482,Microphthalmia, isolated, with coloboma 3 
4483,Microphthalmia;Anophthalmia 
4484,Brachydactyly type E1 
4485,Brachydactyly type D 
4486,Synpolydactyly type 1 
4487,Syndactyly type 5 
4488,Congenital vertical talus 
4489,Tooth agenesis, selective, 1 
4490,Hypoplastic enamel-onycholysis-hypohidrosis syndrome 
4491,Orofacial cleft 5 
4492,Hand-foot-genital syndrome 
4493,Bosley-Salih-Alorainy syndrome 
4494,Human HOXA1 syndromes 
4495,Beryllium disease, chronic, susceptibility to 
4496,Tourette syndrome 
4497,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency 
4498,Hemolytic anemia due to hexokinase deficiency 
4499,Schwartz-Jampel syndrome type 1 
4500,Maturity-onset diabetes of the young type 3 
4501,Type 1 diabetes mellitus 20 
4502,SERUM HDL CHOLESTEROL LEVEL, MODIFIER OF 
4503,Hyperinsulinism due to HNF1A deficiency 
4504,Chromophobe renal cell carcinoma 
4505,Autosomal recessive nonsyndromic hearing loss 39 
4506,Heparin cofactor II deficiency 
4507,HEMOGLOBIN F (ALBAICIN) 
4508,HEMOGLOBIN F (AUCKLAND) 
4509,HEMOGLOBIN F (CALTECH) 
4510,HEMOGLOBIN F (CARLTON) 
4511,HEMOGLOBIN F (CLARKE) 
4512,HEMOGLOBIN F (COLUMBUS-GA) 
4513,HEMOGLOBIN F (FUCHU) 
4514,HEMOGLOBIN F (HEATHER) 
4515,HEMOGLOBIN F (KENNESTONE) 
4516,HEMOGLOBIN F (KINGSTON) 
4517,HEMOGLOBIN F (LA GRANGE) 
4518,HEMOGLOBIN F (LODZ) 
4519,HEMOGLOBIN F (MALAYSIA) 
4520,HEMOGLOBIN F (MALTA) 
4521,HEMOGLOBIN F (MARIETTA) 
4522,HEMOGLOBIN F (MEINOHAMA) 
4523,HEMOGLOBIN F (MELBOURNE) 
4524,HEMOGLOBIN F (MINOO) 
4525,HEMOGLOBIN F (OAKLAND) 
4526,HEMOGLOBIN F (POOLE) 
4527,HEMOGLOBIN F (PORT ROYAL) 
4528,HEMOGLOBIN F (SHANGHAI) 
4529,HEMOGLOBIN F (TOKYO) 
4530,HEMOGLOBIN F (URUMQI) 
4531,Cyanosis, transient neonatal 
4532,HEMOGLOBIN F (GRANADA) 
4533,HEMOGLOBIN F (AUSTELL) 
4534,HEMOGLOBIN F (BROOKLYN) 
4535,HEMOGLOBIN F (ONODA) 
4536,HEMOGLOBIN F (CATALONIA) 
4537,HEMOGLOBIN F (COSENZA) 
4538,HEMOGLOBIN F (SACROMONTE) 
4539,HEMOGLOBIN F (WAYNESBORO) 
4540,HEMOGLOBIN F (LESVOS) 
4541,HEMOGLOBIN F (MACEDONIA II) 
4542,HEMOGLOBIN F (EMIRATES) 
4543,HEMOGLOBIN F (VELETA) 
4544,HEMOGLOBIN F (CALABRIA) 
4545,HEMOGLOBIN F (CLAMART) 
4546,HEMOGLOBIN F (OULED RABAH) 
4547,HBG1 POLYMORPHISM 
4548,HEMOGLOBIN F (SARDINIA) 
4549,Hereditary persistence of fetal hemoglobin 
4550,HEMOGLOBIN F (BASKENT) 
4551,HEMOGLOBIN F (BEECH ISLAND) 
4552,HEMOGLOBIN F (BONAIRE) 
4553,HEMOGLOBIN F (CALLUNA) 
4554,HEMOGLOBIN F (COBB) 
4555,HEMOGLOBIN F (DAMMAM) 
4556,HEMOGLOBIN F (DICKINSON) 
4557,HEMOGLOBIN F (FOREST PARK) 
4558,HEMOGLOBIN F (FUKUYAMA) 
4559,HEMOGLOBIN F (IWATA) 
4560,HEMOGLOBIN F (IZUMI) 
4561,HEMOGLOBIN F (KOTOBUKI) 
4562,HEMOGLOBIN F (JAMAICA) 
4563,HEMOGLOBIN F (KUALA LUMPUR) 
4564,HEMOGLOBIN F (PENDERGRASS) 
4565,HEMOGLOBIN F (PORDENONE) 
4566,HEMOGLOBIN F (SIENA) 
4567,HEMOGLOBIN F (HULL) 
4568,Fetal hemoglobin quantitative trait locus 1 
4569,HEMOGLOBIN F (TEXAS I) 
4570,HEMOGLOBIN F (VICTORIA JUBILEE) 
4571,HEMOGLOBIN F (XINJIANG) 
4572,HEMOGLOBIN F (XIN-SU) 
4573,HEMOGLOBIN F (YAMAGUCHI) 
4574,HEMOGLOBIN F (JIANGSU) 
4575,HEMOGLOBIN F (WOODSTOCK) 
4576,HEMOGLOBIN F (MACEDONIA-I) 
4577,HEMOGLOBIN B(2) 
4578,HEMOGLOBIN A(2)-PRIME 
4579,HEMOGLOBIN A(2) ADRIA 
4580,HEMOGLOBIN A(2) BABINGA 
4581,HEMOGLOBIN A(2) CANADA 
4582,HEMOGLOBIN A(2) COBURG 
4583,HEMOGLOBIN A(2) FITZROY 
4584,HEMOGLOBIN FLATBUSH (GEORGIA) 
4585,HEMOGLOBIN A(2) FLATBUSH 
4586,HEMOGLOBIN A(2) HONAI 
4587,HEMOGLOBIN A(2) INDONESIA 
4588,HEMOGLOBIN A(2) MANZANARES 
4589,HEMOGLOBIN A(2) MELBOURNE 
4590,HEMOGLOBIN A(2) NYU 
4591,HEMOGLOBIN NYU 
4592,HEMOGLOBIN A(2) ROOSEVELT 
4593,HEMOGLOBIN A(2) SPHAKIA 
4594,HEMOGLOBIN A(2) VICTORIA 
4595,HEMOGLOBIN A(2) WRENS 
4596,HEMOGLOBIN A(2) YOKOSHIMA 
4597,HEMOGLOBIN A(2) ZAGREB 
4598,HEMOGLOBIN A(2) PELENDRI 
4599,HEMOGLOBIN A(2) TROODOS 
4600,HEMOGLOBIN A(2) CORFU 
4601,HEMOGLOBIN A(2) PARKVILLE 
4602,HEMOGLOBIN A(2) NIIGATA 
4603,delta Thalassemia 
4604,HEMOGLOBIN A(2) YIALOUSA 
4605,HEMOGLOBIN A(2) GROVETOWN 
4606,HEMOGLOBIN A(2) PUGLIA 
4607,Delta-0-thalassemia 
4608,HEMOGLOBIN A(2) SANT' ANTIOCO 
4609,HEMOGLOBIN A(2) AGRINIO 
4610,HEMOGLOBIN A(2) MONREALE 
4611,HEMOGLOBIN A(2) METAPONTO 
4612,HEMOGLOBIN A(2) CAMPANIA 
4613,HEMOGLOBIN A(2) LUCANIA 
4614,HEMOGLOBIN A(2) CAPRI 
4615,HEMOGLOBIN A(2) NINIVE 
4616,HEMOGLOBIN AALBORG 
4617,HEMOGLOBIN ABRUZZO 
4618,HEMOGLOBIN AGENOGI 
4619,beta Thalassemia 
4620,HEMOGLOBIN ALAMO 
4621,HEMOGLOBIN ALBERTA 
4622,Erythrocytosis, familial, 6 
4623,HEMOGLOBIN ALTDORF 
4624,HEMOGLOBIN ANDREW-MINNEAPOLIS 
4625,HEMOGLOBIN ANKARA 
4626,HEMOGLOBIN ATHENS-GEORGIA 
4627,HEMOGLOBIN ATLANTA 
4628,HEMOGLOBIN ATLANTA-COVENTRY 
4629,HEMOGLOBIN AUSTIN 
4630,HEMOGLOBIN AVICENNA 
4631,HEMOGLOBIN BARCELONA 
4632,HEMOGLOBIN BAYLOR 
4633,HEMOGLOBIN BEIRUT 
4634,HEMOGLOBIN BELFAST 
4635,HEMOGLOBIN BORAS 
4636,HEMOGLOBIN BOUGARDIREY-MALI 
4637,HEMOGLOBIN BEOGRAD 
4638,HEMOGLOBIN D (CAMPERDOWN) 
4639,HEMOGLOBIN BETH ISRAEL 
4640,HEMOGLOBIN BETHESDA 
4641,HEMOGLOBIN BICETRE 
4642,HEMOGLOBIN BOLOGNA 
4643,HEMOGLOBIN BREST 
4644,HEMOGLOBIN BRIGHAM 
4645,HEMOGLOBIN BRISBANE 
4646,HEMOGLOBIN GREAT LAKES 
4647,HEMOGLOBIN BRITISH COLUMBIA 
4648,HEMOGLOBIN BROCKTON 
4649,Hemoglobinopathy 
4650,HEMOGLOBIN BUNBURY 
4651,HEMOGLOBIN BURKE 
4652,HEMOGLOBIN BUSHWICK 
4653,HEMOGLOBIN C 
4654,Hb SS disease 
4655,Heinz body anemia 
4656,HEMOGLOBIN CAMPERDOWN 
4657,HEMOGLOBIN CARIBBEAN 
4658,HEMOGLOBIN CASTILLA 
4659,HEMOGLOBIN CHANDIGARH 
4660,HEMOGLOBIN CHEMILLY 
4661,HEMOGLOBIN CHEVERLY 
4662,HEMOGLOBIN CHICO 
4663,HEMOGLOBIN CHRISTCHURCH 
4664,HEMOGLOBIN CITY OF HOPE 
4665,beta Thalassemia;Hb SS disease;Fetal hemoglobin quantitative trait locus 1;Dominant beta-thalassemia 
4666,Hemoglobin E 
4667,HEMOGLOBIN COCHIN-PORT ROYAL 
4668,HEMOGLOBIN COCODY 
4669,HEMOGLOBIN COLLINGWOOD 
4670,HEMOGLOBIN CONNECTICUT 
4671,HEMOGLOBIN COWTOWN 
4672,HEMOGLOBIN CRETE 
4673,HEMOGLOBIN CRETEIL 
4674,HEMOGLOBIN D (BUSHMAN) 
4675,HEMOGLOBIN D (GRANADA) 
4676,HEMOGLOBIN D (IBADAN) 
4677,HEMOGLOBIN D (IRAN) 
4678,Hb D-Los Angeles 
4679,HBB-Related Disorders 
4680,Hemoglobin D disease 
4681,HEMOGLOBIN D (OULED RABAH) 
4682,HEMOGLOBIN DEER LODGE 
4683,HEMOGLOBIN DETROIT 
4684,HEMOGLOBIN DJELFA 
4685,HEMOGLOBIN DOHA 
4686,HEMOGLOBIN DUARTE 
4687,Beta-plus-thalassemia 
4688,Hemoglobin E/beta thalassemia disease 
4689,Hemoglobin E disease 
4690,Anemia 
4691,HEMOGLOBIN E (SASKATOON) 
4692,HEMOGLOBIN EXTREMADURA 
4693,HEMOGLOBIN FUKUOKA 
4694,HEMOGLOBIN FUKUYAMA 
4695,HEMOGLOBIN G (ACCRA) 
4696,HEMOGLOBIN YAIZU 
4697,HEMOGLOBIN G (COPENHAGEN) 
4698,HEMOGLOBIN G (SASKATOON) 
4699,HEMOGLOBIN G (COUSHATTA) 
4700,HEMOGLOBIN G (HSIN-CHU) 
4701,HEMOGLOBIN G (TAEGU) 
4702,HEMOGLOBIN G (FERRARA) 
4703,HEMOGLOBIN G (TEXAS) 
4704,HEMOGLOBIN G (GALVESTON) 
4705,HEMOGLOBIN G (PORT ARTHUR) 
4706,HEMOGLOBIN G (HSI-TSOU) 
4707,HEMOGLOBIN G (MAKASSAR) 
4708,HEMOGLOBIN G (SAN JOSE) 
4709,HEMOGLOBIN G (SZUHU) 
4710,HEMOGLOBIN GIFU 
4711,HEMOGLOBIN G (TAIPEI) 
4712,HEMOGLOBIN G (TAIWAN-AMI) 
4713,HEMOGLOBIN GAINESVILLE-GA 
4714,HEMOGLOBIN GAVELLO 
4715,HEMOGLOBIN GEELONG 
4716,HEMOGLOBIN JINAN 
4717,HEMOGLOBIN GENOVA 
4718,HEMOGLOBIN HYOGO 
4719,HEMOGLOBIN GRANGE-BLANCHE 
4720,HEMOGLOBIN COMPLUTENSE 
4721,HEMOGLOBIN HACETTEPE 
4722,HEMOGLOBIN HAFNIA 
4723,HEMOGLOBIN HAMADAN 
4724,HEMOGLOBIN HAMILTON 
4725,HEMOGLOBIN HAMMERSMITH 
4726,HEMOGLOBIN CHIBA 
4727,HEMOGLOBIN HAZEBROUCK 
4728,HEMOGLOBIN HEATHROW 
4729,HEMOGLOBIN HELSINKI 
4730,HEMOGLOBIN HENRI MONDOR 
4731,HEMOGLOBIN HIJIYAMA 
4732,HEMOGLOBIN HIKARI 
4733,HEMOGLOBIN HIMEJI 
4734,HEMOGLOBIN HINSDALE 
4735,HEMOGLOBIN HIROSE 
4736,HEMOGLOBIN HIROSHIMA 
4737,HEMOGLOBIN HOFU 
4738,HEMOGLOBIN HOTEL-DIEU 
4739,HEMOGLOBIN I (HIGH WYCOMBE) 
4740,HEMOGLOBIN INDIANAPOLIS 
4741,HEMOGLOBIN SAINT ETIENNE 
4742,HEMOGLOBIN J (ALTGELD GARDENS) 
4743,HEMOGLOBIN J (AMIENS) 
4744,HEMOGLOBIN J (ANTAKYA) 
4745,HEMOGLOBIN J (AUCKLAND) 
4746,HEMOGLOBIN J (BALTIMORE) 
4747,HEMOGLOBIN J (CAIRO) 
4748,HEMOGLOBIN J (CALABRIA) 
4749,HEMOGLOBIN J (BARI) 
4750,HEMOGLOBIN J (COSENZA) 
4751,HEMOGLOBIN J (CHICAGO) 
4752,HEMOGLOBIN J (CORDOBA) 
4753,HEMOGLOBIN J (DALOA) 
4754,HEMOGLOBIN J (GUANTANAMO) 
4755,HEMOGLOBIN J (IRAN) 
4756,HEMOGLOBIN J (LENS) 
4757,HEMOGLOBIN J (LOME) 
4758,HEMOGLOBIN J (LUHE) 
4759,HEMOGLOBIN J (SICILIA) 
4760,HEMOGLOBIN J (TAICHUNG) 
4761,HEMOGLOBIN K (CAMEROON) 
4762,HEMOGLOBIN JIANGHUA 
4763,HEMOGLOBIN JOHNSTOWN 
4764,HEMOGLOBIN K (IBADAN) 
4765,HEMOGLOBIN K (WOOLWICH) 
4766,Beta-thalassemia major 
4767,HEMOGLOBIN KEMPSEY 
4768,HEMOGLOBIN KENITRA 
4769,HEMOGLOBIN KHARTOUM 
4770,HEMOGLOBIN KNOSSOS 
4771,Beta-Knossos-thalassemia 
4772,HEMOGLOBIN KOFU 
4773,HEMOGLOBIN MACHIDA 
4774,HEMOGLOBIN KORLE-BU 
4775,HEMOGLOBIN LA DESIRADE 
4776,HEMOGLOBIN LAS PALMAS 
4777,HEMOGLOBIN LINKOPING 
4778,HEMOGLOBIN MEILAHTI 
4779,Hemolytic anemia 
4780,HEMOGLOBIN LUFKIN 
4781,HEMOGLOBIN M (MILWAUKEE 1) 
4782,Methemoglobinemia, beta-globin type 
4783,HEMOGLOBIN M (MILWAUKEE 2) 
4784,HEMOGLOBIN M (HYDE PARK) 
4785,HEMOGLOBIN M (AKITA) 
4786,HEMOGLOBIN M (SASKATOON) 
4787,HEMOGLOBIN M (RADOM) METHEMOGLOBINEMIA, BETA TYPE 
4788,HEMOGLOBIN MADRID 
4789,HEMOGLOBIN MALAY 
4790,Beta-Malay-thalassemia 
4791,HEMOGLOBIN MALMO 
4792,HEMOGLOBIN MAPUTO 
4793,HEMOGLOBIN MATERA 
4794,HEMOGLOBIN MEQUON 
4795,HEMOGLOBIN MCKEES ROCKS 
4796,HEMOGLOBIN MINNEAPOLIS-LAOS 
4797,HEMOGLOBIN MITO 
4798,HEMOGLOBIN MIYASHIRO 
4799,HEMOGLOBIN MIZUHO 
4800,HEMOGLOBIN MOBILE 
4801,HEMOGLOBIN MORIGUCHI 
4802,HEMOGLOBIN MOSCVA 
4803,HEMOGLOBIN MOZHAISK 
4804,HEMOGLOBIN N (BALTIMORE) 
4805,HEMOGLOBIN N (JENKINS) 
4806,HEMOGLOBIN JENKINS 
4807,HEMOGLOBIN HOPKINS 1 
4808,HEMOGLOBIN KENWOOD 
4809,HEMOGLOBIN N (SEATTLE) 
4810,HEMOGLOBIN N (TIMONE) 
4811,HEMOGLOBIN NAGOYA 
4812,HEMOGLOBIN NEVERS 
4813,HEMOGLOBIN NEW MEXICO 
4814,HEMOGLOBIN NEWCASTLE 
4815,HEMOGLOBIN NORTH CHICAGO 
4816,HEMOGLOBIN NOTTINGHAM 
4817,HEMOGLOBIN O (ARAB) 
4818,HEMOGLOBIN EGYPT 
4819,Sickle cell-Hemoglobin O Arab disease 
4820,HEMOGLOBIN OCHO RIOS 
4821,HEMOGLOBIN OHIO 
4822,HEMOGLOBIN OKALOOSA 
4823,HEMOGLOBIN OKAYAMA 
4824,HEMOGLOBIN OKAZAKI 
4825,HEMOGLOBIN OLMSTED 
4826,HEMOGLOBIN OLOMOUC 
4827,HEMOGLOBIN OLYMPIA 
4828,HEMOGLOBIN P 
4829,HEMOGLOBIN P (GALVESTON) 
4830,HEMOGLOBIN PALMERSTON NORTH 
4831,HEMOGLOBIN PASADENA 
4832,HEMOGLOBIN PERTH 
4833,HEMOGLOBIN ABRAHAM LINCOLN 
4834,HEMOGLOBIN KOBE 
4835,HEMOGLOBIN PETERBOROUGH 
4836,HEMOGLOBIN PHILLY 
4837,HEMOGLOBIN PIERRE-BENITE 
4838,Erythrocytosis 
4839,HEMOGLOBIN QUIN-HAI 
4840,HEMOGLOBIN RADCLIFFE 
4841,HEMOGLOBIN PORTO ALEGRE 
4842,HEMOGLOBIN POTOMAC 
4843,HEMOGLOBIN PRESBYTERIAN 
4844,HEMOGLOBIN PROVIDENCE 
4845,HEMOGLOBIN PYRGOS 
4846,HEMOGLOBIN RAHERE 
4847,HEMOGLOBIN RAINIER 
4848,HEMOGLOBIN RALEIGH 
4849,HEMOGLOBIN RANDWICK 
4850,HEMOGLOBIN REGINA 
4851,HEMOGLOBIN RIO GRANDE 
4852,HEMOGLOBIN RIVERDALE-BRONX 
4853,HEMOGLOBIN ROSEAU-POINTE A PITRE 
4854,HEMOGLOBIN ROTHSCHILD 
4855,HEMOGLOBIN RUSH 
4856,HEMOGLOBIN S 
4857,Sickle cell disease and related diseases 
4858,HEMOGLOBIN SABINE 
4859,HEMOGLOBIN SAINT JACQUES 
4860,HEMOGLOBIN SAITAMA 
4861,HEMOGLOBIN SAKI 
4862,HEMOGLOBIN SAN DIEGO 
4863,HEMOGLOBIN SANTA ANA 
4864,HEMOGLOBIN SAVANNAH 
4865,HEMOGLOBIN SEATTLE 
4866,HEMOGLOBIN SHANGHAI 
4867,HEMOGLOBIN LESLIE 
4868,HEMOGLOBIN SHELBY 
4869,HEMOGLOBIN DEACONESS 
4870,HEMOGLOBIN SHEPHERDS BUSH 
4871,HEMOGLOBIN SHERWOOD FOREST 
4872,HEMOGLOBIN SHOWA-YAKUSHIJI 
4873,Beta-Showa-Yakushiji thalassemia 
4874,HEMOGLOBIN ST. MANDE 
4875,HEMOGLOBIN SOGN 
4876,HEMOGLOBIN SOUTHAMPTON 
4877,HEMOGLOBIN CASPER 
4878,HEMOGLOBIN STANMORE 
4879,HEMOGLOBIN STRASBOURG 
4880,HEMOGLOBIN SOUTH FLORIDA 
4881,HEMOGLOBIN ST. LOUIS 
4882,HEMOGLOBIN SUMMER HILL 
4883,HEMOGLOBIN SUNNYBROOK 
4884,HEMOGLOBIN SYDNEY 
4885,HEMOGLOBIN SYRACUSE 
4886,HEMOGLOBIN TA-LI 
4887,HEMOGLOBIN TAKAMATSU 
4888,HEMOGLOBIN TAMPA 
4889,HEMOGLOBIN TIANSHUI 
4890,HEMOGLOBIN TILBURG 
4891,HEMOGLOBIN TOYOAKE 
4892,HEMOGLOBIN WILLAMETTE 
4893,HEMOGLOBIN TUNIS 
4894,HEMOGLOBIN TY GARD 
4895,HEMOGLOBIN VAASA 
4896,HEMOGLOBIN VANCOUVER 
4897,HEMOGLOBIN VANDERBILT 
4898,HEMOGLOBIN VILLEJUIF 
4899,HEMOGLOBIN VOLGA 
4900,HEMOGLOBIN DRENTHE 
4901,HEMOGLOBIN WARWICKSHIRE 
4902,HEMOGLOBIN WIEN 
4903,HEMOGLOBIN WINDSOR 
4904,HEMOGLOBIN WOOD 
4905,HEMOGLOBIN YAKIMA 
4906,HEMOGLOBIN YAMAGATA 
4907,HEMOGLOBIN YATSUSHIRO 
4908,HEMOGLOBIN YOKOHAMA 
4909,HEMOGLOBIN YORK 
4910,HEMOGLOBIN YOSHIZUKA 
4911,HEMOGLOBIN YPSILANTI 
4912,HEMOGLOBIN YUSA 
4913,Hemoglobin Zurich 
4914,Beta zero thalassemia 
4915,alpha Thalassemia 
4916,Dominant beta-thalassemia 
4917,Beta-Houston-thalassemia 
4918,Beta-plus-thalassemia, dominant 
4919,HEMOGLOBIN CAGLIARI 
4920,HEMOGLOBIN SOUTH MILWAUKEE 
4921,HEMOGLOBIN CALAIS 
4922,Beta thalassemia intermedia 
4923,HEMOGLOBIN IOWA 
4924,HEMOGLOBIN ZENGCHENG 
4925,HEMOGLOBIN TERRE HAUTE 
4926,HEMOGLOBIN VALLETTA 
4927,HEMOGLOBIN JACKSONVILLE 
4928,HEMOGLOBIN CHESTERFIELD 
4929,HEMOGLOBIN COIMBRA 
4930,HEMOGLOBIN KODAIRA 
4931,HEMOGLOBIN ST. FRANCIS 
4932,HEMOGLOBIN YAHATA 
4933,HEMOGLOBIN RANCHO MIRAGE 
4934,HEMOGLOBIN MUSCAT 
4935,HEMOGLOBIN BAB-SAADOUN 
4936,HEMOGLOBIN DURHAM-N.C. 
4937,HEMOGLOBIN BRESCIA 
4938,HEMOGLOBIN BADEN 
4939,HEMOGLOBIN GRAZ 
4940,HEMOGLOBIN KARLSKOGA 
4941,HEMOGLOBIN MUSKEGON 
4942,HEMOGLOBIN TIGRAYE 
4943,HEMOGLOBIN SARREBOURG 
4944,HEMOGLOBIN SAINT NAZAIRE 
4945,Hb camperdown 
4946,HEMOGLOBIN MANUKAU 
4947,HEMOGLOBIN VILLAVERDE 
4948,HEMOGLOBIN HOWICK 
4949,HEMOGLOBIN DENVER 
4950,HEMOGLOBIN BECKMAN 
4951,HEMOGLOBIN D (NEATH) 
4952,HEMOGLOBIN WASHTENAW 
4953,HEMOGLOBIN BRISTOL 
4954,HEMOGLOBIN ALESHA 
4955,HEMOGLOBIN DIEPPE 
4956,HEMOGLOBIN TROLLHAETTAN 
4957,HEMOGLOBIN TYNE 
4958,HEMOGLOBIN HAKKARI 
4959,HEMOGLOBIN PUTTELANGE 
4960,HEMOGLOBIN ARTA 
4961,HEMOGLOBIN AURORA 
4962,HEMOGLOBIN NAKANO 
4963,HEMOGLOBIN HINWIL 
4964,HEMOGLOBIN DEBROUSSE 
4965,HEMOGLOBIN TSURUMAI 
4966,HEMOGLOBIN J (EUROPA) 
4967,Hb aubenas 
4968,HEMOGLOBIN COSTA RICA 
4969,Hb niigata 
4970,HEMOGLOBIN HOKUSETSU 
4971,Hb gambara 
4972,HEMOGLOBIN SILVER SPRINGS 
4973,HEMOGLOBIN RIO CLARO 
4974,HEMOGLOBIN CHILE 
4975,HEMOGLOBIN TENDE 
4976,HEMOGLOBIN LA ROCHE-SUR-YON 
4977,HEMOGLOBIN IRAQ-HALABJA 
4978,HEMOGLOBIN LUCKNOW 
4979,HEMOGLOBIN SAGAMI 
4980,HEMOGLOBIN HARROW 
4981,HEMOGLOBIN BRIE COMTE ROBERT 
4982,HEMOGLOBIN BARBIZON 
4983,HEMOGLOBIN BOLOGNA-ST. ORSOLA 
4984,HEMOGLOBIN VILA REAL 
4985,HEMOGLOBIN SAALE 
4986,HEMOGLOBIN BUSHEY 
4987,HEMOGLOBIN TSUKUMI 
4988,HEMOGLOBIN SITIA 
4989,HEMOGLOBIN ERNZ 
4990,HEMOGLOBIN RENERT 
4991,HEMOGLOBIN WATFORD 
4992,HEMOGLOBIN YAOUNDE 
0,Galloway-Mowat syndrome 1 
1,Mitochondrial complex 1 deficiency, nuclear type 19 
2,Leigh syndrome 
3,Inborn genetic diseases 
4,Mitochondrial complex 1 deficiency, nuclear type 21 
5,Alzheimer disease, susceptibility to 
6,Microvascular complications of diabetes, susceptibility to, 7 
7,Hemochromatosis, juvenile, digenic 
8,Transferrin serum level quantitative trait locus 2 
9,Hemochromatosis type 1 
10,Porphyria cutanea tarda, susceptibility to 
11,Porphyria variegata, susceptibility to 
12,Hereditary cancer-predisposing syndrome 
13,Hereditary hemochromatosis 
14,Porphyrinuria;Cutaneous photosensitivity 
15,Hemochromatosis type 2 
16,Bronze diabetes 
17,Alzheimer disease 
18,7 conditions 
19,Cardiomyopathy 
20,HFE-related disorder 
21,6 conditions 
22,Cystic fibrosis 
23,Abnormality of iron homeostasis 
24,See cases 
25,Variegate porphyria 
26,HFE POLYMORPHISM 
27,Cranioectodermal dysplasia 2 
28,PHARC syndrome 
29,Retinitis pigmentosa 58 
30,Retinitis Pigmentosa, Dominant 
31,Primary hyperoxaluria type 3 
32,Retinitis pigmentosa 28 
33,Retinal dystrophy 
34,Autosomal recessive retinitis pigmentosa 
35,Cone-rod dystrophy 
36,Retinitis pigmentosa 
37,Microcephaly 2, primary, autosomal recessive, with or without cortical malformations 
38,Autosomal recessive primary microcephaly 
39,Bardet-Biedl syndrome 12, modifier of 
40,Meckel syndrome, type 6, modifier of 
41,Familial infantile myoclonic epilepsy 
42,Autosomal dominant nonsyndromic hearing loss 65;Developmental and epileptic encephalopathy, 1;Caused by mutation in the TBC1 domain family, member 24 
43,DOORS syndrome 
44,Nephronophthisis-like nephropathy 1 
45,Microcephaly 9, primary, autosomal recessive 
46,Seckel syndrome 5;Microcephaly 9, primary, autosomal recessive 
47,CEP152-Related Disorders 
48,Bardet-Biedl syndrome 16 
49,Blue color blindness 
50,Familial porphyria cutanea tarda 
51,Hepatoerythropoietic porphyria 
52,Porphyria cutanea tarda 
53,Sporadic porphyria cutanea tarda 
54,Wolman disease 
55,Lysosomal acid lipase deficiency 
56,Cholesteryl ester storage disease 
57,Urofacial syndrome type 1 
58,Congenital anomaly of kidney and urinary tract 
59,Farber lipogranulomatosis 
60,TRANSCOBALAMIN II POLYMORPHISM 
61,Transcobalamin II deficiency 
62,Retinitis pigmentosa 54 
63,Pheochromocytoma, susceptibility to 
64,Pheochromocytoma 
65,Hereditary pheochromocytoma-paraganglioma 
66,Arthrogryposis, renal dysfunction, and cholestasis 2 
67,Homocystinuria, pyridoxine-nonresponsive 
68,HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED 
69,Classic homocystinuria 
70,Homocystinuria 
71,Cardiovascular phenotype 
72,Homocystinuria, pyridoxine-responsive 
73,Intellectual disability 
74,Connective tissue disorder 
75,Autosomal recessive nonsyndromic hearing loss 79 
76,Hearing loss, autosomal recessive 
77,Brown-Vialetto-van Laere syndrome 1 
78,Progressive bulbar palsy of childhood 
79,Ornithine aminotransferase deficiency 
80,Hyperornithinemia 
81,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia 
82,Dihydropyrimidinase deficiency 
83,Frank-Ter Haar syndrome 
84,Autosomal recessive nonsyndromic hearing loss 25 
85,Joubert syndrome 2 
86,Meckel syndrome, type 2 
87,Joubert syndrome 
88,TMEM216-Related Disorders 
89,Meckel syndrome, type 2;Joubert syndrome 2 
90,Poikiloderma with neutropenia 
91,Thyrotoxic periodic paralysis, susceptibility to, 2 
92,Thyrotoxic periodic paralysis, susceptibility to, 1 
93,Prolidase deficiency 
94,Aspartylglucosaminuria, finnish type 
95,Aspartylglucosaminuria 
96,Amelogenesis imperfecta hypomaturation type 2A3 
97,Methemoglobinemia type 2 
98,Methemoglobinemia, type I 
99,NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM 
100,Xeroderma pigmentosum, group C 
101,Xeroderma pigmentosum 
102,Primary ciliary dyskinesia 13 
103,Primary ciliary dyskinesia 
104,Kartagener syndrome 
105,Dilated cardiomyopathy 1DD 
106,Primary dilated cardiomyopathy 
107,Dilated cardiomyopathy 1S 
108,Dilated cardiomyopathy 1A 
109,Primary familial dilated cardiomyopathy 
110,Alpha-2-plasmin inhibitor deficiency 
111,Desbuquois dysplasia 1 
112,Von Willebrand disease type 2A 
113,von Willebrand disorder 
114,von Willebrand disease type 2 
115,Von Willebrand disease type 2B 
116,Abnormality of coagulation 
117,VON WILLEBRAND FACTOR POLYMORPHISM 
118,von Willebrand disease type 1 
119,von Willebrand disease type 2N 
120,Abnormal bleeding 
121,von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3 
122,Abnormal bleeding;Thrombocytopenia 
123,von Willebrand disease type 3 
124,Abnormality of blood and blood-forming tissues 
125,von Willebrand disease type 2M 
126,von Willebrand factor Vicenza 
127,Reduced von Willebrand factor activity;Reduced quantity of Von Willebrand factor 
128,von Willebrand disease, type 1, susceptibility to 
129,Thrombus 
130,Exudative vitreoretinopathy 5 
131,Dilated cardiomyopathy 1CC 
132,Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC 
133,Neuropathy, hereditary sensory and autonomic, type 2B 
134,Charcot-Marie-Tooth disease 
135,Neurofibromatosis, type 1 
136,Optic nerve glioma;Neurofibroma;Cafe au lait spots, multiple;Axillary freckling 
137,Caf√©-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal;Juvenile myelomonocytic leukemia;Neurofibromatosis, type 1 
138,Tibial pseudarthrosis;Neurofibromatosis, type 1 
139,Juvenile myelomonocytic leukemia 
140,Rhabdomyosarcoma 
141,Abnormality of the skin 
142,Neurofibromatosis, familial spinal 
143,Galactosialidosis, late infantile 
144,Combined deficiency of sialidase AND beta galactosidase 
145,Galactosialidosis, early infantile 
146,Tay-Sachs disease, variant AB 
147,Autosomal recessive nonsyndromic hearing loss 77 
148,MORM syndrome 
149,Joubert syndrome 1 
150,16 conditions 
151,Joubert syndrome and related disorders 
152,Paragangliomas 2 
153,Tyrosinemia type II 
154,Urocanate hydratase deficiency 
155,Autosomal recessive optic atrophy, OPA7 type 
156,Cystic leukoencephalopathy without megalencephaly 
157,Glycogen storage disease type X 
158,Mitochondrial complex 1 deficiency, nuclear type 18 
159,Macrothrombocytopenia, isolated, 1, autosomal dominant 
160,Macrothrombocytopenia 
161,Complex cortical dysplasia with other brain malformations 7 
162,Mitochondrial complex 2 deficiency, nuclear type 2 
163,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 
164,Fluorouracil response 
165,Dihydropyrimidine dehydrogenase deficiency 
166,capecitabine response - Toxicity 
167,fluorouracil response - Toxicity 
168,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b) 
169,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b) 
170,BLOOD GROUP--LUTHERAN NULL 
171,Thyroglobulin synthesis defect 
172,Hennekam lymphangiectasia-lymphedema syndrome 1 
173,Coproporphyria 
174,Harderoporphyria 
175,Hereditary coproporphyria 
176,Coproporphyria, digenic 
177,Hereditary fructosuria 
178,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 
179,Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency 
180,Dihydropteridine reductase deficiency 
181,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 
182,Primary ciliary dyskinesia 11 
183,Hereditary spherocytosis type 1 
184,Congenital contractural arachnodactyly 
185,Primary ciliary dyskinesia 10 
186,Retinitis pigmentosa 25 
187,Autosomal recessive nonsyndromic hearing loss 63 
188,Rare genetic deafness 
189,Mitochondrial complex 1 deficiency, nuclear type 17 
190,Protoporphyria, erythropoietic, 1 
191,- 
192,H syndrome 
193,Mitochondrial complex 1 deficiency, nuclear type 16 
194,Mitochondrial complex I deficiency 
195,Kininogen deficiency, total 
196,Phenylketonuria 
197,Hyperphenylalaninemia 
198,Mild non-PKU hyperphenylalanemia 
199,Marfanoid habitus and intellectual disability 
200,Endocrine-cerebro-osteodysplasia syndrome 
201,Cytochrome-c oxidase deficiency disease 
202,Combined oxidative phosphorylation deficiency 44 
203,Ischemic stroke 
204,Budd-Chiari syndrome, susceptibility to 
205,Pregnancy loss, recurrent, susceptibility to, 1 
206,Factor V deficiency 
207,Thrombophilia due to activated protein C resistance 
208,Thrombophilia due to activated protein C resistance;Factor V deficiency 
209,Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process 
210,Factor V Hong Kong 
211,Thrombophilia due to protein C deficiency, autosomal dominant 
212,Thrombophilia due to protein C deficiency, autosomal recessive 
213,Reduced protein C activity 
214,Abnormal thrombosis 
215,Cerebral palsy 
216,Thromboembolism 
217,Deep venous thrombosis 
218,Fucosidosis 
219,FU1/FU2 POLYMORPHISM 
220,Geleophysic dysplasia 1 
221,Mucopolysaccharidosis, MPS-IV-A 
222,Morquio syndrome 
223,Diabetes mellitus, transient neonatal, 1 
224,Slow acetylator due to N-acetyltransferase enzyme variant 
225,Skin/hair/eye pigmentation, variation in, 10 
226,Mitochondrial complex III deficiency nuclear type 4 
227,ANE syndrome 
228,Arrhythmogenic right ventricular dysplasia 5 
229,Arrhythmogenic right ventricular cardiomyopathy 
230,Familial isolated arrhythmogenic right ventricular dysplasia 
231,Hypertrophic cardiomyopathy 
232,Iodotyrosine deiodination defect 
233,Meckel syndrome, type 6 
234,Meckel-Gruber syndrome;Joubert syndrome 
235,Joubert syndrome 9 
236,COACH syndrome 1 
237,Joubert syndrome;Meckel-Gruber syndrome 
238,COACH syndrome 2 
239,Joubert syndrome 9/15, digenic 
240,COACH syndrome 1;Joubert syndrome 9;Meckel syndrome, type 6 
241,Hereditary spastic paraplegia 15 
242,Spastic paraplegia 
243,Parkinson disease 11, autosomal dominant, susceptibility to 
